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Summary
Theiler's Murine Encephalomyelitis Virus (TMEV) has been a favoured model
for Multiple Sclerosis (MS) since 1975 when Lipton first reported that
infection with TMEV caused a biphasic Central Nervous System (CNS)
disease leading to demyelination. TMEV is a picornavirus belonging to the
cardiovirus genus and is a natural enteric pathogen of mice which can
occasionally initiate a chronic persistent infection of the CNS. This depends on
the strain and dose of virus and the strain, age and sex of the mouse.
Intracerebral infection of all mouse strains with the avirulent BeAn strain of
TMEV results in an acute encephalomyelitis which in susceptible mouse
strains, is followed by a persistent CNS infection with lesions of inflammatory
demyelination or in resistant mouse strains eradication of the virus. On the
other hand i.e. infection with the neurovirulent GDVII strain of Theiler's virus
results in a fulminant encephalitis in mice of all genetic backgrounds.
The main aim of this study was to determine the cytokine and
immunoglobulin profiles elicited in different mouse strains during the acute
phase of infection. mRNA transcript levels for numerous cytokines were
studied in the brains and spinal cords in Balb/c (resistant), CBA
(intermediately susceptibility) and SJL/J (susceptible) mice, during the acute
phase of disease, using the technique of RNase protection assay (RPA). The
RPA included analysis of transcripts for TNFp, TNFa, TGFp, IFNy, IL-la, IL-
ip, IL-2, IL-4, IL-5, IL-6, IL-7, IL-10, IL-13, IL-12p40 and IL-12p35. There were
similarities between the strains in the levels of pro-inflammatory cytokines
expressed including TNFa, TNFp and ILla. However, there were several
fundamental differences between the strains including the inability of
susceptible SJL/J mice to express IL-ip in the brain and the spinal cord when
compared to Balb/c and CBA mice. SJL/J mice had an increase in expression
of IL-4 and IL-10 and a decrease in expression of IL-2 and IFNy when
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compared to Balb/c and CBA mice. Expression of pro-inflammatory, anti¬
inflammatory, Thl and Th2 type cytokines correlated with the increase in
levels of cellular infiltrates (CD3+, CD4+, CD8+ and F4/80+) in the CNS. Anti¬
viral immunoglobulin isotypes were also different in the three mouse strains
studied. All strains produced similar levels of IgM however, Balb/c mice had
significantly increased levels of IgGl and IgG2a compared to CBA and SJL/J
mice during the acute phase of disease.
This study also investigated TMEV persistence in CBA (intermediately
susceptible) mice and the cytokine and anti-viral immunoglobulin isotypes
associated with persistence. Virus persisted for >60 days in 50% of infected
CBA mice, as determined by RT-PCR. Animals in which virus persisted had
significantly increased RNA transcripts in the CNS for TNFa, IL-12p35 and
IL-12p40. Persistently infected animals also had increased levels of anti-viral
IgGl, IgG2a and IgG2b when compared to animals which had cleared the
virus.
The importance of interferons a/p and y were investigated. Virus spread
extensively throughout the white matter regions of the brains in IFNa/pR°/°
mice (constructed on a genetically resistant background (FI-2b)), during the
acute phase of infection, indicating the importance of IFNa/p in preventing
infection of oligodendrocytes. Infection of IFNyR°/° mice (also on a
genetically resistant background) resulted in viral persistence and increased
levels of anti-viral IgM, IgGl, IgG2a and IgG2b, demonstrating IFNy is
essential for viral clearance. Perforin is a functional effector molecule in CTL
killing, therefore, its role(s) during the acute and chronic phase of Theiler's
virus infection was investigated to ascertain its importance. Studies in
perforin knockout mice (also on a resistant genetic background) demonstrated
that perforin is essential to control viral infection during the acute phase of
infection, and is an absolute requirement for viral clearance.
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Infection with GDVII resulted in high levels of virus replication in the brains
and spinal cords of infected mice. Levels of TNFa, IL-la, IL-2, IFNy and IL-
12p40 increase throughout infection in the brains of infected animals, and
TNFa, IL-2 and IL-12p40 increase in the spinal cords. High virus titres, and
an increase in the above pro-inflammatory cytokines correlated with an
increase in levels of programmed cell death in CNS tissues.
Infection of neonatal mice with the BeAn strain results in 100% mortality,
with increased virus titres in the CNS. Expression of TNFp, TNFa, IL-4, IL-la
and IL-6 increased throughout the course of infection of neonatal mice. TNFa
has been implicated in the phenomenon of death by shock. Therefore, TNFa
may have important implications in the pathogenesis of Theiler's virus
infection in neonates.
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GTP guanosine triphosphate
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HIV human immunodeficiency virus
HRPO horseradish peroxidase
HSV herpes simplex virus
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ic intracerebral
im intramuscular
in intranasal
lP intraperitoneal
iv intravenous
!g immunoglobulin
IFN interferon
IL interleukin
ISH in situ hybridisation
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L litre
LCMV lymphocytic choriomeningitis virus
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ml millilitre
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mRNA messenger RNA
M molar
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MHV mouse hepatitis virus
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MOI multiplicity of infection
Mr molecular weight
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nu/ nu mice homozygous for the nude mutation (athymic)
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NCS newborn calf serum
NGS newborn goat serum
ORF open reading frame
pH potential hydrogen
PBS phosphate buffered saline
PBSA PBS with 0.75% bovine serum albumin
PBST PBS with 0.05% Tween
PCR polymerase chain reaction
PFU plaque forming unit
PI post-infection
PID post infection day
PIPES 1,4-piperazine diethane sulfonic acici
PRV pseudorabies virus
RNase ribonuclease
RNA ribonucleic acid
RPA RNase protection assay
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RT room temperature
RV rabies virus
sec second
ssDNA salmon sperm DNA
ssRNA single stranded RNA
SDS sodium dodecyl sulphate
SFV Semiliki Forest virus
SSC standard saline citrate
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SSPE subacute sclerosing panencephalitis
tRNA transfer RNA
TMEV Theiler's murine encephalomyelitis virus
TO Theiler's original
Tris 2-amino-2-(hydroxymethyl)-l,3-propandiol
UTP uridine triphosphate
UTR untranslated regions
UV ultra violet
VP viral protein
vRNA viral RNA
vsv Vesicular stomatitis virus
vv Vaccinia virus
vzv Varicella zoster virus
w/ V weight per volume
WNV West Nile virus
YFV Yellow fever virus
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Chapter 1 Introduction
1.0 Introduction
Over the past two decades there has been much progress made in the field of
Central Nervous System (CNS) viral pathogenesis. This is due to a
combination of factors which include:-
• The increasing clinical relevance of viral infections since bacterial and
parasitic infections are becoming preventable either by vaccination or
treatment.
• Advances in technology, such as the recombinant DNA revolution have
made it possible to construct, clone and genetically manipulate viruses.
This biological revolution has allowed scientists to decipher the key
functional viral genes which are important in viral pathogenesis. The
greater availability of reagents such as monoclonal antibodies, riboprobes,
and the construction of genetically manipulated animals (which do or do
not contain important genes) have all contributed to enable researchers to
further characterise the cellular and molecular events of viral disease
pathogenesis.
• The suitability of animal models to be used for studying immunological
and cellular interactions of viruses with the CNS, which can be compared
and contrasted to human diseases.
• CNS viral infections were also brought to the forefront of researchers
minds with the emergence of HIV in the early 1980's. HIV brought world
wide concern with the thought of a lethal viral infection spreading in
pandemic proportions. In the early 1980's the implications and pathology
of HIV infection were largely unknown. However, HIV research has
allowed scientists to characterise previously unknown information about
the CNS, and also has brought with it, due to immunosuppression, the
18
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emergence of other CNS virus manifestations which otherwise would have
been asymptomatic for example progressive multifocal
leukoencephalopathy (PML).
1.1 Determinants affecting the outcome of viral infection
Viral infections range from acute to chronic, asymptomatic to symptomatic,
and non-life threatening to lethal. The ability of the infected species to clear a
viral infection depends upon a variety of different viral and host factors,
these include:-
*Age of the host is an important factor in various human and animal viral
infections. For example children produce a less severe infection when
infected with Varicella zoster (VZV), mumps and Epstein-Barr virus (EBV),
compared to the adult. The opposite is the case with other viral infections
which are more severe in children compared to adults. These include
rotaviruses and respiratory syncitial viral infections (Weinstein,1957;
Morgenson,1979). There are other examples where this is the case for animal
viruses (Fazakerley et al., 1993).
*Host genetics play an important role in determining whether the host
develops pathology following viral infection. The importance of host genetics
has been documented in many viral infections which include, picornaviruses
(Lipton and Dal Canto, 1979; Bureau et al., 1992; Patick et al., 1991),
myxoviruses (Haller et al., 1979, 1980; Staeheli et al., 1986a, b), retroviruses
(Purchase et al., 1977), coronaviruses (Bang and Warwick, 1960; Knobler et al.,
1984), rhabdoviruses (Lodmell, 1983), papovaviruses (Brinton and Nathanson,
1981), arenaviruses (Oldstone et al., 1984), poxviruses (O'Neil and Blanden,
1983) and herpesviruses (Chalmer et al., 1977; Lopez, 1980; Bancroft et al.,
1981; Grundy et al., 1981; Allan and Shellam, 1984; Quinnan, 1987; Sprecher
and Becker, 1987). The susceptibility or resistance to a particular virus is
19
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frequently associated with genes associated with the immune response
(Bureau et al.,1992). However, other non-immune genes have also been
shown to also be important. These may include for example, genes for
receptors which are necessary for viral uptake by cells (Boyle et al., 1987).
*The genotype of virus also determines the outcome of infection. Intranasal
infection of mice with the BeAn strain of TMEV results in asymptomatic
infection, however, when mice are inoculated with the GDVII strain of TMEV
this results in fatal encephalitis in all mice (Lui et al., 1967). Viruses which
exhibit a strain dependant virulence are reviewed by Tyler and Friedmann
(1990).
*Several other factors are also important in determining the outcome of viral
infection and these include dose and route of infection (Theiler and Gard,
1940 a, b; O'Leary et al., 1942; Sigel, 1952; Lui et al., 1967; Lipton et al., 1980),
sex of the animal (Lodmell, 1983, Kappel et al., 1990), hormonal, emotional,
nutritional and immunological status (Sheridan et al., 1998), stress (Hermann
et al., 1993) and concomitant infections.
In the case of the CNS, clearly a major factor is the ability of the virus to gain
access. This is usually via the blood or via the peripheral nerves and viruses
and their different genotypes vary in their ability to cross the blood brain
barrier (BBB) and to track along nerves. Many neurological diseases
associated with viruses are considered to result from the presumably rare
infection of the CNS by an otherwise non-neuroinvasive virus. Visna virus is
an example of this.
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Table 1.1 Virus infections of the CNS of medical and veterinary importance.
Species Virus Family Virus Disease
Human
Sheep
Paramyxoviridae
Papovaviridae
Togaviridae
Picornaviridae
Rhabdoviridae
Flaviviridae
Herpesviruses
Reteroviruses
Retrovirus
Togaviridae
Measles virus
JC papovavirus
Rubella virus
Poliovirus
Rabies virus
JapaneseB
encephalitis virus
Herpes simplex virus
Human
immunodeficiency
virus
Visna virus
Border disease virus
Subacute-sclerosing
panecephalitis
Progressive
Multifocal leuko-
encephalopathy
Chronic-progressive
panencephahtis
Poliomyelitis
Encephalitis
Encephalitis
Encephalitis
Encephalitis
dementia in AIDs
patients
Demyelinating leu-
koencephalopathy
Demyelination
Horses Bornaviridae Borna disease virus Polioencephalitis
Goat Retroviridae Caprine Arthritis
Encephalitis virus
Leukoencephalo-
myelitis of kids
Dog Paramyxoviridae Canine distemper
virus
Post-infectious
encephalitis and old
dog encephalitis
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1.2 Virus can infect cells with a variety of sequelae
The relationship between viruses and the CNS is complex and diverse. The
unique structural and immunological components of the CNS coupled with
the blood brain barrier (BBB), lack of lymphatic tissue and the long-life of
many cells make it an ideal environment for an opportunistic viral infection to
persist, cause damage and/or disease. There are various types of virus
infection which include:-
*Lytic or acute infection- virus infects the cell and produces progeny, often
killing the host cell. The virus may go on to be cleared by an active immune
response.
*Abortive infection- this is when virus enters the cell and produces some early
gene products but is unable to complete a full round of replication. Therefore,
the infection halts at this stage and is aborted.
*Latency- virus infects cells and lies dormant with minimal gene expression
until a specific signal activates gene expression, producing infectious virus.
*Persistent infection- virus persists in a host cell longer than would be
expected in the acute infection, viruses are thought to persist by a variety of
mechanisms (see Section 1.11).
1.3 Cellular tropisms of viruses in the CNS
Viruses target many cell types in the CNS and these include neurones,
oligodendrocytes, astrocytes and microglia. Neurones are the site for lytic
acute infections eg. Japanese encephalitis virus (Ogata et al., 1997) and
poliovirus (Abe et al., 1995), latent infection eg. Herpes simplex viruses
(Garber et al., 1997; Sawtell, 1997), VZV (Mahalingam et al., 1996) and
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persistent infections eg. measles virus (Isaacson et al., 1996; Rail et al., 1997),
rubella, bornaviruses and Lymphocytic choriomeningitis virus (Cao et al.,
1997). Persistent and latent viral infections are established in neurones for
several reasons. Firstly, neurones are long-lived and irreplaceable and are
relatively resistant to apoptosis and immune mediated destruction. Neurones
mnormally lack the expression of MHC molecules for T cell recognition
therefore viral antigen within these cells is not recognised by the immune
system. A number of viruses infect oligodendrocytes and astrocytes and
often cause lesions of demyelination. These include mouse hepatitis virus
(Baraclatas et al., 1997), Theiler's virus (Aubert et al., 1987), JC papovavirus
(Divireddy, et al., 1996; Mesquita et al., 1996), Canine distemper virus (Graber
et al 1995; Summers, et al., 1994), Herpes simplex virus (Kastrukoff, et al.,
1994) and Semiliki Forest virus (Fazakerley et al., 1991). Microglia the
intrinsic brain macrophage are the cell type in which Visna virus (Diguardo,
et al., 1994), HIV (Nottet, et al., 1997) and canine distemper virus (Alldinger,
et al., 1996) persist. Demyelination is also associated with persistent infection
with these viruses. CNS viruses and cell types which they infect are
summarised in Table 1.2.
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Table 1.2 CNS viruses and the cell types they infect.
Cell Virus
Neurons Lymphocytic choriomeningitis virus
Poliovirus
Theiler's virus
Herpes simplex virus
Varicella zoster virus
Visna virus
Rabies virus
Vesicular stomatitis virus
Mouse Hepatitis virus ,MHV-4
Reovirus 3
Measles virus
Semiliki Forest virus
Oligodendrocytes Measles virus
JC papovavirus
Mouse hepatitis virus, JHM, ts8
Theiler's virus
Semiliki Forest virus
Ross River virus
Eastern Equine encephalitis virus
Venezuelan equine encephalitis virus
Visna virus
Herpes simplex virus
Astrocytes Canine distemper virus
Visna virus
JC papovavirus
Herpes simplex virus
Mouse hepatitis virus, JHM
Theiler's virus
Microglia Canine distemper virus
Visna virus
HIV
Theiler's virus
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1.4 Viruses which induce demyelination
As mentioned above one of the consequences of viral persistence in the CNS
is demyelination. Demyelination is the loss of the insulating myelin sheath
which surrounds neuronal axons. There are two forms of demyelination,
primary demyelination which is the direct loss of or destruction to the myelin
and secondary demyelination which is loss of myelin due to neuronal
damage. Lesions of demyelination are associated with several viral diseases
in animals and in man (Table 1.3). Almost all demyelinating diseases in man
and animals of known aetiology are viral. Two well known diseases that
cause demyelination are SSPE of children, which is caused by measles virus
persisting in the CNS (Riadl and Linington, 1996; Allen, et al., 1996; Nagano et
al., 1994), and PML which is produced in adults and children by JC virus
(Armand, et al., 1997; Devireddy, et al., 1996).
Table 1.3 CNS viruses which can cause demyelination.
Family Virus
Togaviridae Semiliki Forest virus
Rhabdoviridae
Papovaviridae
Picornaviridae
Retroviridae
Paramyxoviridae
Coronaviridae
Herpesviridae
Ross River virus
Venezuelan equine encephalitis virus
Mouse Hepatitis virus
Herpes simplex I virus
Marek's disease virus
Measles virus
Canine distemper virus
JC virus
Theiler's virus
Visna virus
HTLV-1
HIV
Vesicular stomatitis virus
Chandipura virus
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In experimental animals there are several viruses which lead to
demyelination. Theiler's virus is one of the best known models of viral
induced demyelination. Although much studied the exact mechanism of
demyelination caused by Theiler's virus is as yet unknown.
1.5 Discovery and Pathology of Theiler's Virus
Theiler's murine encephalomyelitis virus (TMEV) is a picornavirus belonging
to the genus cardiovirus. The virus was originally isolated in 1934 by Max
Theiler from the brains and spinal cords of a mouse with hind limb paralysis
(Theiler 1934,1937).
From Theiler's evidence, it was deduced that TMEV is a naturally occurring
murine virus, whose route of transmission is faeco-oral. Infection of young
adult mice usually leads to asymptomatic enteric infection (Olitsky 1939,1940,
Theiler and Gard, 1940b), however, in rare instances (0.05%) virus may spread
to the CNS and cause clinical disease (Theiler 1937, Olitsky 1939). The clinical
symptoms which may accompany CNS infection are acute encephalitis and
paralysis.
Strains other than Theiler's original isolates (TO) have been isolated from
around the world, and have been experimentally investigated (Daniels et al.,
1952; Lipton et al., 1975; Fazakerley and Buchmeier, 1993). It was soon
discovered that the TMEV family could be subdivided into two subgroups
depending on their biological behaviour in vivo and in vitro (Table 1.4).
The GDVII and FA strains are highly neurovirulent in vivo, causing a rapid
fatal encephalitis in infected mice (Theiler and Gard, 1940a). These strains
predominantly infect neurones and astrocytes although oligodendrocytes
may also be infected (Simas et al., 1995). In cell culture these two strains
produce large plaques (Lipton, 1980).
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Other TMEV isolates include TO, BeAn 8386, DA, Yale, T04 and WW (Lipton
et al., 1979, 1980). These isolates constitute the avirulent subgroup and are
approximately one thousand times less virulent than the neurovirulent
subgroup. In cell culture they form smaller plaques (Lipton, 1980). The
avirulent isolates are capable of producing a biphasic disease in mice (Lipton
et al., 1975). During the acute phase some animals develop hind-limb
paralysis and a waddling gate, occurring 2-4 weeks post-inoculation. During
this phase virus is predominantly in neurones of the grey matter. Animals
that survive the acute phase can go on to develop a persistent CNS infection
which results in a chronic inflammatory demyelinating disease (Lipton et al.,
1984 a, b). During this phase the number of virally infected cells is greatly
reduced, however, virus can be observed in oligodendrocytes, astrocytes and
microglia (Brahic et al., 1981; Aubert et al., 1987; Lipton et al., 1995).
Characteristics GDVII TO strains
Pathology Acute poliomyelitis Early grey matter
disease, persistence,
demyelination.
Target cells (adults) Neurones Neurones,
oligodendrocytes,
astrocytes, macrophage.
Virulence LD50 1-10 104-105
Plaque size (mm in
vitro)
Large (2.5) Small (0.5-1)
Temperature sensitivity Low High
Table 1.4 Comparison of GDVII and TO subgroup of Theiler's virus. The
biological characteristics of the two subgroups are shown. No differences are
seen in the physical properties of the subgroups other than those related to
the protein size.
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1.6 Molecular structure of TMEV
TMEV is a single stranded, positive sense RNA virus of 8100 nucleotides. The
organisation of the TMEV genome is typical of other picornaviruses as shown
in Figure 1.1 (Stanway, 1990) . The 5' untranslated region (UTR) of TMEV is
longer than that seen in other picornaviruses. It also lacks the poly C tract
preceding the open reading frame (ORF), seen in other picornaviruses. The
single ORF encodes a polyprotein of 2303 amino acids. The polyprotein
begins with a short leader sequence followed by 11 other genes that are
typical of the picornavirus 4:3:4 genomic arrangement. The coding region is
followed by another UTR at the 3' end which is followed by a poly (A) tail.
The structural proteins are encoded towards the 5' end of the ORF designated
the PI region. This PI area consists of 4 genes, VP1 (37 kDa),VP2 (34 kDa),
VP3 (18 kDa) and VP4 (6 kDa), these are the capsid proteins. The P2 and P3
regions are the areas that code for the non-structural proteins which are
downstream from the PI region. P2 consists of 3 genes, encoding the 2A, 2B
and 2C proteins, and P3 encodes 4 proteins 3A, 3B, 3C and 3D. These non¬
structural proteins are involved in viral replication and protein processing,
and much is known of their activity (Roos et al.,1989; Palmenburg et al., 1990;
Reuer et al., 1990; Hellen et al., 1991; Johnson and Sarnow, 1991; Hambidge
and Sarnow et al., 1992; Kean et al., 1993; Johnson et al., 1995).
TMEV virions are small icosohedral particles approximately 20-30 nm in
diameter with a sedimentation coefficient of 150 S and are stable at pH 3 or
lower (Lipton and Friedmann, 1980). Inside the icosohedral protein capsid is
a single stranded, positive sense RNA , the 5'- terminal UpUp of which is
linked by a phosphodiester bond to the phenolic (04) hydroxyl group of a
tyrosine residue of a small virus encoded protein, Vpg, which is
approximately 20 amino acids in length.
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Recently the 3 dimensional structures of the BeAn, GDVII and DA strains of
TMEV have been elucidated by X-ray crystallography ( Lou et al., 1992; Grant
et al., 1992; Toth, 1993 and Lou et al., 1996), see Figure 1.2.
The virion consists of 60 copies of each capsid protein VP1, VP2, VP3, and
VP4. The arrangement of these capsid proteins forms a classsical iscosohedral
structure (Figure 1.2). VP1, VP2, and VP3 are exposed on the surface of the
virion whereas VP4, which is the smallest protein, is completely internal.
Picornaviruses have a five, three, and two fold axis of symmetry, and these
are used to orientate the surface features.
VP1, VP2 and VP3 all have similar wedge shaped eight stranded anti-parallel
P barrel sheets that package together to form the continuous protein shell of
the virion . Along with VP4 the amino termini of VP1, VP2 and VP3 interact
to form a detailed network on the inner surface of the capsid, whereas the
carboxy termini of the three major capsid proteins, and most of the loops on
the p strands ( BC, CD, EF loops of VP1 and EF of VP2) are exposed on the
outer surface. None of the capsid proteins are glycosylated, however, VP4
has a molecule of myristic acid linked to the amino terminal glycine.
A broad protrusion is present at the five fold axis where the VP1 molecules
are clustered, forming a star-shaped plateau which slopes downwards across
the surface of VP2 to the three fold axis . On the two fold axis there is a deep
depression corresponding to the surface of VP3, which has been described as
a "canyon" or "pit" on other picornaviruses, and has been proven to be of
functional significance (Hogle et al., 1985; Rossmann et al., 1985; Luo et al.,
1992 and Rossmann and Palmenberg, 1988). There are subtle structural
differences between the neurovirulent GDVII and the avirulent BeAn and DA
strains of TMEV. These structural differences are in small local areas and
involve the interactions of the side chains of the amino acids involved.
However small the differences may be they appear to have important
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implications in determining the difference between neurovirulence and
avirulence (Luo et al., 1987; Kim et al, 1990).
1.7 Viral Entry Into The Target cell
In in vitro cultures poliovirus (a picornavirus) RNA can be detected two hours
after infection, and 30 minutes later infectious virus is detectable. In this time
the virus replicates the positive sense genome, packages it into virions and
effectively releases it from the cell. It is then recognised by a receptor on a
neighbouring cell. A putative receptor for TMEV has been proposed
(Kilpatrick and Lipton, 1991). Radiolabeled virus binds to a 34 kDa
membrane protein on susceptible tissue culture cells, and more weakly to two
other proteins which are 18 kDa and 100 kDa. The 34 kDa receptor is a
sialoglycoprotein and the same receptor appears to be utilised by both BeAn
and GDVII ( Fontiadis et al., 1991). Interestingly however, if cultures of BHK-
21 cells are pre-treated with neuraminidase before infection, the binding of
BeAn infection is markedly inhibited (ie up to 90%), and GDVII binding is
unaffected. This suggests that sialic acid residues are required for BeAn
binding but not for GDVII. It has been hypothesised that the canyon which is
present on the poliovirus and human rhinovirus (HRV) surface is the
putative receptor binding site (Hogle et al., 1985; Rossman et al., 1985). In
Mengo virus the canyon is replaced by a pit and the receptor binding site
(which has been identified for Mengo virus) is in this pit. By analogy with
Mengo virus the TMEV pit residues have been identified (Kim et al., 1990). Of
the 30 pit residues in GDVII and BeAn there are only two differences, both of
which occur in the VP1 region at positions 88 and 219 (Pevear et al., 1987).
These differences may account for the differential binding to the cellular
receptor observed between BeAn and GDVII.
The molecular events which include viral entry into the cell, translocation to
the cytosol and initiation of transcription/ translation are still poorly
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understood for picornaviruses. Subsequent to attachment of ligand to
receptor it has been proposed that the mechanism of viral entry into the cell is
via receptor mediated endocytosis (Madshus et al., 1984a, 1984b). After
attachment of the ligand to the receptor(s) (which cluster in clathrin coated
pits, which are depressions in the cellular membrane) the complex is
internalised by an invagination process, which leads to the formation of
clathrin coated vesicles. Subsequently, a drop in pH inside these vesicles
initiates changes in the capsid proteins, which in turn causes the RNA to be
transferee! from the virion to the cytosol of the infected cell. It is still
unknown by what mechanism the viral RNA is released from the virion,
however it has been suggested that the release occurs through the centre of a
pentamer (Rossmann et al., 1985). However, it has been argued that since
TMEV is insensitive to changes in pH, uncoating may be induced by virion
binding to the host receptor (Luo et al., 1992).
1.8 Translation and Replication Strategies
After entry of viral RNA into the cytosol is completed the next steps to occur
are the binding of viral RNA to ribosomes, formation of polyribosomes,
transcription and translation (Figure 1.3). The positive sense viral RNA is
translated into a single polyprotein using the host cell translational apparatus.
This polyprotein is then proteolytically cleaved to yield components which
are essential for viral replication. The cell does not contain all the necessary
components for complete replication. These include specific proteases for
cleavage of the polyprotein and an RNA-dependant RNA polymerase.
Following the production of the polyprotein and its functional protein
products, the next stage in viral replication is the production of negative
stranded RNA, which is subsequently used as a template to produce message
sense viral RNA, which in turn will produce the capsid and other essential
proteinaceous components for complete viral production (Figure 1.3).
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The precise mechanisms of picornavirus RNA replication are not yet fully
understood, however there is evidence that 3 forms of RNA are found in the
cytoplasm of infected cells. These are 1) positive sense, single stranded RNA
that is either viral RNA or mRNA (Hewlett et al., 1977; Nomoto et ah, 1977),
2) double stranded replicative form RNA, ( Baltimore 1966; Richards and
Ehrenfeld, 1989) and lastly 3) partially double stranded and partially single
stranded replicative intermediate RNA ( Flanegan and Baltimore, 1977, 1979).
These differences in RNA type may be accounted for by the way in which
picornaviruses replicate. However, their exact role has yet to be elucidated.
There are two main models for replication of the positive stranded RNA into
the complementary negative stranded RNA. In the first of these models VPg,
or VPg linked to uridine monophosphate in the form of VPg-pU-pU is
postulated to prime RNA synthesis ( Flanegan and Baltimore, 1977; Lee et ah,
1977 and Nomoto, 1977). Baltimore suggested that uridinylated VPg
hybridises to the 3' poly A tail of the positive stranded vRNA and this primes
complementary strand synthesis with the assistance of the viral RNA
dependent RNA polymerase (3Dpol).
The alternative theory of picornavirus replication is that a hair pin structure
forms at the 3' end of the picornavirus RNA (Semler et ah, 1989), possibly as a
result of uridinylation of the poly A by terminal uridylyl transferase. The hair
pin primes the elongation of the complementary strand. In this model VPg is
thought to function in the trans-esterification required to break off the
phosphodiesterase bond within the hair-pin loop (Tobin et ah, 1989). The
positive template strand and the complementary negative strand then
separate meaning that the next stage of replication can occur. The
transcription from positive sense to negative sense RNA by 3Dpol occurs on
the smooth endoplasmic reticulum in the cell cytosol. Smooth membranes are
essential for complete viral replication (Dales et ah, 1965; Calguiri and Tamm,
1970; Freidmann and Lipton, 1980 and Lorch et ah, 1981).
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One of the most intensively researched areas of picornavirus replication is
how the viral RNA can be translated when it lacks the 5 ' methylated GpppN
(N being any nucleotide) cap structure generally present on eukaryotic
mRNA's (Pilipenko et al., 1994, 1995). Cap independent initiation of
translation is replaced by the encoding of an internal ribosome binding site in
the 5 ' UTR (Bandyopadhyay et al., 1992). All picornaviruses have an
unusual 5' UTR, they are comparatively long. In TMEV the length of the 5'
UTR is 1064 nt. As stated previously, these mRNA's lack the methylated cap,
but have a small viral polypeptide VPg, which is 20 amino acids in length.
Viral RNA molecules which are to be translated lose their VPg proteins which
results in the formation of elaborate secondary structures which form an IRES
(Internal Ribosome Entry Site) or RLP (Ribosome Landing Pad), which the
ribosomes bind to. The IRES has been mapped for TMEV between nt 500
andl043-45 in the 5'UTR (Bandyopadhyay et al., 1992). Deletions in the IRES
drastically reduce translation in BHK-21 cells.
Once the initiation complex is set, the ribosome scans the 5'UTR until it finds
a starting window. The starting window is defined as the area where the
ribosome begins translation, the starting window for TMEV was mapped to
be 16-17 nt downstream of the IRES and was approximately 12 nt in length.
Once an appropriate AUG initiation codon is recognised, translation occurs,
providing that essential cellular factors are also present.
Translation of the large single ORF occurs in the absence of viral gene
products and yields a single polypeptide. The polypeptide precursor is
processed by a series of proteolytic cleavages into the mature gene products
which are essential for further replication. The final products of a series of
cleavages include structural proteins (VP1, VP2, VP3 and VP4), which
assemble into monomers, pentamers, provirions and virions in that order,
and the 8 non-structural proteins ( L, 2A, 2B, 2C, 3A, 3B, 3C, 3D) which are
involved in viral replication. Briefly, the mature proteins 2A (Roos et al.,
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1989; Batson and Rundell, 1991) and 3C (Cheah et al., 1990; Jia et al., 1991;
Kean et al., 1993) are the main proteases involved in cleavage of the
polypeptide, although autocatalytic events are also involved in cleavage. The
leader or L protein has been shown in in vitro studies to occur in two distinct
forms termed L and L* (Roos et al.,1989; Kong and Roos, 1991). L* is
synthesised from an alternative AUG codon 13 nt upstream of L's initiation
codon. The significance of L* remains uncertain; however mutational studies
within the L region, which disrupt L* have shown a decrease in
demyelination. This data is consistent with results from a previous study that
showed that in recombinant virus which substituted GDVII for DA sequences
in the 5' terminus (therefore lacking L* initiation codon) exhibited a decrease
in demyelination. Interestingly, mutagenesis of the L protein has shown that
it is completely dispensable in the infection of BHK 21 cells (Kong, 1994),
however, in foot and mouth disease virus the L protein is a protease and is
involved in proteolytic cleavages. It may have a similar role in TMEV
infection (Palmenberg et al., 1990, Medina et al., 1993). The 3B (VPg) protein
is covalently linked to the 5' end of the RNA and has been shown to play a
role in the initiation of viral RNA synthesis (see above) (Barron and Baltimore,
1993, Ward and Flanegan, 1992; and Reur et al., 1990). The most conserved
protein among picornaviruses is 3D. This is the RNA-dependant RNA
polymerase which is vital for replication. It has conserved sequences with
every other known DNA and RNA polymerase (Kuhn and Wimmer, 1987;
Sankar and Porter, 1992). Very little is known about the involvement and
interaction of these non-structural proteins, and it is still an area of research.
The morphogenesis of TMEV is a three step process which (1) involves the
capsid proteins assembling from monomers into pentamers, (2) these
pentamers assemble into provirions, which consist of the positive sense RNA
genome packaged inside a 12 plated capsid, and finally (3) maturation of the
provirion into the virion which involves cleavage of VPO. This occurs as
infectious virions are released from the infected cell. Virus replication may
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cause programmed cell death (apoptosis) or necrosis of the infected cell,
which subsequently leads to the release of active virus which can then go on
to infect other cells. Apoptosis has been a reported mechanism of cell death
after infection with many different viruses, and recent in vitro studies have
indicated that TMEV can also cause cell death by apoptosis (Jelachich and
Lipton, 1996; Tsunoda et al., 1996). Interestingly the neurovirulent GDVII
strain is at least 50 fold more efficient at inducing apoptosis relative to the
avirulent BeAn strain. It has also been shown that in BHK-21 cells infected
with BeAn virus the virions are associated with smooth membranes and it has
been suggested that virions may exit the cell via channels or pores in the
smooth membrane. However, very little evidence exists to substantiate this
finding (Friedmann and Lipton, 1980). Cell necrosis or apoptosis is
dependent on the cell type infected and the mechanism by which TMEV exits
the cell may also depend on the infected cell type. Cell lysis has been
observed in vitro in various cell types after TMEV infection i.e. BHK-21
(McCright and Fujinami, 1997), and in vivo in neurones (Lui et al., 1967; Stroop
et al., 1981; Lipton, 1975; Rosethal et al., 1986; Wada and Fujinami, 1992).
However, in other cell types TMEV is able to establish a persistent infection
such as oligodendrocytes in vivo where viral RNA is said to be restricted at
the negative strand stage (Cash et al., 1985, 1986, 1988). Also in vitro
persistent infections have been established in a number of cell types including
macrophage/microglia CNS cultures (Levy et al., 1992), glioma cell cultures
(Patick, 1991), mixed astrocyte cell cultures (Rodriguez et al.,1988 and O'Hara
et al., 1992), pure astrocyte cultures (Usherwood Thesis, 1994) and mouse
fibroblast cell lines (Roos et al., 1982).
1.9 Differences Between Strains of TMEV at the Molecular Level
As stated previously, TMEV can be divided into 2 subgroups. The TO strains
are avirulent whereas the neurovirulent strains FA and GDVII are lethal in
mice inoculated i.e. within days after infection. The cloning and sequencing of
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these 2 serologically related subgroups of TMEV strains has proven to be an
invaluable tool in determining which regions in the neurovirulent and
avirulent strains cause virulence and pathogenesis (Aubert and Brahic, 1995).
The virulent and persistent strains did not evolve as two separate groups but
rather the neurovirulent strains arose from a subgroup of persistent strains
(Michaels and Brahic, 1996).
Following i.e. inoculation the neurovirulent strains of TMEV, GDVII and FA
cause an explosion of viral replication and rapidly spread throughout the
brain causing a fulminant encephalitis which results in death (Theiler and
Gard, 1940b; Olistky, 1945; Simas et al., 1995). This occurs in mice of all
genetic backgrounds and affected mice show breathing difficulties, fur which
is stark and ruffled, circling behaviour, weight loss and flaccid paralysis
culminating in death. The neurovirulence of GDVII is dependent on route of
entry and dose of virus, with i.e. inoculation causing the highest mortality
rates, with a LD50 of 0.1 PFU (Theiler and Gard, 1940b; Lui et al., 1967; Lipton,
1980). Intraperitoneal, intravenous, intranasal and oral inoculations are less
effective, but they also give rise to abnormalities in the CNS, however
demonstrating the neuroinvasiveness of the virus.
GDVII and FA strains of the virus contrast dramatically with the avirulent
strains which constitute the TO subgroup and include TO (Theiler, 1934,1937;
Olitsy, 1939,1945; Daniels et al., 1952), BeAn, DA, Yale and WW. The TO
subgroup of viruses after i.e. inoculation can produce a chronic CNS infection
in mice that survive acute infection (Daniels et al., 1952; Lipton, 1975; Dal
Canto and Lipton, 1975; Lehrich et al., 1976). Chronic infection results in a
persistent CNS infection with lesions of CNS demyelination, however this is
dependent on mouse strain. All mouse strains undergo the acute phase of the
disease, however susceptibility to chronic infection is dependent on genetic
background (Bureau et al., 1992), age, sex of the animal (Kappel et al., 1990),
dose, route and strain of virus. Penney and colleagues observed that neonates
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or suckling mice are highly susceptible to the acute phase of the disease
exhibiting 100% mortality (Penney et ah, 1979; Rodriguez et al., 1983b). But,
as mice increase in age they become increasingly resistant to infection (Steiner
et ah, 1984). Mouse strains can be divided on the basis of the incidence of
chronic demyelination after TMEV infection. C57B1/6 and one sub-strain of
Balb/c mice are resistant, CBA, AKR and Swiss are intermediate and SJL/J
and PLJ and SWR are highly susceptible (Lipton and Dal Canto, 1976; Clatch
et ah, 1987b; Bureau et ah, 1992). This is discussed in Section 1.10.
The clinical signs associated with the acute disease (which occur 7-30 days
post infection) are hunched posture, flaccid paralysis (most commonly
associated with the hind limbs but forelimbs may also be affected), unsteady
gait which usually results in waddling, weight loss, incontinency, shivering
and stark ruffled fur (Theiler, 1934, 1937; Daniels et ah, 1952; Lipton, 1975;
Lipton and Dal Canto, 1976; Lehrich et ah, 1976). Mortality during the acute
phase of the disease is dependent on mouse strain. Mice surviving the acute
phase of the disease, whether they show clinical signs or not, may, depending
on mouse strain go on to develop chronic infection. Clinical signs associated
with chronic infection are; ruffled fur, severe hind limb and/or forelimb
paralysis, tremors, hunched posture and severe gait disturbance. This usually
occurs around 60 days after infection, but can occur after this time (Daniels et
al., 1952; Lipton, 1975; Lipton and Dal Canto, 1976).
Nucleotide sequences have been established for the DA (O'Hara et al., 1988),
BeAn (Pevear et al., 1987) and GDVII (Pevear et al., 1987) strains of TMEV.
When the nucleotide and amino acid sequences are compared it can be noted
that there is a large degree of identity between the three strains, although
obvious differences do exist. BeAn and GDVII are 90.4% identical at the
nucleotide level and 95.7% identical at the amino acid level, whereas BeAn
and DA (both TO subgroup) are 92% identical at the nucleotide level and
94.2% identical at the amino acid level. The 5' and 3' UTRs are relatively well
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conserved between strains with 94.5% and 99.2% identity, between GDVII
and BeAn and BeAn and DA. This implies that there are important functional
elements located in these areas, therefore only a limited amount of variability
is permitted to ensure the virus remains viable. On the other hand the largest
sequence differences between the TMEV strains exists in the PI region of the
viral genome. The VP1 region shows the most divergence with 92% amino
acid identity between BeAn and DA and 92.75% identity between GDVII and
BeAn. This is an area of particular interest. Construction and phenotyping of
chimeric viruses suggests that the VP1 region is involved in determining
persistence and demyelination.
Isolation and characterisation of two subgroups of TMEV strains with
distinctive phenotypes has made it possible to construct chimeric recombinant
viruses to elucidate the molecular components responsible for virulence,
persistence and demyelination. It is known that persisting virus is an
absolute prerequisite for demyelination to occur. However, is persistence the
result of attenuated virulence or not? Full length cDNA clones for GDVII
(Tangy et al., 1989; Calenoff et ah, 1990), DA (McAllister et ah, 1989; Roos et
ah, 1989), and BeAn (Calenoff et ah, 1990) were constructed.
It has been discovered using chimeras derived from the above infectious viral
cDNAs that the PI region coding for the capsid proteins is the most important
region in determining neurovirulence. Neurovirulence is the result of
complex interactions involving at least two genetic determinants one in the PI
region and the other in the 5' UTR. Both these regions may contain other
elements which confer virulence but how they interact with each other is as
yet still unknown.
It is also clear that the determinants of demyelination and persistence are also
multigenic. Mutations in the VP1 region in TO strains are able to affect their
ability to persist and cause demyelination (Jarousse et al., 1994b), suggesting
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that the VP1 region may be involved. Studies have also shown that amino
acid 101 in the VP1 region can affect the viruses ability to persist (Zurbriggen
and Fujinami, 1989; Zurbriggen et al., 1991); and a more recent study also
showed that a mutation in amino acid 100 completely attenuates the ability of
the virus to persist ( Lui et al., 1998). The 5' UTR and L regions may also be
involved in persistence and influence demyelination (Stein et al., 1992).
The VP2 area is also important in determining viral persistence, more
specifically a change in a single amino acid at position 141 in VP2 from lysine
to asparagine affects the virus's ability to persist (Jarousse et al., 1996), and
also a mutation at amino acid 173 in VP2 from threonine to phenylalanine
results in failure to persist and induce demyelination (Sato et al., 1996).
Further evidence supporting McAlister's hypothesis that the determinants of
persistence lie in PI (McAlister et al., 1990), is that recombinant viruses in
which BeAn sequences are gradually replaced by GDVII sequences starting at
the NH2 terminal suggest that confirmational determinants requiring
homologous sequences in both the VP2 puff and VP1 loop regions which are
in close contact at the virion surface, may underlie persistence (Adami et al.,
1998).
All the above evidence indicates the viral capsid proteins contain
determinants for persistence and demyelination. Although many important
areas have been mapped in the TMEV genome and several amino acids have
been identified as being important in virulence, demyelination and
persistence, it is probable that even more exist and ongoing research will
identify them
It should be noted that work involving chimeras should be treated with
caution, because chimeras are complex and may involve constructs from
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different laboratories, whereby the infectious parental clones may differ.
Contamination is also a major consideration.
1.10 Mouse Strain Susceptibility
It was first reported by Lipton and colleagues that there was a variation in
demyelinating disease depending on which mouse strain was infected with
TMEV (Lipton and Dal Canto, 1979). According to these authors, all strains of
mice were susceptible to the acute phase of the disease, however, whether the
mice went on to show signs of chronic infection depended upon mouse strain.
Further work has shown that mouse strains can be classified into 3 groups.
SJL/J and PL/J mice have a high susceptibility to chronic infection. An
intermediate group consists of CBA, AKR and Swiss mice. Mice which are
resistant to chronic infection include BALB/c and C57B1/6. Differences in
susceptibility were reported in the BALB/c strain of mice. There are two
strains of BALB/c mice known as BALB/cAnNG and BALB/cByJ (Nicholson
et al., 1994). The differences in susceptibility are due to unknown genetic
differences within these strains .
It is of particular interest to note that CBA mice are intermediate in
susceptibility to chronic infection. In a study particularly pertinent to this
thesis, RNA and sections from the brains and spinal cords of CBA mice,
sampled at various time points during the chronic phase of disease were
investigated for viral persistence by using RT-PCR and in situ hybridisation.
The results showed that 50% of mice had virus in both tissues, however, the
remaining 50% were negative. Persistence of virus in the CNS thus varies
between individual CBA mice (Simas & Fazakerley, 1996). This leaves the
intriguing question of why individuals in an inbred strain of mouse with
identical genetics should differ in susceptibility?
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Lipton and Melvoid (1984b) further investigated the genetic basis of
susceptible and resistant mice. They crossed susceptible SJL/J (H-2S) mice
with resistant (H-2b) mice and found that resistance was dominant, with only
15% of heterozygotes having chronic infection compared to 80-100% of the
homozygous SJL/J mice. Subsequent studies have demonstrated that the H-
2D locus has a role to play in susceptibility (Clatch et al., 1985; Rodriguez and
David, 1985; Patick et al., 1991). Studies in congenic mice on a resistant
C57B1/6 background showed the haplotypes conferring susceptibly to
demyelination were s, f, p, r, v and q and resistance were b, k and d. To
define and map the MHC gene(s) involved in susceptibility, recombinant
inbred strains of mice were used. Within the H-2 complex susceptibility was
mapped to the H-2D region between genes D and L (Clatch et al., 1985,1987b;
Rodriguez et al., 1986). The role of MHC class I molecules was confirmed by
later studies demonstrating that P-2-m -/- mice on a resistant background
develop demyelinating lesions as compared to the wild type controls which
did not (Fiette et al., 1995). Also congruent with this hypothesis is the
observation that Lindsley et al. (1991) made which was that resistant C57B1/6
mice had high numbers of virus-specific CD8+ T cells at day 7 post infection,
but susceptible SJL/J mice had low levels of CD8+ T cells that were not
detectable until day 13 post infection. These data illustrate the importance in
developing a good CTL response early on in a viral infection.
Other non H-2 genes are also linked to susceptibility. These include T cell
receptor p chain (Melvold et al., 1987), IFNy gene on chromosome 10 (Bureau
et al., 1993, Fiette et al., 1995), myelin basic protein on chromosome 18 (Bureau
et al., 1993) and a gene located near to the carbonic anhydrase gene on
chromosome 3 (Melvold et al., 1990). Sex of the animal may also be important
when considering susceptibility with the general trend of males being more
susceptible than females (Kappel et al., 1990). The reasons for this are largely
unknown.
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The above paragraph shows that the susceptibility to TMEV induced
demyelination is a complex process involving many genes. It should be noted
that many of these genes are linked to the immune response ie TCR, MHC,
IFNy. It also should be stressed that in some cases these genes have only
been linked to susceptibility and are not necessarily the genes involved, only
further research will discover the precise locations.
1.11 Sites and Mechanisms of Persistence
The sites of viral persistence and the mechanisms by which the virus evades
an active neutralising antibody and cellular DTH responses have been areas
of much research over the last ten to fifteen years.
It is still the subject of much controversy as to which is the dominant cell type
where the virus establishes a persistent infection. It has been debated as to
whether macrophages or oligodendrocytes are the predominant cell type
involved.
In the acute phase of TMEV infection, depending on mouse strain, age, virus
strain and dose, neurones are the predominantly infected cell type and in
particular copies of viral RNA and antigen were discovered in the thalamic
nuclei, hypothalamus, brain stem and spinal cord motor neurones (Lipton,
1975; Wroblewska et al., 1977; Brahic, 1981; Dal Canto and Lipton, 1982).
These are mainly grey matter areas and no virus is detectable in the white
matter (Simas et al., 1995).
The cellular tropism is very different in the chronic infection. There have
been conflicting arguments as to what the dominant cell type is during
chronic infection. Lipton and co-workers suggest that astrocytes and
macrophages are the sites of viral persistence, in particular the macrophages
(Dal Canto and Lipton, 1982; Lipton, 1995). In contrast to this, Rodriguez
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reported that oligodendrocytes were the main sites of virus persistence, and
not macrophages, with a small proportion of astrocytes infected (Rodriguez et
al., 1983a). Aubert and colleagues estimated only 10% of cells infected during
persistence were macrophages/microglia, 25-40% were oligodendrocytes and
5-10% were astrocytes (50% of infected cell types were uncharacterisable due
to limitations in the technique used) (Aubert et al., 1987). Infection of
oligodendrocytes during the chronic infection was also observed by Simas &
Fazakerely, 1996.
The mechanisms by which virus persists despite an active immune response is
an area of tremendous interest Several theories have been proposed as to
why this is the case.
One hypothesis is that viral variants exist. The theory is that mutations in
genes of the outer capsid proteins cause an antigenic drift and virus evades
antibody. Rodriguez and co-workers isolated several viral variants from the
CNS of an infected mouse, however when the isolated strains were
challenged with anti-serum, it was discovered that all variants could be
neutralised (Liebowitz and Rodriguez, 1983). This only accounts for antibody
variants, CD4+ or CD 8+T cell variants may exist and evade an active
immune response.
An alternative hypothesis is that once the infected cell is lysed the infected
TMEV virions remain associated with the cellular membranes, and these
cellular membranes occlude B cell epitopes, therefore denying access to the
neutralising antibody and allowing virus to persist (Friedmann and Lorch,
1984; Frankell et al., 1987).
It has also been suggested that proteases contained in infected macrophages
digest the B cell epitopes (Nitayaphan et al., 1985), rendering the virus
undetectable by the neutralising antibody. This work has been reiterated in
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vitro showing that there are trypsin sensitive epitopes in VP1. Neutralisation
epitopes also exist at protease cleavage sites in other picornaviruses such as
FMDV and PV.
Restricted replication has also been implicated in viral persistence. It has been
postulated that TMEV exists in a state of restricted replication in glial cells
(Cash et al., 1985, 1986, 1988), with a decrease in viral proteins expressed by
the cells. This could result in the virus avoiding confrontation with the
immune response and hence persistence. The restricted replication
hypothesis was supported by findings by Johnston et al. (1995). They
discovered that the levels of 3D polymerase were decreased in the spinal
cords of mice with a persistent infection, indicating that a decreased amount
of viral replication was occurring.
Blakemore also suggested the "Trojan Horse" hypothesis, whereby
macrophages are persistently infected in the periphery, and recruitment of
persistently infected macrophages into the CNS causes disease (Blakemore et
al., 1988). It still remains an objective to recognise the mechanism by which
virus persists. Perhaps more than one of the mechanisms suggested occur.
1.12 Mechanisms of Demyelination
Demyelination can occur either by direct damage to the myelinating cell the
oligodendrocyte. This is primary demyelination. Alternatively, secondary
demyelination can occur, which is the result of damage to the neurone leading
to axonal loss and then loss of myelin. Infection with TMEV usually results in
primary demyelination however, the mechanism of this demyelination is still
unknown and several postulates exist as to how demyelination occurs.
There have been several mechanisms suggested for the pathogenesis of
demyelination which occurs in susceptible mice after Theiler's virus infection.
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The first mechanism is that demyelination is directly due to viral infection
and that there is no involvement of the immune response. The evidence
supporting this is that nude mice (mice with no functional T cells) and mice
depleted of CD4+ T cells do have areas of demyelination (Rosenthal et al.,
1986; Zurbriggen et al., 1991). Other evidence which supports this hypothesis
is that within the infected oligodendrocytes the inner glial loops swell prior to
demyelination (Rodriguez et al., 1985), and also paracrystalline arrays of virus
can be found in oligodendrocytes (Blakemore et al, 1988). However, it is
unlikely that oligodendrocyte lysis is the major mechanism of demyelination
because there is overwhelming evidence to substantiate the "non-specific
bystander effect" theory.
A second hypothesis suggests that demyelination is immune-mediated.
Immunosuppressive treatments result in a decrease or no demyelination
(Lipton and Dal Canto, 1976, 1977). Other evidence that implicates the
involvement of the immune system is that mononuclear cells have been
observed stripping myelinated axons of their myelin while the
oligodendrocyte cell bodies appeared normal (Lipton,1975). The model
proposed by Clatch and colleagues suggests an effector role for TMEV-
specific DTH, wherein proinflammatory cytokines released by virus specific
DTH T cell leads to recruitment, accumulation and activation of macrophages
in the CNS. This subsequently leads to non-specific bystander demyelination
(Figure 1.4). Evidence supporting this theory includes; the lack of a
demonstrable peripheral or CNS activated T cell response to the
immunodominant myelin epitopes within the first 40 days post infection
(Barbano and Dal Canto, 1984; Miller et al., 1987b); the correlation between
disease and high levels of MHC class II induced DTH (Clatch et al., 1985,
1986, 1987b); the disease acceleration after inoculation with CD4+ Thl cell
lines (Gerety et al., 1994b); demonstration of activated CD4+ T cells in the
CNS post infection (Pope et al., 1996) and finally the tolerisation of animals to
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developing disease after treatment with UV inactivated virions (Karpus et al.,
1995) but not with myelin proteins (Miller et al., 1989).
Mice which have demyelinating lesions induced by TMEV have similarities in
their histopathological features when compared to animals which have EAE
(Experimental Autoimmune Encephalitis) (Dal Canto et al., 1996; Tsundoa
and Fujinami, 1996; Dal Canto, 1995). EAE is a CNS inflammatory reaction
induced by inoculating mice with myelin proteins in CFA. EAE is caused by
antibody and T cell recognition of myelin basic protein, proteolipid protein or
myelin oligodendrocyte protein (these proteins are all components of myelin).
It has been speculated that TMEV induced demyelination may also be a result
of the autoreactivity of T and B cells to myelin constituents.
It is possible that TMEV infection generates neoantigens in a number of ways,
which include lysis of oligodendrocytes or DTH bystander damage resulting
in the potential to generate autospecific T and B cells. There is also the
possibility that TMEV may contain similar B and T cell epitopes as the CNS
components (molecular mimicry) priming the immune system to attack self
and cause demyelination. Until recently previous studies had failed to
recognise any specific autoimmune responses after TMEV infection.
However, there is now significant evidence to suggest that autoimmunity
may be an important component in TMEV induced demyelination. Miller et
al. (1997) recently showed that TMEV infected mice develop T cell reactivity
(T cell proliferation and DTH) to an immunodominant epitope on PLP139-
151. This was first detectable 3-4 weeks after the first signs of chronic disease
were noticed. As myelin damage progressed 5-6 months post infection T cell
and antibody responses to multiple myelin epitopes PLP178-190, PLP56-70
and MOG 92-106 were evident. Examination of the epitopes indicated that
the responses did not arise by cross reactivity (molecular mimicry) with
TMEV specific T cell epitopes (Figure 1.4.), but instead "Epitope spreading"
was postulated to be involved.
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These data suggest that autoimmune responses to myelin epitopes arise in the
chronic phase of TMEV induced demyelination and these responses appear to
be induced by de novo priming of self reactive T cells to autoantigens released
secondary to virus specific T cell mediated demyelination. Miller's current
model for demyelination (Figure 1.4) is a continuation of Clatch's, basically it
suggests that persistent infection of CNS cells provides a continuous supply
of viral epitopes which are presented via MHC class II and recognised by
primed CD4+ Thl cells of the Thl cell subtype. This reaction releases pro
inflammatory cytokines which cause recruitment of activated macrophage
into the CNS. The products of these activated macrophages and T cells (ie
TNFa, NO, IFNy and O2 radicals) mediate the effector phase of demyelination
but consequently cause the release of myelin proteins which causes the
generation of autoreactive T and B cells which further contribute to the
demyelination.
1.13 TMEV as a model for Multiple Sclerosis
In the 1940's it was recognised that mouse TMEV infection had similarities to
human polio virus infection causing flaccid paralysis, therefore TMEV was
initially used as an animal model for polio. However, it was soon recognised
that TMEV had the potential to be used as a model for MS which is a
relatively prevalent disease in Westernised societies, affecting one in 2000
people. It is important on a human, social and economic scale that a
cure/treatment for this disease is discovered. MS is one of the most common
CNS diseases among young adults and yet its etiology remains largely
unknown. Although inflammatory demyelinating lesions are a common
pathological feature of the disease, the clinical course is very variable.
Epidemiological evidence indicates that MS may be acquired
environmentally, possibly by a virus. Several viruses have been implicated as
the agent which causes MS, including recently HHV6 (Liedtke et al., 1995).
There are numerous comparisons that can be made between TMEV-induced
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disease and MS (Tsunoda and Fujinami, 1996; Dal Canto, 1996).
Fundamentally, both are natural endemic CNS diseases of a chronic nature.
Both MS and TMEV-induced disease are genetically influenced by several loci
including MHC and TcR. Like MS TMEV's disease process is primarily
immune mediated with disease associated with CNS mononuclear
inflammatory infiltrates. The triggering agent of TMEV is a virus and the
triggering nature of MS may also be viral. TMEV is an excellent model for MS
for several reasons. Firstly, it has the advantage of being a naturally
occurring murine virus and therefore infection is studied in its natural host.
Another major advantage is the ever increasing number of laboratory
reagents available to investigate the molecular events and the disease
pathogenesis. In nature only a small percentage of mice develop
demyelinating disease after infection with TMEV, and it can also be noted that
in a human population only a small percentage of people develop clinical
signs of MS. This point must be highlighted as it is consistent with MS
having a common viral aetiology. Almost all of the naturally occurring CNS
demyelinating diseases of animals and man of known aetiology are viral, MS
may be no exception.
1.14 Immune Response to TMEV
The immune response to TMEV is a complex and multifactorial interaction
between both the cell mediated and humoral arms of the immune response.
There are quantitative and qualitative differences between these two arms of
the immune response and this may determine the difference between viral
clearance and persistence which is observed between mouse strains. Also the
difference in the immune response in mice resistant to and mice susceptible to
viral persistence is not only important in viral clearance but it also has
implications for the neuropathology observed in susceptible strains, although
this as yet is still poorly characterised.
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1.14.1 B Cell Immunity to TMEV
The role of antibodies in controlling and clearing picornaviruses has been well
documented previously (Lea et al., 1994; Mateu et al., 1995; Smith et al., 1995).
TMEV is no different from any of the other picornaviruses in this respect and
it has been shown that B cells play an important role in the immune response
to TMEV. However, although they play a crucial role in immunity to TMEV,
they appear only to form part of the protective response.
The neutralising antibody response to TMEV was first shown by Lipton and
Gonzalez-Scarano, (1978). They demonstrated that antibody able to neutralise
virus was first detectable one week following inoculation but was slow to
develop and did not peak until four to eight weeks post inoculation.
Although the increase in neutralising antibody is slow to develop it does
correlate with the decrease in infectious virus titre, in the acute phase of the
disease. However, antibody clearly lacks the ability to clear virus, because
TMEV can still persist in a susceptible mouse which has high antibody levels
(Rabinowitz and Lipton, 1976).
Since Lipton's initial studies there have been many others who have tried to
further characterise the antibody response to TMEV. Pena Rossi and co¬
workers elucidated that IgM was the major isotype produced one and two
weeks post inoculation in both resistant and susceptible strains (Pena Rossi et
al., 1991). However, the levels of IgM were much higher in resistant C57B1/6
mice than they were in susceptible SJL/J mice. Serum taken from C57B1/6
mice at 2 weeks post infection was then transferred into susceptible SJL/J
mice during the acute phase of Theiler's virus disease. This dramatically
decreased the number of virus antigen positive cells in the spinal cord,
whereas serum taken from infected SJL/J mice at 2 weeks P.I. had no such
effect. These data suggest that IgM is the major isotype involved in clearing
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the virus during the acute phase of the disease. Decreased levels of IgM in
SJL/J mice may contribute to their inability to clear virus.
SJL/J mice were protected from TMEV induced demyelinating disease after
being pretreated with an attenuated virus. This protection was due to the
presence of B cells and CD4+ T cells but was not connected with CD8+ T cells
(Kurtz et al., 1995). While protection could not be transfered by neutralising
antibody or serum from previously inoculated mice it did correlate with the
number of plasma cells in the CNS during the first week post-infection.
A number of studies have observed intrathecal antibody synthesis in the CNS
during Theiler's virus infection (Lipton and Gonzalez-Scarano, 1978; Roos et
al., 1987; Cash et al., 1989). Antibody levels are increased in the CSF when
compared to the serum of animals infected with TMEV (Lipton and Gonzalez-
Scarano, 1978). It was discovered by isoelectric focusing that the antibodies in
the CSF were oligoclonal IgM (Rodriguez et al., 1988). The antibodies in the
CSF had a restricted repertoire, (predominantly for neutralisation) with some
of the clones not present in the serum (Roos et al., 1987).
The antibody response during the chronic phase of the disease was the focus
of a study carried out by Karpus and colleagues (Karpus et al., 1994). They
discovered that C57B1/6 mice without virus persistence had a significantly
lower anti-viral antibody response at 7 weeks P.I. compared to SJL/J mice
with a persistent infection, and that C57B1/6 mice predominantly produced
antibodies of the subclass IgGl, whereas SJL/J mice predominantly produced
antibodies of the subclass IgG2a. These IgG's are considered to be indicative
of the T helper cell response (Mossman et al., 1986, 1991; Huber et al., 1994,
Kelso et al., 1995). The dogma suggests that IgGl is associated with T helper
cells of subclass 2 (Th2), whereas, IgG2a is associated with the T helper
subclass 1 (Thl). Thl responses are associated with production of
proinflammatory cytokines involved in DTH which increase macrophage
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activity. Differences in Ig class or subclass may directly influence the
progression of the disease and/or be a marker of T-helper cell activity.
Xid mutant mice are unable to mount an antibody response. Intermediately
susceptible CBA mice which have the Xid mutation have increased
demyelination as compared to wild type CBA's (Rodriguez et al., 1990). The
explanation proposed for this is that Xid mutant CBA's are unable to clear the
virus effectively resulting in an increased virus titre and as a result increased
demyelination. This confirms the importance of the antibody response in
prevention of the pathology. However, mice on a resistant genetic
background with the Xid mutation did not develop demyelination suggesting
another mechanism of viral clearance is sufficient to eradicate the infection in
these animals (perhaps anti-viral cytotoxic lymphocytes).
Other evidence supporting the importance of B cells in providing protection
from disease includes the inability of B cell deficient mice to clear TMEV
resulting in demyelinating disease; unlike the control group (Kurtz et al.,
1995). Rodriguez et al. (1993) reported that anti-p treatment from birth, aimed
at suppressing B cells and antibody production, resulted in aggravation of
inflammatory lesions in SJL/J mice infected with TMEV. This indicated that
antibodies play a role in limiting spread in susceptible strains. No accurate
conclusive results could be given as the p depletions were incomplete.
Antibody epitopes which are involved in neutralisation of viral infectivity
have been investigated (Inoue et al., 1994,; Kurtz et al., 1995, Usherwood et al.,
1995). The antibody response is directed against the capsid proteins VP1 and
VP2. However, serum from individuals immunised with purified VP1
showed a greater neutralisation capacity when compared to those individual
immunised with purified VP2. This indicates that the viral capsid protein
VP1 contained immunodominant epitopes (Clatch, 1987a; Scheu et al., 1989,
Cash et al., 1989). This is consistent with other Picornaviruses such as
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poliovirus and foot and mouth disease virus, where vaccination with VP1
prior to infection can lead to eradication of virus.
The use of synthetic peptides has defined the major linear antibody epitopes
on BeAn virus which are recognised by SJL/J, BALB/c and C57B1/6 mice.
These were recognised to be VP1 12-25, VP1 146-160, VP1 262-276, VP2 2-16,
VP2 165-179 and VP3 24-37 (Inoue et al„ 1994). Only antibodies to VP1 262-
276, VP2 2-16 and VP2 165-179 were able to neutralise plaque formation in
vitro. Interestingly, the epitopes recognised by SJL/J mice are different from
those recognised by BALB/c and C57B1/6 mice. This may have important
implications in viral pathogenesis. It has recently been found that
preimmunisation with fusion proteins for VP1 and VP2 (but not VP3) results
in the protection of susceptible mice from demyelination. These mice
displayed high levels of neutralising antibody to the capsid proteins of the
immunogen, indicating that immunisation with VP1 and/or VP2 results in
complete protection from TMEV induced demyelinating disease.
In a separate study also using synthetically generated peptides Usherwood et
al., (1995) determined B cell epitopes in the VP1 region, using serum from
CBA mice. The immunodominant epitope was in the C terminal region and
consisted of 52 amino acids VP1 225-276. Other peptides also strongly
recognised included, VP1 25-39, VP1 81-95 and VP1 121-135. However, one
must remember that in the assays used the peptides may not assume the same
conformation as the corresponding areas on the intact virion therefore
generally only linear epitopes can be determined.
In addition to virus specific antibodies it has been suggested by several
authors that autoantibodies are generated during TMEV persistent infection
(Rauch et al., 1987, Welsh et al., 1987). Antibodies against whole myelin and
myelin basic protein have been shown to parallel chronic demyelinating
disease. Whether autoantibodies promote disease or whether their
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production is induced by the release of myelin proteins following damage,
and is non-pathogenic, remains unclear.
The generation of antibodies is partially dependant on T cells, as was shown
by Borrow and colleagues who depleted CBA mice of CD4+ lymphocytes
before inoculation with TMEV. This resulted in an inability to generate
neutralising antibody and death of the animals (Borrow et al., 1992).
However, in another study, nude mice (which were on a C57B1/6
background) were able to generate an antibody response, although it was 3
fold less that the control group inoculated in parallel, suggesting that T cells
were not absolutely required for the generation of B cell responses during the
acute phase of the disease (Rodriguez et al., 1986, Zurbriggen et al., 1991).
1.14.2 T cell response
The cell mediated arm of the immune response is equally as important as the
humoral arm. It is imperative to understand that both arms do not act
independently of each other, but instead communicate to constitute a fully
functional and competent immune response.
The cell mediated arm of the immune response to TMEV is very complex and
has been the centre of much research carried out over the last ten to fifteen
years. Lipton and co-workers first detected a splenic TMEV specific T cell
proliferative response in SJL/J mice that had been inoculated with virus i.c
(Lipton and Dal Canto, 1976). This splenic T cell proliferation response was
first detectable 78 days post infection, and persisted for one year. To prove
that the delayed detection of both neutralising antibody levels and T cell
proliferation were not a result of virus-induced immunosuppression, sheep
red blood cells (SRBC) were also inoculated. The immune response to these
SRBC was normal, eliminating the possibility that neutralising antibodies and
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T cell proliferation were delayed due to generalised immunosuppression
(Lipton and Dal Canto, 1976).
Clatch and colleagues tried to characterise further the cell mediated immune
response by comparing the responses in resistant and susceptible mouse
strains (Clatch et al., 1985, 1986, 1987b). Both resistant and susceptible mice
developed high anti-viral antibody responses during the chronic phase which
rose with the same kinetics, however, the splenic TMEV specific proliferation
response varied greatly between mouse strains. It was observed that
susceptible SJL/J mice developed a specific DTH and T cell proliferation
response within 10-14 days post infection, preceding the onset of clinical
disease, and this remained elevated for 180 days. In contrast, resistant
BALB/c mice developed low levels of T cell proliferation response and no
measurable DTH (Clatch et al., 1987b). The results from this set of
experiments led to the hypothesis that TMEV infected susceptible mice
develop a virus specific DTH reaction which is absent in resistant strains, and
that this subsequently causes the recruitment of T cells and macrophages into
the CNS which causes non-specific bystander damage to the myelin sheaths
and hence demyelination (Clatch et al., 1986; Miller et al., 1987,1990; Peterson
et al., 1993; Gerety et al., 1994a, 1994b). A pathological DTH is supported by
the observation that demyelinating lesions contain many mononuclear cells
and macrophages engaged in myelin stripping from nerve axons (Dal Canto
and Lipton, 1975).
Further evidence supporting this hypothesis came from lymphocyte depletion
studies. Susceptible mouse strains depleted of CD4+ lymphocytes before the
onset of demyelinating disease showed a marked decrease in the incidence of
disease. 77% of immunocompetent animals developed paralysis as compared
to only 36% of animals depleted of CD4+ cells before the demyelination phase
(Borrow et al., 1992; Welsh et al., 1987).
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The depletion studies also showed that if animals were CD4+ depleted before
infection, then they died approximately 1 month after inoculation. This was
probably due to the fact that in the absence of CD4+ cells animals were unable
to produce anti-viral antibodies and consequently were unable to clear the
virus from the CNS resulting in a fatal infection (Borrow et al., 1992, Welsh et
al., 1987). However, during the acute phase of the disease CD4+ cells probably
play an important role in providing help to produce a good antiviral antibody
response, and therefore protect the animal from fulminant encephalitis.
However, antibody alone is incapable of completely clearing the virus from
the host. Transfer of hyper-immune serum was able to prevent death in
CD4+ depleted animals, but virus persisted and was able to induce
demyelination (Welsh et al., 1987).
In conclusion, these studies have shown that although CD4+ cells are
important, and play a protective role in clearing the virus in the acute phase
of the disease, probably via antibody production, they conversely play a role
in the pathogenesis of TMEV induced demyelination during the chronic
phase.
The role of antigen specific CD4+ T cells was extended by Karpus and
colleagues in some classical immunotolerance experiments (Karpus et al.,
1994). A susceptible mouse strain was intravenously inoculated with UV
inactivated TMEV which was coupled to syngeneic splenocytes via a
carbodiimide bond, prior to inoculation with active TMEV. This resulted in
decreased DTH and T cell response. There was also a decrease in the levels of
splenic mRNA for IL-2, IFNy and TNFp, however there was no decrease in
the levels of mRNA for IL-4, IL-6 and IL-10. Surprisingly anti-TMEV
antibody levels in tolerised mice were 20-100 fold greater with a decrease in
IgG2a and a dramatic increase in the amount of IgGl when compared to the
sham tolerised control group. These data suggest that Thl cells (ie cells
associated with IL-2, IFNy and TNFp and antibodies of the IgG2a isotype)
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were specifically anergized with concomitant stimulation of Th2 cells (cells
associated with IL-4, IL-6 and IL-10 cytokines and also antibodies of the IgGl
isotype). These data implicate Th2 cells in protection from developing
chronic demyelinating disease and Thl cells as effectors of disease. The
induction of antigen specific in vivo anergy has important implications in the
design of therapeutic strategies for immunopathological diseases mediated by
Thl cytokines especially T cell mediated autoimmune disorders.
Several other studies have been undertaken which have demonstrated the
importance of T cells and these have all involved modulating the immune
response, either by drugs or by monoclonal antibodies (Welsh et al., 1987;
Borrow et al., 1993; Gatrill unpublished observations). Cyclophosphamide
and/or anti-thymocyte serum cause a general immunosuppression (Lipton
and Dal Canto, 1976, 1977; Roos et al., 1981). Treated mice show a decrease in
the degree of mononuclear cell inflammation and demyelination. However,
more specifically, animals given monoclonal antibodies to la MHC class II
molecules after acute disease show a decrease in demyelination indicating
that the expression of I-A antigen in the CNS between different strains may
contribute to susceptibility (Rodriguez et al., 1986; Friedmann et al., 1987).
MHC Class II molecules are expressed on antigen presenting cells and present
foreign antigen to CD4 + T cells. RHAp°/° mice were constructed on a
resistant background (H-2b) and are deficient in their ability to express MHC
class II molecules, when these mice were infected with TMEV they were
unable to clear the virus and developed lesions of demyelination (Fiette et al.,
1996). However, the foci of demyelination were much smaller and fewer
when compared to susceptible SJL/J mice. These studies indicate that
demyelination can occur without CD4 + T cells, however the levels are not as
large as they would be if CD4 + T cells were present. This implies that CD4 +
T cells as important effector cells in the demyelinating process, but also
demonstrates that demyelination can occur by a non-CD 4+ T cell dependent
mechanism.
56
Chapter 1 Introduction
The importance of T cells in preventing demyelination is also observed in
nude mice which are congenially deficient in T cells and which provide a
useful model in which infection can be elucidated in the absence of mature T
cells. TMEV infected nude mice had increased levels of CNS virus load and
mortality when compared to a control group (Rosenthal et al., 1986;
Zurbriggen et al., 1991). They did not generate any anti-viral antibodies and
rapidly developed small lesions of demyelination. These studies illustrate
that T cells provide an important contribution to controlling infection during
the acute phase of the disease, but as with the RHAp°/° mice it also illustrates
that demyelination can occur in the absence of T cells. In these nude mice
CNS virus persisted at high levels and was unable to be cleared. It is thought
that in these mice demyelination results from lytic infection of
oligodendrocytes. This is suggested by electron microscopy of the spinal
cords of these animals which showed dying oligodendrocytes containing viral
material (Blakemore et al., 1988). These data suggest that in resistant strains T
cells prevent demyelination during the acute phase. Conversely, in
susceptible and intermediately susceptible strains during the chronic phase, T
cells cause demyelination.
T cell responses against whole virus have been widely reported (Lipton and
Dal Canto, 1976) however, only recently has there been data to suggest the
fine specificity of the T cell response to TMEV. As with other picornaviruses
TMEV is composed of 4 structural proteins VP1, VP2, VP3 and VP4 . It has
been well documented in other epitope mapping studies of picornaviruses
such as Mengo virus, Coxsackie B4 and FMDV (McPhee et al., 1994;
Zamorano et al., 1994, Duque and Palemberg; 1996) that T cell epitopes are
present in the VP1 capsid protein. This is also true of Theiler's virus. A study
using fusion proteins and synthetic peptides reported that for H-2S mice a
CD4+ T cell epitope was present in VP1 between amino acids 233-244 (Yauch
et al 1994). Other CD4+ T cell epitopes were elucidated by Gerety et al.
(1994a, 1994b) in SJL/J (H-2S) mice VP2 274-284. Usherwood et al. (1995)
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determined CD4+ T cell epitopes in CBA (H2-k) mice were located at VP1 33-
47, 153-167, 166-180, 225-239, 233-244 . Yauch also discovered a CD4+ T cell
epitope at VP3 24-37 (Yauch et al., 1995). All of the above epitopes were
located in capsid proteins. However, it is not to say that more epitopes do not
exist as no studies have been carried out on the P2 and P3 regions of the
genome. The further identification of determinants recognised by the virus
specific T lymphocytes will help elucidate the mechanisms involved in cell-
mediated immunopathogenesis and may have important implications in
peptide therapy for virally induced demyelinating diseases.
Immunostaining of CNS material during the acute phase showed CD8+,
CD4+ and MAC-1+ cells were all present by day 7 in resistant C57B1/10 mice
whereas only CD4+ and MAC-1+ cells were present in susceptible SJL/J mice.
The authors suggested that CD8+ cells were involved in clearing the virus
from C57B1/10 mice, however, the markedly slower response in the SJL/J
mice allowed the virus to persist and hence cause demyelination (Lindsley
and Rodriguez, 1989).
The role of CD8+ T cells in the chronic infection is still unclear (Lindsley et al.,
1991; Pena Rossi et al., 1991). As mentioned previously resistance to Theiler's
virus induced demyelination genetically maps to the MHC class I D region
and is associated with up-regulation of class I products and the presence of
class I restricted virus specific cytotoxic CD8 + T cells in the CNS. Haplotypes
associated with susceptibility are s, f, p, r, v, q and with resistance are b, k, d.
Pena Rossi et al. (1991) showed for the first time that TMEV was able to elicit a
CTL response. This was unusual because the only other known picornavirus
to generate a CTL response was coxsackie B3 (Seko et al., 1996). Lindsley et
al. (1991) also demonstrated that TMEV infection produced a specific CTL
response which peaked at day 7 post infection, and noted no difference in
response between resistant and susceptible strains. These experiments also
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demonstrated that CTL's were present during the acute and chronic phases of
the disease. As well as being detected in the CNS as early as day 7 post
infection, virus specific CTL's were isolated from the CNS of SJL/J mice with
a chronic infection on day 226 post-infection. The above data argue against
the hypothesis that CD8 + T cells confer resistance, however; although both
resistant and susceptible strains generate specific CTL's they may recognise
different epitopes and this may explain the difference between viral clearance
and persistence.
Capsid proteins VP1 and VP2 of TMEV serve as targets for T cell mediated
cytotoxicity in resistant H-2b mice but not susceptible H-2S mice. This
difference may be related to their differences in ability to clear virus from the
CNS. Analysis is continuing to elucidate CD 8+ T cell epitopes (Lin et ah,
1995).
Rodriguez and colleagues (1993) reported that the CD8+ depleted animals
had a reduced severity of demyelination and the results were the same
whether the animals were depleted at the time of infection or 15-17 days after.
However, contradictory to Rodriguez, Borrow and co-workers reported that
animals depleted of CD8+ T cells had an increase in severity of clinical disease
and viral clearance was slower (Borrow et al., 1992). Borrow et ah, 1992 also
reported that depletion of animals at 4 weeks post-inoculation had no effect
on the onset of clinical disease. Gerety and colleagues confirmed similar
results to Borrow (Gerety et al., 1994a, 1994b). Obviously, these latter reports
suggest opposite roles for CD8 + T-cells to the Rodriguez study. Rodriguez's
study suggests that CD8+ T cells contribute to demyelination perhaps by
lysing virally infected oligodendrocytes, whereas Borrow suggests that CD8+
cells are restricting pathology and preventing demyelination presumably by
clearing virus and thereby removing the stimulus for a continued DTH
response.
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(3-2-microglobulin is a constituent of the MHC class I molecule, therefore (3-2-
microglobulin deficient mice have no functional CD8+ T cells. These mice
were bred on a resistant background (C57B1/6 x SV129). The results obtained
when wild type and knockout mice were inoculated with virus were that the
knock out mice were not able to clear virus and established a persistent
infection and consequently demyelination (Rodriguez et ak, 1993; Fiette et al.,
1993). Encouragingly, the converse was true of wild type mice with no virus
antigen or demyelination detectable. Also the anti-viral antibody response
was unaffected by the absence of functional MHC class I.
Recent studies by Pope et al., (1996) have also illustrated by flow cytometry
that CD8+ T cells exist in the CNS from day 20 to day 120 post infection in
SJL/J mice however, the level of activated CD8+ T cells is low. This was
measured by determining the amount of IL-2R on the surface of the CD8+ T
cells. These results argue against a major role for CD8 + T cell mediated
cytotoxicity mechanisms in the pathogenesis of chronic demyelinating disease
in the SJL/J mouse strain inoculated with the BeAn strain of TMEV. Whereas
CD8 + T cells infiltrating the CNS of SJL/J mice do not appear to function
directly to cause demyelination they might have as yet an undefined role in
the pathogenesis of the disease.
Further evidence demonstrating the importance of CTLs during the acute
phase of infection was provided by Larsson-Sciard et al., (1997). It was
discovered that in vivo administration of IL-2 by inoculation of transfected
tumour cells resulted in complete protection from chronic demyelinating
disease in the usually susceptible DBA/2 mice. IL-2 treatment resulted in a 3-
4 fold increase in TMEV specific CTL precursors (Larsson-Sciard et al., 1997).
As mentioned earlier CTL's have a critical role in viral clearance therefore
Larsson-Sciard's results suggest that induction and recruitment of TMEV
specific CTLs are necessary for clearing the virus, perhaps before it reaches
immunoprivileged sites allowing chronic infection. The observation that
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CD8+ T cells are detected earlier in the CNS of resistant mice supports the
idea that CTLs are important in clearing the virus from the CNS during the
acute phase of infection. Therefore the levels of IL-2 appear to be important
in generating CTL precursors and CTLs necessary for clearing the viral
infection.
The picture is not entirely clear but it seems that antibody is important in
limiting the spread of the infection but appears to be incapable of clearing the
infection whereas CD8+ T cells may have a role in eliminating remaining
virus in the acute stage of the disease, but they are not absolutely required to
prevent death from overwhelming viral replication. Demyelinating lesions are
present in the absence of CD8+ cells, suggesting that these cells do not play a
direct role in the pathology of demyelination. On the other hand mice
depleted of CD4+ cells previous to virus inoculation all die due to lack of anti¬
viral antibodies, and animals CD4+ depleted after the acute phase of the
disease have a decrease in demyelinating lesions. This implies that CD4+ cells
have a protective role during the acute phase of the disease by facilitating
production of anti-viral antibodies, but alternatively have a pathogenic role in
the formation of demyelinating lesions during chronic infection. Further,
there is some indication that Th2 reponses may be protective and Thl
pathogenic.
1.14.3 Cytokines in TMEV infection
As with other CNS viral infections the cytokine response elicited during
TMEV infection appears to be complicated.
There is evidence to suggest that TNFa is important in the demyelinating
process. Levels of TNFa in cells isolated from spinal cords of SJL/J mice were
investigated by ELISPOT assay, and it was demonstrated at day 40 post
infection that relative to uninfected control mice, SJL/J mice had elevated
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levels of TNFa. Levels of this cytokine correlated with disease severity and
levels of inflammatory infiltrates in the CNS (Inoue et al., 1996). The number
of TNFa producing cells in spinal cords of SJL/J were comparatively higher
than the levels in resistant BALB/c and C57B1/6 mice. Also the levels of
TNFa in supernatants from cultured cells isolated from the CNS or spleens
were much higher in clinically affected animals compared to resistant control
animals. SJL/J mice treated with a monoclonal antibody to TNFa before the
onset of clinical signs disease had decreased disease severity. The identity of
the TNFa producing cells was not characterised. However it is known that
TNFa is secreted by a variety of different cells of both immune and CNS
origin. There is evidence that shows that TMEV infected astrocytes from
both resistant and susceptible mouse strains produce IL-la, IL-6 TNFa and
TNFa receptor in vitro ( Rubio and Torres, 1991; Rubio, 1994; Rubio and
Seirra, 1993).
TNFa has been identified in acute and chronic MS lesions (Navickas and Link,
1996; Spuler et al., 1996; Brown et al., 1996; Philippe et al., 1996) and TNFa
was discovered to have a profoundly cytotoxic effect on in vitro cultures of
oligodendrocytes (Soliven et al., 1995; Qi and Dal Canto, 1996). TNFa also
decreases mRNA expression of myelin proteins in primary oligodendrocyte
cultures. These data all support a role for TNFa in the pathogenesis of
Theiler's virus infection
Contradicting the above data, treatment of TMEV infected animals with TNFa
ameliorated demyelination (Paya et al., 1990). There was no effect on grey
matter disease but white matter disease was dramatically reduced. A possible
explanation for this, as it contradicts the other results could be that it down
regulates destructive T cells and macrophages, or it may be due to
desensitisation of oligodendrocytes due to the large initial dose
(tachphylaxis).
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The interferon systems are extremely important in many viral infections. This
is also true for TMEV. IFNa/p is an absolute requirement to prevent mortality
from TMEV infection as described by Fiette et al., (1995). TMEV infection of
mice with dysfunctional IFNa/p receptors died as early as day three post
infection with extensive dissemination of virus throughout the CNS. IFNy is
also important in TMEV infection. Its functional role was elucidated by
inoculating genetically engineered IFNy receptor knockout mice which were
on a resistant genetic background (Fiette et al., 1995). These mice had an
inability to clear virus from the CNS and had extensive white matter
demyelination, unlike the resistant WT control group. It has also been
reported that treatment of susceptible mice with a monoclonal antibody to
IFNy increases viral persistence (Kohanawa et al., 1994). It could be
speculated that IFNy is necessary for generating an activated and fully
functional cytotoxic T cell response which is necessary for viral clearance.
With regards to other viral infections, LCMV infected IFNyR°/° mice have
normal antibody levels but greatly reduced levels of CTLs which results in
persistence of LCMV in the CNS, this could also be true for TMEV
(Moskophidis et al., 1994; Orange et al., 1996; Planz et al., 1997).
Evidence of the importance of IL-ip in TMEV infection was illustrated by
experiments with LPS (Pullen et al., 1995). LPS is produced by gram negative
bacteria and is known to potentiate immune responses and to trigger resident
CNS cells to produce various inflammatory cytokines. The ability of LPS to
augment demyelination after TMEV infection was investigated in resistant
C57B1/6 mice. When treated with LPS these mice developed clinical disease
as compared to the control group which did not display any clinical signs.
This indicated that the type and levels of cytokines produced are instrumental
in determining whether or not the animal develops clinical signs. The effects
of LPS could be mimicked in C57B1/6 mice by administering IL-ip,
suggesting that the increase in susceptibility to TMEV induced demyelination
following LPS stimulation may function via IL-lp. These results have
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important implications because they indicate how altering the balance of
inflammatory cytokines may determine the difference in susceptible and
resistant strains.
Therefore, it can be seen from the above data that many different cytokines
have many different roles in TMEV infection, and the specific role(s) of
individual cytokines is an area of active research.
1.14.4 Natural Killer Cells
Natural killer (NK) cells are important mediators of the innate immune
response and are particularly important in some viral infections (Kagi et al.,
1995). NK cells function by lysing infected cells in a non-MHC restricted
manner, this is mediated by the perforin molecule. The importance of NK
cells in TMEV infection was first investigated by Paya and colleagues (1989).
They reported that susceptible SJL/j mice had increased levels of virus when
compared to the resistant C57B1/10 strain and suggested that this could be
attributed to the SJL/J mice having a 50% reduction in NK cells compared to
C57B1/10 mice. Resistant C57B1/10 mice when rendered NK cell deficient
either by depletion using mAb NK1.1 or polyclonal anti asialo-GMl, had
diffuse encephalitis in the grey matter during the acute phase of the disease,
and mice treated with the anti asialo-GMl developed lesions of
demyelination. This data suggests that NK cells help to protect resistant mice
from encephalitis.
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1.15 Aim of thesis
The main aim of this thesis was to investigate the temporal changes in
cytokine and immunolglobulin levels during the acute phase of disease. The
rational for this was that different mouse strains have different
susceptibilities, therefore it was of interest to determine whether different
mouse strains elicit different immune responses during the acute phase of
disease, which in turn may account for the differences between viral clearance
and viral persistence. The powerful new technique of RNase Protection
Assay was used to determine the expression of numerous cytokine mRNAs.
Therefore from the cytokine environment it was possible to determine
whether there was a pro or anti inflammatory, Thl or Th2 immune response
present. The cytokine and immunoglobulin profiles were determined during
the chronic phase of Theiler's virus infection in intermediately susceptible
CBA mice. During the chronic phase of Theiler's virus disease 50% of CBA
mice clear the infection. Therefore comparing the cytokines expressed in
animals in which virus was cleared and in which virus persisted would
determine whether a particular type of cytokine environment i.e. type 1 or
type 2 was present during the demyelinating phase of the disease.
Microsatellite DNA mapping has isolated a region near the IFN gene in
determining susceptibility. Therefore the roles of type I and II interferon
were investigated during the acute and chronic phase of Theiler's virus
disease in IFNa/pR and IFNyR knockout mice. The importance of CTLs in
clearing Theiler's virus was discussed in the introduction, however, the
mechanism by which CTLs function during Theiler's virus was not known.
Therefore, Theiler's virus infection in perforin deficient mice was investigated
to ascertain its role during the acute and chronic phases of Theiler's virus
infection.
65
Chapter 1 Introduction
Very little research has been carried out on the immunology of the
neurovirulent GDVII strain of Theiler's virus therefore the levels of infectious
virus, cytokine levels and amount of programmed cell death was investigated
in detail. It has been recently reported that Sindbis virus induces a TNFa
associated shock phenomenon in neonatal mice, therefore it was of interest to
determine whether neonatal animals infected with Theiler's virus were
undergoing the same process of TNFa shock.
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Figure 1.1 The arrangement and function of genes in the Theiler's viru
genome. Showing the typical 4:3:4 arrangement seen in picornaviruses
Figure 1.2 X-ray crystallography of a picornavirus ( Human Rhinovirus 14).
Figure 1.3 The picornaviral infection cycle (adapted from Reukert, 1990) The
first step in infection is the attatchment of the virion to a cellular receptor (1).
Transfer of the VPg-RNA genome occurs by a poorly understood mechansim
involving a conformational change and loss of VP4. The viral genome is then
translated by the normal host cell translation factors (2) and the resulting
polyprotein is cleaved by viral proteases to liberate mature viral proteins.
These are involved in viral replication (3 and 4) and in assembly of virions
(6). The first stage of RNA replication is to copy the genomic RNA into
negative strand RNA which involves the formation of double stranded (RF)
replicative form (RF) RNA (3). Replicative intermediate (RI) forms of RNA
are present when more positive stand RNA is sythesised for further
translation (5) and for packaging into assembling virions (7). The packaging
of the VPg-RNA is accompanied by a maturation cleavage of VPO to form
VP4 and VP2. Cell necrosis and/or apoptosis are the main routes of virion
exit from the cell (8).
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Figure1.4 Immune mediated theory of demyelination ( adapted from Miller
et al., 1997). l)Viral antigen is recognised in the periphery and T cell is
stimulated to proliferate and differentiate. 2) Activated T cell penetrates the
blood brain barrier and gains access to the CNS. 3) Activated Thl cells
recognise viral antigen which is presented by MHC class II on the surface of a
tissue antigen presenting cell. 4) Proinflammatory cytokines and chemokines
are released which attract monocytes from the periphery, stimulate
macrophage activation, and cause tissue destruction. 5 & 6) Activated
macrophages produce proinflammatory cytokines as well as nitric oxide and
O2 radicals leading to further tissue destruction. 7) Myelin is released into
the periphery where it is presented by an APC, and recognised by a Thl cell,
8) which then proliferates and differentiates and then crosses the BBB leading
to further autoimmune destruction.
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2.1 Chemicals and reagents
Unless otherwise stated the chemicals used in this study were obtained from
BDH Chemicals Ltd. (Dagenham, England), Sigma Chemical Company
(Poole, England), GIBCO BRL (Paisley, Scotland) or Fissons Ltd.
(Loughborough, England). All radiolabelled isotopes were obtained from
Amersham International Pic (Amersham, England). The composition of
buffers and reagents used in this thesis are listed in Appendix 1.
2.2 Virus
The BeAn 8386 and GDVII strains of TMEV used in this study were a gift
from Prof. H. L. Lipton (Mount Sinai Medical Centre, New York, USA). Both
BeAn 8386 and GDVII were grown in confluent BHK-21 cells maintained in
Glasgow's modified Eagles Medium (GMEM), supplemented with 10% foetal
calf serum, 200 mM L-Glutamine, penicillin and streptomycin at 37°C, 4%
CO2. Infectious supernatant from these cultured cells was collected at day 3
post infection and clarified by centrifuging at 1000 g for 15 min, and stored at
-70°C. The same batches of BeAn and GDVII were used throughout this study.
2.3 Animals
3-4 week old female CBA, SJL/J, BALB/c and C57B1/6 mice were obtained
from Bantin and Kingman. Female CBA and BALB/c mice older than 4
weeks old, Sv 129, interferon a/p receptor knock-out, interferon y receptor
knock-out, C57B1/6 and perforin knock-out mice of various ages were all
obtained from the Department of Veterinary Pathology's animal unit
(University of Edinburgh, Scotland). Mice were maintained on a dry diet and
lighting was set on the standard 12 hr light and 12 hr dark cycle.
2.4 Inoculation and clinical scoring of mice
2.4.1 Intracranial inoculations
Mice were inoculated intracranially with 104 PFU of TMEV BeAn or GDVII in
20 pi of sterile phosphate buffered saline, under halothane anaesthetic.
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2.4.2 Clinical grading of mice during the acute and chronic phases of
Theiler's virus.
Mice suffering from acute and chronic Theiler's virus induced disease were
graded from 1-5. A score of 1 indicated a gait impairment and increasing
scores to 5 indicated a more severe paralysis, with 5 indicating 2 or more
limbs been paralysed, leading to wasting and death.
2.5 Sampling and preparation of tissues for histology
Mice were bled by cardiac puncture and transcardially perfused with PBS,
and tissues removed, 100 U of heparin was administered around the cardiac
area to prevent clotting. Removed tissues were either fixed in isopentane or
4% phosphate buffered formal saline and subsequently processed for
histology, or snap frozen in liquid nitrogen and stored at -70 °C until use in a
virus titration assay or an RNA extraction assay. Serum was obtained from
all sacrificed animals by centrifuging blood samples at 10,000 g for 5 min, and
retaining the serum, this was then stored at -20°C.
2.6 Tissue Culture
Unless otherwise stated all tissue culture plasticware was obtained from
Falcon Laboratories (Becton Dickinson, UK). All tissue culture procedures
were carried out under standard aseptic conditions. New born calf serum was
supplied by GIBCO BRL and Glasgows modified Eagles medium (GMEM),
tryptose phosphate broth, Hank's buffered balanced salts (HBBS) and PBS
were all prepared at the Department of Veterinary Pathology, University of
Edinburgh (see Appendix 1).
2.7 Virus Plaque Assay
Brains and spinal cords were removed from infected mice and homogenised
in GMEM supplemented with 20 mM HEPES. Brains were homogenised 1:5
w:v and spinal cords 1:10 w:v. A polytron homogeniser was used to
homogenise the samples. Ten-fold serial dilutions were made of the
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homogenised tissues and 200 pi of the appropriate dilution was added to
HBBS (Hank's buffered balanced saline) washed subconfluent monolayers of
BHK cells in 6-well plates and incubated for 45 min at room temperature.
Monolayers were then overlaid with 1% agar in GMEM and once the agar
had set the cultures were overlaid with 2 ml GMEM to prevent dehydration.
The samples were then incubated for 3 days at 37°C, 4% CO2. They were
subsequently fixed in 4% formal saline for 30 min and stained with 0.1%
toludine blue before counting.
2.8 Virus neutralisation assay
Virus neutralisation assays were carried out to determine the amount of
neutralising antibody. Serial dilutions of serum samples from infected mice
were assayed for neutralising antibody as described before (Rabinowitz and
Lipton, 1976).
2.9 Total RNA Extraction
2.9.1 GTC Method
Total brain RNA was extracted from brains of infected mice using the GTC
method (Chomczynski et ah, 1987).
Half brains were homogenised in 12 ml of ice cold guanidinium thiocyanate
(GTC) solution (4.0 M GTC, 25 mM Na Citrate pH 7.0, 0.5% Sarkosyl, 0.1 M p-
Mercaptoethanol, 1-2 drops of Sigma anti-foam) using a glass dounce
homogeniser that had been specifically prepared for RNA extraction. The
dounce homogenisers were steeped in 10% DECON, rinsed thoroughly, stood
in 1 M NaOH for 1 hr, rinsed in sterile distilled water, and steeped for a
further hour in chromic acid 1 M, rinsed 6X in sterile water, dried and
autoclaved. Homogenised tissue suspensions were laid onto a 2 ml cushion
of CsCl (5.7 M) and EDTA (0.1 M, pH 7.0), which was DEPC treated; in
Beckman polyallomer ultracentrifuge tubes (Beckman, UK) and centrifuged at
35 K for >16hr at 15°C, in a SW40 rotor (Beckman, UK). After centrifugation
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was complete the GTC layer was removed and the interface washed with ice
cold GTC solution, the GTC solution and CsCl, EDTA cushion was
subsequently removed, leaving a gelatineous pellet which was washed with
70% ethanol and IX TNE (0.1 M NaCl, Tris 10 mM, 1 mM EDTA). The pellet
was spun down, resuspended in sterile water and ethanol precipitated at -
20°C. The resulting pellet was lyophilised and resuspended in IX TE,
analysed (see Section 2.10) and stored at -20°C.
2.9.2 Extraction of RNA from cellular cultures
GMEM medium was discarded from the cells from which RNA was to be
purified from, the monolayers were washed twice with PBS. 10 ml of GTC
solution was added (5 min/RT) to instantaneously lyse the cellular
monolayer. The thick viscous solution was removed and transferred to a
screw capped tube. The tube was vigorously shaken to shear any DNA that
was present. The preparation was then added onto a CsCl cushion and RNA
extraction was continued and completed as for the mouse brain samples (see
Section 2.9.1).
2.9.3 Trizol Method
RNA was extracted from spinal cords and baby mouse brains using the Trizol
extraction method (GIBCO BRL, UK). Trizol is a ready to use RNA extraction
buffer. Tissues were thoroughly homogenised in 1 ml of trizol using a tight
fitting glass dounce homogeniser (which had been previously treated for
RNA use only). Once a smooth suspension was achieved by homogenisation
the preparation was allowed to stand for 10 min to enable the complete
dissociation of nucleoprotein complexes. Next 0.2 ml of chloroform was
added and samples were vortexed vigorously for 15 sees and incubated (15
min/RT). The samples were then centrifuged at 10,000 g for 15 min/4°C.
Two phases were apparent and the RNA remained exclusively in the upper
phase. The upper phase was extracted and transferred to a fresh eppendorf,
0.6 ml of isopropanol was added and samples were incubated (15 min/RT).
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Samples were then centrifuged at 10,000 g lOmin/RT. The precipitated RNA
was then lyophilized, resuspended in IX TE buffer, quantitated and
qualitated (see Section 2.10).
2.10 Analysis of RNA
The integrity of RNA samples was analysed by running them in a 1% or 2%
agarose gel in 40 mM Tris, 40 mM acetic acid and 1 mM EDTA, pH 7.2. Gels
were run at 90 V, stained with ethidium bromide 0.5 mg/ ml, and products
were visualised under long wave uv radiation. The concentration and purity
of the RNA was determined by measuring the aborbance at 260 nm and 280
nm on the spectrophotometer (Phillips, Scientific Instruments, UK).
2.11 RNase Protection Assay
The cDNA clones which were used to generate subclones for the RNase
protection assay have been previously described (Hobbs et al., 1993). The
brains and spinal cords were removed from infected animals, which had been
perfused with sterile PBS, and total RNA was prepared using the GTC
method (brains) and Trizol method (spinal cords) as described above.
Cytokine transcripts were quantified by using a method previously described
(Melton et al., 1984).
Probe synthesis
Radiolabeled RNA probe sets were synthesised as described by Hobbs et al.,
(1993). Briefly, UTP (10 pM), GTP ( 2.5 mM), ATP (2.5 mM), CTP (2.5 mM)
and 32P UTP 300 Ci/mmol were lyophilised for 45 min. To the dried
nucleotides DTT (100 mM), transcription buffer (5X), RNasin (40 U/pl) and
linearised templates (50-100 pg/ml) were added, with the initiation of
transcription occuring by the addition of T7 Polymerase (10 U/pl). This
reaction was stopped after 1 hr by the addition of RQ1 DNase (2 U/ pi) for 30
min at 37°C. The probes were then purifed by phenol/chloroform,
chloroform and isoamyl alcohol extractions and precipitated with ethanol and
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ammonium acetate. The probes were then lyophilised and resuspended in
hybridization buffer (80% formamide, 1 mM EDTA, 400 mM NaCl,40 mM
PIPES, pH 6.7).
Hybridizations
1.9 pi of probe was added to 14 pg of lyophilized total RNA and dissolved in
8 pi of hybridization buffer. Uninfected total brain RNA was used as a
control and yeast transfer RNA was used as a control for the digestions. All
the samples were overlaid with mineral oil, heated to 90 °C and incubated
overnight (12-16 hr) at 56°C.
Digestions
After the hybridization step unhybridized single stranded RNA was digested
by the addition of RNase A (100 pg/ml) and RNase T (1500 U/pl), in Tris (1
M, pH 7.5), NaCl (5 M), EDTA (0.5 M, pH 8.0). After incubation for 45 min at
30 °C samples were treated with 18 pi of a mixture of Proteinase K (0.5
mg/ml), SDS (10%), yeast tRNA (2 mg/ml). The duplexes of RNA were
isolated by extraction/ precipitation as before, air dried and dissolved in
loading buffer (80% formamide, 1 mM EDTA, 50 mM Tris Borate pH 8.3, 0.05
w/v xylene cyanole and bromophenol blue) and electrophorised in a
standard 5% acrylamide/8 M urea sequencing gel. Dried gels were placed on
film with intensifying screens and were developed after a 2 week exposure at
-70°C. Densitometry was used to quantitate the autoradiographic images.
The length (nt) of the mRNA transcripts for the different probes were known,
therefore to ensure the correct band was identified, the distance travelled by
the different bands was plotted against known length, so that accurate
identification of the bands occurred. Once the bands were identified the
autoradiographic image was sent to Dr Monte Hobbs (Scripps Research
Institute) to double check that the correct bands had been identified.
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2.12 RNA Dot Blot Hybridization
Various concentrations of brain RNA were added to 100 jul of blotting buffer
(50% formamide, 7% formaldehyde, IX SSC and 10 pg/ml of tRNA). Samples
were heated to 68°C for 15 min and cooled on ice. 200 pi of 20X SSC was
added to each sample, giving a final concentration of 14X SSC. The
membrane used for Northern blotting was a positively charged nylon
membrane (Boehringer-Mannheim, Germany). Prior to use the membrane
was soaked in sterile distilled water. The dot blot apparatus was set up
according to the manufactures instructions (Biorad, UK). Wells in the dot blot
apparatus were washed with 200 pi of 20X SSC under vacuum. Samples were
applied with no vacuum, then once samples were loaded in the wells a
vacuum was gently applied. The wells were washed with 15X SSC and the
membrane was allowed to air dry. RNA was crosslinked to the membrane
using uv radiation (12,000 joules/3 min). The membrane was prehybridized
in prehybridization solution (see Appendix 1) >1 hr at 65°C. Unhydrolysed
digoxigenin labelled riboprobe specific for TMEV was used at a concentration
of 1/1000 and boiled in hybridization buffer before being added to the
membrane. Hybridization occurred for 12-16 hr at 65°C. After hybridization
the membrane was washed twice in 2X SSC, 0.1% SDS (15 min/37°C) once in
2X SSC, 0.1%SDS (15 min/65°C) and finally washed twice in 0.2X SSC, 0.1%
SDS (8 min/65°C).
Detection of Digoxyigenin
After hybridization, hybridized digoxigenin probe was detected by
incubating with a sheep anti-digoxiygenin antibody and by using an
enhanced chemiluminescence kit according to the manufacturers instructions
(Boehringer-Mannheim, Germany). Luiminescence was determined by using
autoradiography.
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2.13 PCR
2.13.1 Oligonucleotide primers
Oligonucleotide primers and their genomic location are shown in Table 2.1.
All primers were derived from the area spaning nucleotides 3078 to 4000
which are in the VP1/VP2 region.
Primers were selected based on the sequences published by Pevear et al.
(1987), and the primers used for nested PCR were selected internally from the
original first round primers.
Table 2.1.
Sequence Primer Nucleotide Tm°Cc Mwtd
No.
CTGTAATCAAAGGTGATGAACTG 2B' 3879/3901 60.6 5213
ACCCAGCCTTGGTGAGA 2A 3494/3510 59.8 6214
CACTAAGGACTTTGGAGTCG Nl' 3635/3654 62.5 6205
GTTGTCAGCATTGATCTTGG N2 3787/3806 67.7 6154
c Tm (melting temperature) at 100 pM oligo and 1M salt.
' indicates complementary to the published sequence.
d calculated molecular weight of the primer.
2.13.2 One Step Reverse Transcription Polymerase Chain Reaction
Reverse transcription polymerase chain reaction of viral RNA was performed
using a GeneAmp Thermostable rTth Reverse Transcription RNA PCR kit
(Perkin Elmer, UK). Viral RNA was reverse transcribed in a 20 pi reaction
mixture containing 1 pg of total brain RNA, IX reverse transcription buffer (1
mM MnCh, 200 mM of GTP, CTP, ATP, TTP) 5 U of rTth polymerase and
primer 2B "the down stream primer" (at 0.75 mM). Each sample was overlaid
with mineral oil and incubated for 15 min at 58 °C. After incubation and
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cDNA synthesis the 20 jllI was transferee! to 80 pi of PCR cocktail (0.8X
chelating buffer, 2.5 mM MgCU, 0.15 pM of primer 2A the "upstream primer"
then reactions were subjected to 35 cycles of amplification.
94°C for 30 sees
55°C for 30 sees
60°C for 60 sees
The cycles of replication were carried out in a Techne PH3 thermal cycler
(Techne Ltd., UK). One tenth of the RT-PCR product was run on a 1% or 2%
agarose gel in IX TAE. The gel was then stained with ethidium bromide (0.5
mg/ ml), and viewed under a UV light. To obtain maximum sensitivity gels
were Southern blotted.
2.13.3 Nested PCR
To obtain maximum sensitivity without Southern blotting a nested PCR was
developed in which products from the first round of RT-PCR were further
amplified by nested PCR (Hofner et al., 1994; Tilson et al., 1995).
The nested PCR cocktail contained 2 pi of the first round RT-PCR product, 46
pi of the PCR cocktail as described above and 0.15 pM of primer N1 the
"upstream primer" internal to the first round PCR primers and 0.15 pM of
primer N2 the"downstream primer" internal to the first round PCR primers,
and 5 U of rTth polymerase. The samples were subjected to 35 cycles of
amplification as described above (Section 2.13.2) and the products of nested
PCR were run as described previously on a 1% agarose gel (Section 2.13.2).
2.13.4 Analysis of Nucleic Acids by Southern Blot
10 pi of RT-PCR products were run on a 1% agarose gel. The DNA was
transferred to a Hybond N+ membrane (Boeheringer-Mannheim, Germany)
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by Southern blotting (Maniatis, 1989), and cross-linked to the membrane by
uv radiation 1200 joules/30 sees.
The blotted membrane was then prehybridized at 65°C, >1 hr in 50%
formamide, 5X SSC, 2% blocking solution (Boeheringer-Mannheim, Germany)
0.1% SDS, and 0.002% tRNA. Hybridization occurred overnight with a non-
hydrolysed digoxigenin-labelled riboprobe used at a concentration of 1:1000.
After hybridization a series of washes were undertaken:-
2, 2X SSC, 0.1% SDS, 15 min RT
1, 2X SSC, 0.1% SDS, 15 min 65°C
2, 0.2 XSSC, 0.1% SDS, 8 min at 65°C
After the stringency washes the DNA was detected using an anti-digoxigenin
antibody and CSPD enhanced chemiluminescence kit according to the
manufacturers instructions (Boehringer-Mannheim, Germany).
2.14 Enzmye-linked immunosorbent assay (ELISA)
2.14.1 Antigen Purification
Thirty T175 flasks of BHK clone 2 cells were grown at 37°C and 4% CO2 until
80% confluent. Monolayers were washed three times with PBS and infected
with TMEV at an M.O.I, of 0.1 PFU and incubated for three days. Tissue
culture supernatants were collected and centrifuged at 1,000 g (15 min/RT).
10% SDS was added to give a final concentration of 0.8% SDS (92 ml of
supernatant and 8 ml of 10% SDS). Supernatants were centrifuged in an
ultracentrifuge (Beckman, UK) at 35K (2 hr/20°C) in a 45 rotor. Once pelleted
the virus was soaked in 10 mM Tris-HCl (pH7.5) (0°C/l-2 hr). The pellets
were pooled in 3 ml and added to 6.6 ml of CsCl in 10 mM Tris-HCl (pH 7.5)
with a density of 1.51 g/ml. The preparation was cooled (20 min/0°C), and
centrifuged (10,000 g/10 min/4°C). This step was included to precipitate the
SDS. The solutions density change was readjusted with CsCl to give a final
weight of 1.35 g/ml. The preparation was centrifuged for 48 hr, 40 K, 4°C in a
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SW 55 rotor (Beckman, UK). After high speed centrifugation the virus
banded in the centre of the tube, this band was removed and dialysed in 10
mM Tris-HCl (pH7.5).
2.14. 2 Protein Assay of TMEV BeAn Virus yield
A standard Bradford protein assay was carried out to determine the
concentration of TMEV (BeAn) virus obtained after the rigorous purification
described above (Section 2.14.1). 1 ml of Biorad Bradford protein dye reagent
(1/5 dilution, in water) was added to variety of standards, and to purified
virus (see Table 2.2)
Table 2.2
Group Sample h2o
A 30.0 pi standard (2 mg/ml Bovine Serum Albumin) + 20.0 pi
B 15.0 pi + 35.0 pi
C 7.5 pi + 42.5 pi
D 2.5 pi + 47.5 pi
E 1.5 pi + 48.5 pi
F 0.5 pi + 49.5 pi
G 50.0 pi + 0.0 pi
The above were vortexed and the absorbance was measured at 595 nm in a 1
ml quartz cuvette using a spectrophotometer (Phillips Scientific Instruments,
UK). Optical densities are displayed (Figure 2.1). Virus yield was obtained by
extrapolation on the standard curve obtained from the BSA standards
measured. The concentration of purified virus obtained was around 600
Eg/ml
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2.14.3 Purified TMEV (BeAn) quantification by plaque assay.
Purified TMEV (BeAn) was also quantified by viral plaque assay as described
in Section 2.7. The titre obtained was 6.5xl08 PFU/ml. Therefore 1 mg of
viral protein is equal to approximately l.lxlO9 PFU/ml.
2.14.3 ELISA Procedure
A variety of 96 well plates were tested, but one, Immulon 4 (Dynatech, USA)
had a significantly lower background with a higher specific absorbance
compared to the rest. This absorbance decreased with serial dilution of
antigen. These plates were chosen to carry out the assay. All wells were
coated with 3 pg/ ml of purified virus diluted in 50 pi of ELISA coating buffer
(see appendix 1). Plates were wrapped in clingfilm and incubated O/N at
4°C, plates could be stored like this for several days. Serum samples that
were to be analysed were diluted (1/100) in 0.05% Tween in PBS (PBST)
containing 5% rabbit serum, 50 pi of each sample was added per well and
samples were always analysed in duplicate. Positive and negative controls
were always included in every assay, these were hyperimmune serum and
serum from a known positive, also 5% rabbit serum and serum from mice
inoculated with an unrelated virus were included as the negative controls.
The wells were washed 3X PBST prior to the addition of the diluted serum
samples, once the serum samples were added they were allowed to incubate
for 2 hr at RT. Samples were then removed and the plates washed 3X PBST.
50 pi of secondary antibody (either rabbit anti mouse IgM, IgGl, IgG2a or
IgG2b, which were all conjugated with horseradish peroxidase) diluted in 5%
rabbit serum in PBST were added per well and the plates were incubated at
RT/1 hr. Wells were again washed 3X with PBST prior to the addition of
substrate. The substrate solution used was 5-aminosalicylic acid (Sigma, UK).
100 mg of 5-salicylic acid was dissolved in 100 ml 0.02 M sodium phosphate
buffer (see appendix 1). 1 ml of 1% hydrogen peroxide was added to the
mixture, 50 pi of the mixed solution was then immediately added to the wells
and the colour was allowed to develop 5 min-1 hr. The reaction was stopped
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by the addition of 3 M NaOH, and the plates were then read on an ELISA
plate reader (Dynatech, USA) at 570 nm. Samples were considered positive
when the mean of the duplicates was greater than the mean plus two
standard deviations of the negative controls.
The ELISA experiments were not carried out as accurately as they might
have been, therefore the value of these experiments is questionable. In
these ELISA experiments for convenience a standard 1/100 dilution of
serum was used for all samples. However, if ELISA experiments were to be
carried out more thorough, the exact total immunoglobulin levels in each
individual sample should be determined by a separate ELISA.. Therefore
when reading the ELISA data this point should be remembered.
2.15 Histology
2.15.1 Preparation of Slides
Slides used to mount the tissues on were biobond (British Biocell
International, UK) treated. Biobond produces a very strong adhesive between
glass and tissue and also minimises the amount of background.
Slides were soaked in 2% DECON for 1 hr and thoroughly washed with
distilled water to remove any residual DECON, slides were then dried at RT
and were covered to protect from dust. The slides were then treated for 4 min
at RT with 2% biobond solution in acetone. The slides were then rinsed for 5
min in distilled water and allowed to air dry, and stored until use in a dust
free environment.
2.15.2 Tissue Sectioning
Tissue section was undertaken by Neil Mclntyre at the Elistology Department,
Department of Veterinary Pathology, University of Edinburgh.
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2.15.3 Immunocytochemistry
There were two methods of immunostaining used throughout this study
depending on the type of tissue fixation method used. Method 1 was used for
paraffin sections and method 2 was used on cryostat sections.
2.15.3.1 Method 1
Dewax 7 micron thick paraffin embedded tissues in xylene (15 min). Leave
sections in 100% ethanol (5 min/RT). Place sections in 100% methanol, 0.3%
H2O2 (30 min/RT). Hydrate sections through graded alcohols (1 min in each
100%, 95%, 70%, 50%, 30%), and wash in H2O twice (1 min/RT). Sequentially
treat sections with 1% Triton-XlOO (1.5 min/RT), wash twice in H2O (5
min/RT), wash in PBS (5 min/RT), digest the tissues in 10 pg/ml proteinase
K in 20 mM Tris, 2 mM CaGh (pH 7.0). Stop reaction by washing slides in
PBS, glycine 2 g/L and 5 mM EDTA.
Sections were placed in a humidity chamber and blocked with 10% blocking
solution. The blocking solution was made up as 5% animal serum which is
the same species as the secondary antibody in PBS. Primary antibody was
added at the appropriate dilution (see Table 2.3) in 2% blocking serum/ PBS,
(> 1 hr/RT) Biotinylated secondary antibody was added at 200 pl/slide (see
Table 2.3) and incubated >lhr at room temperature. Sections were then
incubated with ABC peroxidase reagent according to the manufacturers
instructions (Vector Laboratories, UK), sections were washed between each
step three times in PBS. Diaminobenzidine (DAB) was used as a detection
substrate according to the manufacturers instructions (Sigma, UK), sections
were washed in PBS (5 min/RT), counterstained with haemotoxylin,
dehydrated in graded alcohols (1 min in each), left in xylene (10 min) and
mounted using Surgipath micromount medium (Surgipath, UK).
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2.15.3.2 Method 2
10 micron thick cryostat sections were treated with 0.03% H2O2 in PBS for 10
minutes, again this was to block any endogenous peroxidase activity.
Sections were placed in a humidity chamber and incubated sequentially with
primary antibody (Table 2.4) diluted in PBS containing 5% blocking serum
for 1 hr. The blocking serum used was the same as the species of secondary
antibody. The sections were then treated with biotinylated secondary
antibody for 1 hr, and then with ABC peroxidase (see Section 2.15.3.1) for 30
min. To enhance reactivity the sections were further incubated with swine
anti-rabbit or a rabbit anti-goat peroxidase conjugate for 30 min. Between
each stage sections were washed three times with PBS containing 0.01% Brij.
The immunostaining was visualised using DAB (see Section 2.15.3.1) and the
sections were counterstained with haemotoxylin and mounted using glycerol.
The working dilutions of primary antibodies were determined using
concancavalin A stimulated splenocytes and CNS tissue from mice with
clinical signs of chronic relapsing experimental autoimmune encephalitis.
The degree of immunoreactivity was determined on a 4-point scale based on
the intensity of the staining and the number of positive cells or
immunopositive areas in sections from three mice sampled at each time point.
2.15.4 Double staining with Terminal deoxynucleotide transferase
mediated UTP Nick End Labelling (TUNEL) and Immunostaining
Sections were dewaxed in xylene (15 min/RT) and sequentially hydrated
through graded alcohols (1 minute in 100%, 95%, 70%, 50%, 35%), treated
with 1% Triton-XlOO (1.5 min/RT), washed in PBS (5 min/RT) and then
dipped in water and treated with 10 pg/ ml of proteinase K in 20 mM Tris-
HC1, 2 mM CaCE, pH 7.0. This reaction was stopped with PBS, 2 g/L glycine
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and 5 mM EDTA (5 min/RT). These treatments were to permeabilise the
tissue, after these treatments the sections washed in PBS (5 min/RT).
Positive control
As positive control for TUNEL, one section was equilibrated with DNase
buffer ( 30 mM Tris-HCl pH 7.2,140 mM sodium cacodylate, 4 mM MgCE and
0.1 mM DTT) for 20 minutes at RT, then 5 pg/ml of DNase 1 in DNase buffer
was added to the section (20 min/37°C). The slides were then washed three
times in PBS (5 min/RT).
Next all tissues were equlibrated in TUNEL buffer (30 mM Tris-HCl pH 7.2,
140 mM sodium cacodylate, 1 mM cobalt chloride), sections were then
incubated with 0.3 U/jdl of TdT (Terminal deoxynucleotide Transferase) and
20 jaM digoxigenin labelled UTP in TUNEL buffer (2 hr/37°C). To prevent
dehydration sections were covered with Nescofilm and incubated in a
humidity chamber. The TUNEL reaction was terminated by removing the
Nescofilm and leaving the section in 2X SSC (5 min/RT).
Immunostaining and Alkaline Phosphatase Detection
Sections were blocked with 3% normal goat serum (NGS, Sigma, UK) in PBS
(20 min/RT), then incubated for > 1 hr at room temperature with sheep anti-
digoxigenin (1/100) which was alkaline phosphate conjugated (Boehringer
Mannheim, Germany), then washed three times with PBS (5 min/RT).
BCIP/NBT Detection
The BCIP/NBT detection was undertaken following the manufacturers
instructions (Boehringer-Mannheim, Germany). The BCIP/NBT solution was
incubated on the tissue sections (20 min/RT), until a blue/black colour
appeared. Sections were then washed three times in PBS.
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Immunostaining for viral protein
Tissue sections were incubated in 100% methanol with 0.3% H2O2 (> 30
min/RT), this was to quench endogenous peroxidase activity. Sections were
blocked with 10% goat serum in PBS (20 min/RT) The primary antibody,
which was rabbit anti BeAn in 2% goat serum and PBS was incubated (> 1
hr/RT). Sections were then incubated with the secondary antibody, goat anti-
rabbit which was biotinylated and diluted in 2% NGS in PBS (> 1 hr/RT).
Then washed three times in PBS.
ABC/DAB Detection
ABC/DAB detection was undertaken according to the manufacturers
instructions (see Section 2.15.3.1). Sections were rinsed after this detection
step and dehydrated through the graded alcohols and counterstained with
methyl green, then mounted using Surgipath mountant.
2.15.5 Restriction Endonuclease Digestion of DNA
The starting plasmid contained the B2 fragment of TMEV which had been
subcloned into pGem3 as described before ((Pevear et al., 1988). The construct
contained the VP4, 3, 2, and 1 regions of the TMEV genome. The TMEV viral
cDNA which was used for riboprobe synthesis was isolated by a standard
restriction digest with Hind III yielding a cDNA fragment, of approximately 3
kb in length. This was purified by chloroform/ phenol extraction. In all of the
restriction digest reactions all the restriction endonucleases and reaction
buffers were supplied by GIBCO BRL and were used according to the
manufacturers instructions.
2.15.6 In vitro Synthesis of Riboprobes
Riboprobes were synthesised from a recombinant pGEM3 vector harbouring
the 3.4 kb Sail, Xbal cDNA restriction fragment of BeAn corresponding to
nucleotides 1729-4733. Probes were labelled according to the manufacturers
instructions. 35S probes were synthesised using the riboprobe Gemini kit,
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according to the manufacturer's instructions (Promega). A Boehringer RNA
labelling kit was used to produce biotin and digoxygenin labelled riboprobe.
These riboprobes were synthesised according to the manufacturer's
specifications (Boeheringer-Mannheim). The different transcription reactions
are listed below for each probe. The purification and alkaline hydrolysis steps
for all probes were the same, as recorded below.
2.15.6.135S Labelled Riboprobe Synthesis
Transcription Reaction
Sterile water (DEPC treated) 1.1 pi
Transcription buffer (5X) 4.0 pi
DTT (100 mM) 2.0 pi
RNasin (25 U/pl) 1.0 pi
GTP(lOmM) 1.0 pi
CTP (10 mM) 1.0 pi
UTP (10 mM) 1.0 pi
ATP (300 pM) 1.0 pi
DNA linearized plasmid template 1.0 pi (1 pg)
35S-ATP (1350 Ci/mM) 4.0 pi
T7 RNA polymerase 1.0 pi
This mixture was thoroughly mixed by vortexing, pulse centrifuged and
incubated at 37°C overnight in a heat block.
2.15.6.2 Digoxigenin labelled riboprobes
Transcription Reaction
Linearized plasmid template DNA 1.0 pi (1 pg )
NTP labelling mix containing digoxygenin 2.0 pi
Transcription buffer (10X) 2.0 pi
Sterile water 11.0 pi
RNase inhibitor 1.0 pi
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T7 RNA polymerase (20 U/pl) 2.0 pi
This mixture was thoroughly mixed by vortexing, pulse centrifuged and
incubated at 37°C overnight in a heat block.
2.15.6.3 Biotin labelled, riboprobe
Transcription Reaction
This mixture was thoroughly mixed by vortexing, pulse centrifuged and
incubated at 37°C overnight in a heat block.
2.15.7 Purification of35S, Biotin and Digoxygenin labelled riboprobes
After transcription samples were taken out of the heat block and pulse
centrifuged to spin down any condensation which may have occurred. To
terminate the reaction 1 pi of RQ1 DNase (1U) was added and incubated for
15 min/37°C. The reaction mixture was then made up to 100 pi with sterile
water and 1 pi of 1 mg/ml of tRNA was added. An equal volume of
phenol/chloroform was added and centrifuged for 5 min/lOOOOg the upper
aqueous phase which contained the RNA was transferred to another tube and
an equal volume of chloroform added, the solution was then vortexed and
centrifuged for 5 min at 10000 g. The upper phase was again removed and
transferred to a fresh eppendorf and RNA precipitated by addition of 3 M
sodium acetate pH 5.5 (1/10 volume) and 100% ethanol (2.5X volume). The
solution was incubated at -80°C for > 30 minutes, and then centrifugation for
20 min at lOOOOg. The RNA pellet was washed in 90% ethanol, lyophilized
and resuspended in 45 pi of sterile distilled water.
Linearized plasmid DNA
Transcription buffer (10X)
NTP labelling mixture containing biotin8.0 pi
Sterile water
T7 RNA polymerase
6.0 pi
2.0 pi
1.0 pi (1 pg)
2.0 pi
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2.15.8 Alkaline Hydrolysis
If the probe was to be used for in situ hybridization it was hydrolysed into
smaller fragments (200 bp or less). The precipitated RNA probe was
hydrolysed by resuspension in 5 pi of 0.4 M NaHCCL, 0.6 M Na2CC>3 (pH 10.2)
and incubating for 30 min at 50°C. The reaction was neutralised by adding 3
M sodium acetate (pH 4.6). The RNA was ethanol precipitated again as
above, washed, dried and resuspended in the required volume.
Determination of the optimum time for hydrolysis was as follows:-
t = Lo-Lf
K x Lo x Lf
t = time in minutes
Lo = initial fragment length in kb
Lf = final fragment length in kb
K = 0.11 kb/min
35S riboprobes were counted in a scintillation counter in order to determine
the effectiveness of labelling.
2.15.9 In situ Hybridization
The in situ hybridization method used has been described previously
(Fazakerley et al., 1991).
Presentment ofslides
All glassware was thoroughly washed with sterile distilled DEPC treated
water and then autoclaved prior to use, and all solutions used in this
technique were made under RNase free conditions. Sections which were 7
microns thick and embedded in parafin were dewaxed in xylene (15 min/RT)
and hydrated through graded alcohols (1 min in each of 100%, 95%, 70%, 50%,
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and 30%) containing 0.33 M ammonium acetate. The sections were then
sequentially treated twice with sterile H2O (1 min/RT), 0.2 M HC1 (10
min/RT), twice with sterile H2O (1 min/RT), 1% Triton-XlOO (1.5 min/RT),
twice with sterile H2O (1 min/RT), PBS (5 min/RT), 10 qg/ml proteinase K in
20 mM Tris, 2 mM CaCh, pH 7.0 (20 min/37°C). This reaction was stopped by
treating the slides with PBS, 2g/L glycine and EDTA (5 min/RT) slides were
washed in PBS (5 min/RT) and sterile H2O (3 min/RT). These tissue
treatments were to optimise permeabilisation of tissues. After the
permeabilisation treatments sections were treated with 0.1 M triethanolamine-
HC1 pH 8.0 (10 min/RT) and rinsed in PBS. Finally tissues were dehydrated
through graded alcohols as before all containing 0.33 M ammonium acetate
except for the 100% ethanol. The sections were then left to air dry (1 hr/RT).
Prehybridization and Hybridization
After the above tissue treatments the tissues were prehybridized (see
appendix 1) for >1 hr at 65°C. Labelled probes were then added to
hybridization buffer (see appendix 1) boiled for 2 min and subsequently
quenched on ice before being added to the sections, hybridization occurred
for 12-16 hr at 55°C.
Prior to hybridization the 35S labelled probe was diluted to give a
concentration of 2xl05 cpm/ml whereas, biotinylated and digoxigenin
labelled riboprobes were diluted to 1/100. DTT was added to radiolabelled
riboprobes to give a final concentration of 10 mM, this was to protect the
radiolabelled sulphur groups. To prevent dehydration tissue sections were
covered with Nescofilm (Bando Chemical Industries, Japan) and incubated in
a humidity chamber.
Washing ofsections
After hybridization the Nescofilm was removed and sections placed in 4X SSC
(with 50 qM DTT included for the radiolabelled riboprobes). The sections
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were washed once in 0.5 M NaCl/TE. Then any unhybridized riboprobe was
digested with 20 pg/ml RNase A in 0.5 M NaCl/TE (30 min/37°C). Sections
were then washed four times in 0.5 M NaCl/TE (15 min/37°C), twice in 2X
SSC (15 min/37°C) and twice in 0.2X SSC (15 min/55°C). After the stringency
washes the final stages of detection differed depending on whether the
riboprobe was labelled with 35S, biotin or digoxygenin.
2.15.9.1 Detection of35S Riboprobes
After the last stringency wash at 55°C the sections were dehydrated through
graded alcohols with 0.33 M ammonium acetate and left to air dry, 1 hr/RT.
Once dry the sections were then exposed to P-max film (Amersham, UK)
which gave autoradiographic images of areas which contain viral RNA
sequences.
Viral RNA at the cellular level was detected by dipping the slides five times
in succession in a 50% solution of LM1 photographic emulsion (Amersham,
UK) in 0.66 M ammonium acetate at 42°C, the slides were then allowed to dry
and were stored at 4°C in the dark, until development.
At appropriate times post-dipping slides were developed in a 1/5 dilution of
Phenisol developer 2min/RT (Ilford, UK) and the reaction was stopped in a
1/200 dilution of glacial acetic acid (1 min/RT). The sections were fixed in 4%
sodium thiosulphate in distilled water (10 min/RT) and subsequently rinsed
prior to haemotoxylin and eosin counterstaining (RT), and mounting in DPX .
2.15.9.2 Biotinylated Probe Detection
Following the last stringency wash of the in situ hybridization, slides were
washed three times in PBS (5 min/RT) and then incubated with avidin
congugated to FITC. Avidin has a high specificity for biotin. This was
incubated for 1 hr at RT, and then washed three times in PBS, sections were
mounted or secondary immunostaining was carried out after this.
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2.15.9.3 Digoxygenin Probe Detection
After the stringency washes of the in situ hybridization, slides were
dehydrated through the graded alcohols (1 min in 30%, 50%, 75%, 90%,
100%). The sections were then washed in 0.3% LhCLin 100% methanol for 30
min at RT, then hydrated through the graded alcohols. Sections were then
blocked with 2% rabbit serum in PBS for 30 min at RT, primary antibody,
sheep anti-digoxygenin was incubated on each section for > 1 hr, sections
were reblocked and secondary antibody (rabbit anti-sheep, biotinylated) in
2% blocking serum in PBS was incubated for 1 hr at RT. After each step
sections were washed three times with PBS. ABC reagent (Vector
Laboratories, UK) was used according to the manufacturers instructions.
ABC reagent binds to bound biotinylated antibody, this was incubated on
sections for 30 min/RT, signal was visualised by using DAB substrate (Sigma,
UK) and sections were counterstained with haemotoxylin, or sections went on
to be secondary immunostained.
2.16 Statistical Methods Used
Student's t-test was employed to calculate the significance between different
experimental groups when comparing levels of virus titre, cytokine
transcripts and antibody isotypes.
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Table 2.3 Antibodies used for staining mouse tissues (method 1).
Clone or code Specificity Dilution Source
Primary
A53 BeAn viral proteins 1:250 In house
A47 GDVII viral proteins 1:250 In house
Secondary
A82 Rabbit biotinylated 1:500 Vector
Table 2.4 Antibodies used for staining mouse tissues (method 2).
Clone or Isotype Specificity Dilution Source
code
Primary
1837-01 H.IgG IL-la 1 50 Genzyme
BDA 21 G.IgG IL-lp 1 50 R and D systems
54B6 R.IgG IL-2 1 50 Serotype
14-F5 R.IgGl IL-4 1 50 Serotec
MPS-20F3 R.Ig IL-6 1 500 Pharmingen
JE55-2A5 R.IgM IL-10 1 200 Serotech
MP1-22E9 R.IgG GM-CSF 1 100 Pharmingen
MP6-XT3 R.IgGl TNFcc 1 100 Pharmingen
1222-00 H.IgG IFNy 1 100 Genzyme
C122A polyclonal TGFpi 1 100 Pharmingen
C1:A3-1 R.IgG2b F4/80 antigen 1:100 Serotec
KT3 R.IgG2aT cell (CD3) 1:200 Serotec
KT174 R.IgG2aT helper (CD4) 1:50 Serotec
YTS 105.18 R.IgG2aT cytotoxic cells (CD8) 1:50 Serotec
A174 R.? VLA-4 1:100 In house
A183 R.? V-CAM1 1:100 In house
A219 R.? LFA-1 1:250 In house
A53 R.IgM TMEV (BeAn) 1.300 In house
A47 R.IgM TMEV (GDVII) 1:300 In house
Secondary
BA-4001 Rb.Ig Rat Ig (mouse Ig absorbed)[biotin]l:100 Vector Lab.
BA-9100 G.Ig Hamster Ig [biotin] 1:100 Vector Lab
BA-9200 G.Ig Mouse Ig [biotin] 1:100 Vector Lab
BA-1000 G.Ig Rabbit Ig [biotin] 1:200 Vector Lab
RAG/Ig/PO Rb.Ig Goat Ig [peroxidase] 1:50 Nordic Lab
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Table 2.3 Antibodies used for staining mouse tissues (method 1).
Clone or code Specificity Dilution Source
Primary
A53 BeAn viral proteins 1:250 In house
A47 GDVII viral proteins 1:250 In house
Secondary
A82 Rabbit biotinylated 1:500 Vector
Table 2.4 Antibodies used for staining mouse tissues (method 2).
Clone or Isotype Specificity Dilution Source
code
Primary
1837-01 H.IgG IL-la 1:50 Tartour et al., 1994
BDA 21 G.IgG IL-lp 1:50 R and D systems
54B6 R.IgG IL-2 1:50 Wee et al., 1992
14-F5 R.IgGl IL-4 1:50 O'Hara, et al., 1985
MPS-20F3 R.Ig IL-6 1:500 Suda et al., 1990
JE55-2A5 R.IgM IL-10 1:200 Mossman et al., 1990
MP1-22E9 R.IgG GM-CSF 1:100 Nelson et al., 1991
MP6-XT3 R.IgGl TNFa 1:100 Ferran et al., 191
1222-00 H.IgG IFNy 1:100 Cherwinski et al., 1987
G122A polyclonal TGFpi 1:100 Pharmingen
C1:A3-1 R.IgG2b F4/80 antigen 1:100 Lee et al., 1985
KT3 R.IgG2aT cell (CD3) 1:200 Mc Michael et al., 1987
KT174 R.IgG2aT helper (CD4) 1:50 Cobbold et al., 1986
YTS 105.18 R.IgG2aT cytotoxic cells (CD8) 1:50 Cobbold et al., 1986
A174 R.? VLA-4 1:100 In house
A183 R.? V-CAM1 1:100 In house
A219 R.? LFA-1 1:250 In house
A53 R.IgM TMEV (BeAn) 1.300 In house
A47 R.IgM TMEV (GDVII) 1:300 In house
Secondary
BA-4001 Rb.Ig Rat Ig (mouse Ig absorbed)[biotin]l:100 Vector Lab.
BA-9100 G.Ig Hamster Ig [biotin] 1:100 Vector Lab
BA-9200 G.Ig Mouse Ig [biotin] 1:100 Vector Lab
BA-1000 G.Ig Rabbit Ig [biotin] 1:200 Vector Lab
RAG/Ig/PO Rb.Ig Goat Ig [peroxidase] 1:50 Nordic Lab
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Protein concentration/ug per 50ul
Figure 2.1 Bradford protein assay to determine the concentration of purified
virus to be used in a TMEV-specific ELISA. The absorbance of standard
proteins was measured at 595 nm as described in the Materials and methods,
The y-axis depicts the optimum density and the x-axis shows the dilution of
Bradford proteins. The concentration of virus preparation was found by
measuring its absorbance at 595 nm and then determining its concentration
from the curve derived from the absorbances of the standards.
Chapter 3
Cytokine and antibody responses during the acute
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infection.
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3.1 Introduction
Over the last few years with development in RNA technology, profiles of
cytokine transcripts in the CNS during experimental viral infections have
been elucidated for Sindbis, LCMV and HIV viruses (Wesseligh & Griffin,
1994; Watkins et al.,1995;). The ideal immune response towards a virus
would be one which clears the infection with minimal tissue damage. It is
particularly important that viruses are cleared from the CNS with minimal
neuronal damage and dysfunction, since these cells cannot be replaced.
Generally, it is thought that a cytokine response which skews towards the Th2
array of cytokines (which is associated with humoral immunity and decreased
cell-mediated immunity) is the best scenario for neuronal survival, if it is
effective in clearing the invading virus. The Thl spectrum of cytokines is
generally associated with increased cell-mediated immunity and antibody of
the isotype IgG2a. This inflammatory response can be very damaging,
therefore it is often considered that a predominantly Thl cytokine response in
the CNS would be negative and destructive (Mossman et al., 1986;
Abehsiraamar et al., 1992; Heinzel et al., 1995; Romagni, 1996; Sedlik, 1996;
Constant & Bottomley et al., 1997; Umetsu & DeKruyff, 1997).
Cytokine mRNA's elevated during the acute phase of Sindbis virus infection
include IL-1 (3, TNFa, IL-4, IL-6 and IL-10. These are exclusively produced by
cells of the CNS as opposed to infiltrating leukocytes (Wesseligh & Griffin,
1994). mRNA levels for IFNy and IL-2 were also elevated in the CNS during
Sindbis virus infection and these were associated with infiltrating
mononuclear cells. Levels of IL-4 and IL-10 were at higher levels than IL-2
and IFNy, suggesting that a Th2 cytokine profile dominates in the CNS of
mice infected with Sindbis virus (Wesseligh & Griffin, 1994). Cytokine
profiles in the brains of patients with AIDS dementia were examined and it
was found that levels of TNFa were elevated (Wesseligh et al., 1993). There
was no increase in IL-4, IL-6 or IL-10, and no distinctive Thl or Th2 profile
could be determined (Tyor et al., 1990, 1992, 1993). Intracerebral infection of
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adult mice with LCMV usually results in death. This is associated with an
elevation in mRNA levels for TNFa, IL-la, IL-lp, IL-6 and IFNy (Campbell et
al, 1994).
The levels and type of antibody generated during a CNS viral infection may
be important in either prevention or pathology. Antibodies of the IgGl
subclass are associated with a Th2 response which is documented to be anti
inflammatory, in contrast to this antibodies of the IgG2a subclass are linked to
cell mediated immunity and in some cases tissue damage (Peterson et al.,
1992; Karpus et al., 1995). In the case of Theiler's virus there is data indicating
that antibodies generated in resistant C57B1/6 mice are predominantly of the
IgGl subclass, whereas, IgG2a antibodies are dominant in susceptible SJL/J
mice (Peterson et al., 1992). This would suggest a Th2 and a Thl bias in these
mouse strains, respectively.
The objective of this chapter was to determine the CNS cytokine and serum
antibody profiles during the acute phase of Theiler's virus infection, in
Balb/c, CBA and SJL/J mice. The objective of Chapter 4 was to investigate the
same profiles during the chronic, persistent phase of Theiler's virus infection.
3.2 Experimental design
To examine CNS cytokine profiles and serum antibody levels in mice infected
with Theiler's virus four different strains of mice Balb/c, CBA, SJL/J and
SCID (severe combined immunodeficient) mice were inoculated ic with 104
PFU of TMEV (BeAn). Different mouse strains have differences in their
susceptibilities (see Section 1.10) (Lipton and Dal Canto, 1979, Nicholson et al.,
1995). Balb/c mice are resistant to chronic disease whereas, CBA mice are
intermediate in susceptibility to chronic disease (Lipton and Dal Canto., 1979,
Simas & Fazakerley, 1996) and SJL/J mice are susceptible (Lipton and Dal
Canto., 1979). Three to four mice were sampled on days 3, 7,10,14, 21 and 35
post infection. At each time point half a brain and half a spinal cord were
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snap frozen and RNA was prepared from these tissues. The other halves
were frozen in isopentane, and sections were cut on a cryostat. Sections were
then immunostained for cellular infiltrates, adhesion molecules and cytokines.
Sera were also taken from the animals and the specific anti-viral isotypes
generated were determined by ELISA (see materials and methods).
3.2.1 Techniques for which total RNA was purified
RNA prepared from brains and spinal cords was used in a dot blot assay to
determine levels of viral RNA, and to investigate levels of cytokine transcripts
in an RNase protection assay (RPA). RPA is a novel and sensitive method for
detection and quantitation of specific RNA species. The basis of the RPA is
solution hybridisation of a radio-labelled, anti-sense RNA probe to its target
in a complex mixture of total RNA (extracted from the tissues/ samples in
question). Samples then undergo digestion to degrade unhybridised probe,
and are then run on a polyacrylamide gel. The gel is subsequently exposed to
film (Figure 3.1) which is then scanned for accurate quantitation of the bands
of interest. RPA has several advantages over other techniques which include,
1) it is highly specific and very sensitive, 2) it is 100+ fold more sensitive than
Northern blotting, due to the solution based hybridisation as opposed to a
filter based hybridisation, 3) it is more tolerant of partially degraded RNA, 4)
multiple probes can be used in a single assay, therefore multiple species of
RNA can be detected simultaneously, 5) many samples can be investigated in
a single assay, 6) relative quantitation is possible because equimolar amounts
of probes are used in the same reaction at the same time.
3.2.2 Development of a TMEV specific isotyping ELISA
TMEV (BeAn) was purified by caesium chloride banding following several
rigorous purification steps as described in the material and methods. The
optimum concentration of virus used in the ELISA was obtained by serially
diluting the antigen preparation and coating it onto ELISA plates. A dilution
of 1:10 of the antigen preparation gave a high absorbance on a linear section
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of the dilution curve (Figure 3.9) and was therefore chosen as the dilution of
antigen to be used. The actual concentration of antigen used was 5 pg per
well as determined by a Bradford's protein assay, as detailed in the materials
and methods, (Figure 2.1).
Four different manufacturers ELISA plates were tested, however, only one,
immulon 4 gave a good positive, reproducible result with a low background.
This type of plate was used in all assays.
Further ELISAs were undertaken to determine the optimal working
concentration of isotype specific secondary antibodies and the optimal
concentration of test serum to be used in the assays. Pooled sera from CBA
mice at 28 days post infection, was serial diluted to obtain the appropriate
dilution to be used in the assay, 1:100 was the dilution chosen (Figure 3.10).
The optimal concentrations of secondary antibodies were previously
determined in the lab and were as follows anti-IgM 1:500, anti-IgGl 1:500,
anti-IgG2a 1:1000, anti-IgG2b 1:500. As TMEV was grown on BHK-21 cells,
BHK-21 cell lysates were used as a control antigen to determine the
background absorbance. Sera from animals inoculated with SFV were used as
a negative controls.
The ELISA experiments were not carried out as accurately as they might have
been therefore the value of these experiments is questionable. In these ELISA
experiments for convenience a standard 1/100 dilution of serum was used for
all samples. However, if ELISA experiments were to be carried out more
thorough, the total immunoglobulin level in individual samples should be
determined by a separate ELISA. Therefore when reading the ELISA data this
point should be remembered.
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3.3 Results
A large amount of data is presented in this chapter. In an attempt to clarify
this, the major findings are restated at the end of each section and are marked
• and printed in italics.
3.3.1 Levels of viral RNA in brains and spinal cords
Previous studies in a number of mouse strains have indicated that peak levels
of viral RNA are generally present in the brain at 7 days post infection with
no significant differences between resistant and susceptible strains (Simas and
Fazakerley, 1996). Fig 3.2 shows the levels of viral RNA in the brains of
Balb/c, CBA, SJL/J and SCID mice. Virus was detectable in all strains at the
earliest sampling point day 7 or day 10. No or minimal virus was detectable
after this time in 9/9 brains from Balb/c mice sampled at days 14, 21 and 35.
Similarly, only 1/8 SJL/J mice had detectable brain virus after day 10. In
contrast, individual CBA mice were highly variable at days 10, 14 and 21
although all 3 animals sampled at day 35 had no detectable virus. In SCID
mice brain virus titres increased from day 7 to 21. At this time point SCID
mice started to appear moribund and die. Lack of an effective B or T cell
response in SCID mice therefore results in unrestricted viral replication and
death.
Previous studies have indicated that virus persists in the spinal cords of SJL/J
mice and not in brains. This was confirmed by N-PCR. 6 out of 6 SJL/J mice
had detectable levels of persisting virus in their spinal cords on days 21 and
35 post infection.
• Balb/c and SJL/j mice clear viral RNA from brain by day 14.
• Individual CBA mice vary in their ability to clear brain virus.
• Virus persists in the spinal cords of SJL/J mice.
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3.3.2 Cytokine Levels in the brains of Balb/c mice
In the brains of Balb/c mice between days 3-10 mRNAs were detected for a
number of cytokines including IL-la, IL-ip, IL-2, IL-4, IL-5, IL-6, IL-7, IL-10,
IL-12p35, IL-12p40, IL-13, IFNy, TNFa, TNFp and TGFp (Figure 3.3 A-O).
There were clear differences in the levels and the time points at which peak
expression of different cytokines occurred. Levels of the inducible IL-2 and
IL-12p40 were high by the earliest sampling time point, day 3 post infection.
These were the only cytokines that were almost maximal as early as day 3
(Figure 3.3 C, J). Other cytokines which were elevated as early as day 3
included IL-la, IL-ip, IL-6, IL-13, IFNy, TNFa, and TNFp (Figure A, B, F, K-
N). Cytokines which peaked by day 7 post infection included IL-6, IL-10, IL-
12p40, IL-13 and IFNy. After this time these cytokines decreased and
returned to basal levels by day 14 (Figure 3.3 F, LI, K, L). At day 10 post
infection levels of IL-la, IL-ip, IL-4, IL-5, TNFa, TNFp and TGFp were
maximal (Figure 3.3 A, B, D, E, M-O). The largest amounts of mRNA were for
the pro-inflammatory cytokines, including IL-la, IL-ip, TNFa, and TNFp
(Figure 3.3 A, B, M, N, Table3.1) and the lowest levels of transcripts were for
the Th2 cytokines IL-4, IL-5 and IL-10 (Table3.1). TNFa levels returned to
basal by day 21 post infection, however TNFp, IL-la and IL-lp did not return
to basal levels until day 35 or thereafter (Figure 3.3 A, B, M, N). IL-10 peaked
at day 7, and IL-4 and IL-5 at day 10, however they all returned to basal levels
by day 14 (Figure 3.3 D, E, H). There was no or relatively little consistent
change from the controls in the levels of message for IL-7 although levels of
this were clearly maximal at days 7 and 10 (Figure 3.3 G). Although elevated
from day 3 the levels of IL-12p35 were highly variable. The differences in
cytokine profiles and their levels in different strains are discussed in Section
3.3.6. and the differences between individual mice are discussed in Section
3.3.11.
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3.3.3 Cytokine levels in the brains of CBA mice
Like Balb/c mice IL-2 and IL-12p40 were the first cytokines to peak being
maximal by 3 days post infection (Figure 3.3 C, J). Other cytokines clearly
elevated at day 3 included IL-la, IL-ip, IL-6, IL-13, TNFa and TNFp. At day 7
IL-la, IL-ip, IL-4, IL-5, IL-6, IL-10, IL-13, IFNy and TNFa all peaked (Figure
3.3 B, D-F, FI, K-M). Thereafter levels of cytokines varied between individual
mice. In some animals levels declined whereas in others high levels were
present on days 14 and 21. However, all 3 mice sampled on day 35 had basal
levels of most transcripts. TNFp peaked at day 10. As in the Balb/c mice the
highest transcript levels were observed for the pro-inflammatory cytokines
TNFa, IL-la and IL-ip. Levels of IL-12p35showed little or no consistent
change throughout the course of infection (Figure 3.3 I). For the
constitutively expressed transcripts there were increased levels of IL-7 and
TGFp, however these varied little above basal. The differences and
comparisons in cytokine profiles between different strains are discussed in
Section 3.3.6. Differences between individual CBA mice are discussed in
Section 3.3.11.
3.3.4 Cytokine levels in the brains of SJL/J mice
As with Balb/c and CBA mice, IL-12p40 levels were maximal by 3 days post
infection (Figure 3.3 J). As with Balb/c and CBA mice although IL-2 levels
were maximal by day 3 these levels were dramatically reduced and were only
a little above background (Figure 3.3 C). The only other transcripts clearly
elevated at day 3 in SJL/J mice were IL-6, IL-7, IL-13 and IFNy (Figure 3.3 F,
G, K, L). Levels of mRNA for IL-10 peaked at day 7 and returned to basal
levels by day 14 (Figure 3.3 H). IL-la, IL-4, IL-5, IL-6, IL-7, IFNy, TNFa, and
TNFp were all maximal at day 10 post infection and returned to basal levels
by day 21 post infection (Figure A, D-G L-N). An early day 7 peak in TGFp
was observed which was not present in CBA and Balb/c mice. As with IL-2 a
major difference was observed in the levels of IL-ip, which were markedly
reduced in this strain compared to Balb/c and CBA (Figure 3.3 B). Levels of
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IL-12p35 were maximal at day 14, and showed much less variability than
levels in Balb/c and CBA mice. The differences and comparisons in mRNA
expression for the cytokines between different mouse strains are discussed in
Section 3.3.6., and the differences and similarities between individual SJL/J
mice are discussed in Section 3.3.11.
3.3.5 Consistencies between strains
• Levels oflL-12p40 and IL-2 were maximal or near maximal by day 3.
• High leiiels ofTGFfi were constitutively present, as were lower levels of IL-7 and
IL-12p35.
• The highest levels of inducible transcripts were for IL-l a, TNTa, TNFfi.
• Maximum levels of transcripts were generally present at or between days 7 and 10.
3.3.5.1 In brains of Balb/c mice.
• The first cytokines detecTable(at day 3) were IL-l a, IL-lfi, IL-2, IL-6, IL-I2p40,
IL-13 and IFNy
• Maximum levels of Till (IFNy) transcripts xvere more than 2 fold higher than
maximal levels ofTh2 (IL-4, IL-10) transcripts.
3.3.5.2 In brains of CBA mice
• The first transcripts detecTable( at day 3) xvere IL-la, IL-lfi, IL-2, IL-6, 1L-I2p40,
IL-13, TNFaand TNFJ3.
• Between days 10 and 35, levels of cytokines showed large variations betxveen
individual mice.
• Maximal levels of Thl (IFNy, IL-12p40) and Th2 (IL-4 and IL-10) transcripts
xvere equivalent.
3.3.5.3 In the brains of SJL/J mice
• The first transcripts detectable( at day 3) xvere IL-2, IL-6, IL-7, IL-12p40, IL-13,
IFNyand TGFfi.
• T ranscripts for IL-2 and IL-lfixvere not present.
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• Maximal levels oflFNy(Thl) were less than IL-4 (Th2).
3.3.6 Comparison of levels of viral and cytokine RNA in the brains of
individual Balb/ c, CBA and SJL/J mice
It is important to emphasise that individual animals are represented by the
same symbol at each time point i.e. the red circle on day 10 represents the
same animal in all the Figures for both virus and cytokines (Figures 3.2, 3.3,
3.4). Comparisons in the level of virus in the brain (Figure 3.2) with the levels
of proinflammatory cytokines (Figure 3.3) indicates a positive correlation. For
example:-
1) The green and blue CBA mice at day 10 (Figure 3.2B) both have high and
very low levels of virus. Relative to the blue mouse the green mouse (high
virus) had higher levels of IL-la, IL-lp, IL-4, IL-5, IL-6, IFNy, TNFa, TNFp,
and lower levels of IL-7, IL-10, IL-12p40 and IL-13.
2) The green and blue CBA mice sampled at day 14 have moderate and very
low levels of virus, respectively. Relative to the blue mouse the green
mouse ( high virus) had higher levels of IL-la, IL-4, IL-5, IL-6, IL-7, IL-10,
IL-12p35, TNFa, TNFp and lower levels of IL-12p40 and IL-13.
3) The green and red CBA mice sampled on day 21 have respectively very
high and low levels of virus. Relative to the red mouse the green mouse
(high virus) had higher levels of IL-la, IL-4, TNFa, TNFp and lower levels
of IFNy and IL-13.
4) In SJL/J mice on day 14 (Figure 3.2 C) the blue mouse had detectable levels
of virus whereas the green and red mice had none. Relative to the green
and red mice the blue mouse (with virus) had higher levels of IL-la, IL-4,
IL-5, IL-6, TNFa, TNFp and lower levels of IL-13.
Generally in all of these cases and consistently in at least % cases there is a
positive correlation between presence of virus and high levels of IL-la, IL-4,
IL-5, IL-6, TNFa and TNFp and a negative correlation with IL-13.
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To investigate this further levels of IL-la, IL-6 and TNFa were compared with
the levels of virus between days 10 to 21 post infection (Figure 3.7). Clearly,
the amount of these cytokines is proportional to the amount of virus.
• For nil 3 mouse strains at early time points, and in CBA mice with persistence
there urns a clear positive correlation between the level of brain virus and the levels
of transcripts for IL-la, IL-4, IL-5, IL-6, TNFa and TNFJ3, and a negative
correlation between virus and levels of transcripts for 1L-13.
• In general in Balb/c and SJL/J mice levels of cytokines (particularly IL-la, IL-4,
IL-5, IL-7, IL-10, and TNFa) rapidly declined following clearance ofbrain virus.
3.3.7 Comparisons of cytokine levels in the brains of Balb/ c, CBA
and SJL/J mice.
Figure 3.5 provides a comparison of the average level of individual cytokine
transcripts during the acute phase of disease in the different mouse strains.
There were both similarities and differences between strains. Statistical
analysis was performed on the individual samples using the Student t-test,
with a p value of 0.05 being taken as significant. Baseline levels were taken
into consideration when statistical analysis was carried out.
3.3.7.1 Pro-inflammatory cytokines
IL-la. Levels of IL-la were consistently higher in CBA than SJL/J mice at
days 3 , 7 and 10 post infection (p=0.001, p=0.02, p=0.02, respectively) (Figure
3.3 A), and levels in Balb/c mice were higher than SJL/J mice at day 3
(p=0.03).
IL-ip. One of the most dramatic differences between mouse strains was in
the levels of IL-lp. No transcript expression above background for this
cytokine was detected in SJL/J mice, consequently levels of this message were
significantly lower in SJL/J mice than Balb/c and CBA mice at days 3, 7, 10,
106
CHAPTER 3 CYTOKINES, ANTIBODIES AND THE ACUTE PHASE
14 and 21 post infection (see Figure 3.3 B). ( SJL/J:Balb/c p=0.01/ p=0.002,
p=0.007/ p=0.01, p= 0.005 and SJL/J:CBA mice p=0.03, p=0.005, p=0.03,
p=0.002, p=0.005). Maximum levels were higher (60, 40) and earlier (d7, dlO)
in CBA than in Balb/c mice.
IL-6. Levels of IL-6 followed a similar pattern of expression in all strains,
however there were subtle differences, with SJL/J mice having increased
levels at post infection day 10 compared to Balb/c mice (p=0.02), and CBA
mice having increased levels on day 21 compared to both Balb/c (p=0.001)
and SJL/J (p=0.02) mice. The high levels of IL-6 in 2/3 CBA mice at day 21 is
consistent with the continued presence of virus in the brains of these mice at
this time.
IL-12p40. There were early consistencies between the Balb/c (resistant), CBA
(intermediate) and SJL/J ( susceptible) mice. Levels of IL-12p40 were the first
to peak in the brains of all strains of mice (Figure 3.3 J). This was apparent by
day 3 post infection, the earliest sampling point. At this time levels were high
or maximal in all three strains. The maximum levels of mRNA expression for
this cytokine were similar in all three strains. In Balb/c and SJL/J mice levels
returned to basal by day 21. In contrast, levels remained elevated at day 21 in
CBA mice all of which continued to have virus detectable in their brains (
Figure 3.2B).
TNFa. Levels of TNFa followed similar kinetics in all 3 mouse strains.
However, SJL/J mice had significantly decreased levels on day 3 compared to
Balb/c (p=0.04) and CBA (p=0.06) mice.
TNFp. Levels of TNFp were similar in all strains until day 35 post infection at
which time Balb/c mice had elevated levels compared to CBA (p=0.03) and
SJL/J (p=0.004) mice. This is interesting because in Balb/c mice (the resistant
strain) at day 35 virus is undetectable. Continuing inflammation in Balb/c
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mice with no detectable viral RNA has been observed (M. Brahic personal
communication), this may explain the high levels of TNFp.
3.3.7.2 Thl cytokines (IFNy, IL-2 and IL-12p40)
Levels of the classically defining Thl cytokines IFNy and IL-2 showed clear
differences between strains.
IL-2. There were dramatic differences in the levels of IL-2. SJL/J mice made
few transcripts for this cytokine, consequently, CBA and Balb/c mice had
significantly higher levels of IL-2 than SJL/J mice at all time points. This is a
similar pattern to that observed in the SJL/J mice for IL-ip.
IFNy. There were differences in the levels of IFNy. Maximum levels of IFNy
were present at day 7 in the Balb/c and CBA mice and declined rapidly
whereas levels were maximal at days 10 and 14 in SJL/J mice and did not
return to basal by day 35. CBA mice had significantly elevated levels on day
7 compared to SJL/J mice (p=0.01). However the situation was reversed by
day 35 by which time SJL/J mice had the highest levels of this cytokine.
3.3.7.3 Th2 cytokines (IL-4, IL-5, IL-10)
There were differences in levels of Th2 cytokines (IL-4, IL-5 and IL-10) in the
brains of the different mouse strains studied.
IL-4. Relative to both CBA and SJL/J mice, Balb/c mice had lower levels of
IL-4 transcripts (Balb/c:CBA day 7 p=0.05; Balb/c: SJL/J day 10 p=0.004).
IL-10. This phenomenon was also observed for levels of IL-10, with Balb/c
mice having significantly lower levels of IL-10 on day 7 when compared to
CBA and SJL/J mice (p=0.03, p=0.002, respectively).
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3.3.7.4 Anti-inflammatory cytokines
Although there were high constitutive levels of TGF(3 in all three mouse
strains, these were elevated in most mice during infection. SJL/J mice
showed an early peak at day 7, when titres were lower or not elevated above
background in Balb/c and CBA mice.
• In addition to the absence of IL-I/3 and IL-2, relative to Balb/c and CBA mice,
SJL/J mice made a slow TNFa and IL-la response, and had lower titres oflL-1 a.
• SJL/J mice had a delayed but prolonged IFNyrespoiise.
• Balb/c mice had a low Th2 (1L-4 and IL-10) response relative to CBA and SJL/J
mice, whereas, Balb/c mice had higher levels of IFNy than IL-4, this was reversed
in SJL/J mice.
• SJL/J mice had an earlier peak ofTGFj3 expression (at day 7) than Balb/c and CBA
mice.
3.3.8 Cytokine levels in the spinal cords of Balb/c mice.
As with the brains, mRNA's for several cytokines were detected in the spinal
cords of animals infected with TMEV. In Balb/c mice on day 3 levels of IL-2,
IFNy, TNFa and TNFp were above basal levels. In the spinal cords of Balb/c
mice the majority of cytokines detected peaked on day 7 post infection, these
included IL-la, IL-4, IL-13, IFNy, TNFa and TNFp (Figure 3.4 A, D, F, J- L).
Levels of IL-6 peaked on day 10 post infection (Figure 3.4 E). The majority of
cytokines returned to basal levels between days 14-21 post infection.
Interestingly, in this mouse strain IL-10 remained at control levels throughout
the course of infection (Figure 3.4 F). Unlike brain, no transcripts for IL-5 and
IL-7 were detected. Some animals had high and even maximal levels of IL-ip,
IL-2 and IFNy at late time points (Figure 3.4 B, C, J).
During the first two weeks of infection relative to brains generally, with the
exception of IL-4 levels of transcripts for all the cytokines were lower in the
spinal cord than in the brain. This was pronounced (2 fold difference) for IL-
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la, IL-10 and IL-13, and was particularly striking for IL-1 (3, where average
maximum levels in the brain at day 10 were 40 and in the spinal cords were 5
(Figures 3.3 B, 3.4 B); and for IL-6 where average maximum levels in the
brains at day 7 were 34 and in the spinal cords 9 (Figures 3.3 F, 3.4 E).
Constitutively levels of IL-12p35 were lower in the spinal cords (18) than in
the brains (75) (Figures 3.3 I, 3.4 G).
3.3.9 Cytokine levels in the spinal cords of CBA mice.
Most cytokines did not peak until day 14 post infection, these included IL-la,
IL-1 (3, IL-4, IL-10, IL-12p40, TNFa, and TNF(3 (Figure 3.4 A, B, D, F, H, K)). At
day 7 post infection IFNy peaked (Figure 3.4 J). Levels of TGFp were elevated
from day 7 (Ligure 3.4 M). Unlike brain, no transcripts for IL-5 and IL-7 were
detected. At day 35 post infection levels of TNFp, TNFa, IL-2, IL-la IL-lp
and IL-6 were high and in many of these maximal. These cytokines are pro¬
inflammatory cytokines and it is likely virus is persisting in the spinal cords
and continues to drive the inflammatory response. Interestingly, no virus
was detected in the brains of the 3 CBA mice sampled at day 35 and the levels
of these cytokines were not above background in the brains at this time.
The first cytokines elevated (day 3) were IL-la, IL-2, IL-ip, IL-12p35, IL-
12p40, IL-13, ILNy, TNFa and TNFp. The expression of various cytokines
differed between brains and spinal cords. In brains the induction of most
cytokines was more rapid peaking at around day 7, this contrasted with
spinal cords where peak expression of most cytokines was around day 14. In
general, maximum levels were also slightly lower in the spinal cords and
there was also more variability in the data. As with Balb/c mice levels of
spinal cord transcripts were generally lower again with levels of IL-1 p and IL-
6 being the most significant. The basal levels of IL-12p35 were lower in the
spinal cords than the brain and there were consistent increases in the spinal
cord but not the brain following infection (Ligures 3.3 I, 3.4 G). Levels of IL-
ip, IL-la and IL-6 did not show early peaks as in the brains but showed a
110
CHAPTER 3 CYTOKINES, ANTIBODIES AND THE ACUTE PHASE
slow steady increase (Figure 3.3 A, B, E). This would be consistent with the
later arrival of virus in this location (ic inoculation) and a slow build up of
viral titres.
3.3.10 Cytokine levels in the spinal cords of SJL/J mice.
Like Balb/c mice most cytokines peaked on day 7 in the spinal cords of SJL/J
mice, these included IL-6, IL-10, IL-12p40, IL-13, IFNy, TNFa and TGFp
(Figure 3.4 A, E, F, H-K, M). IL-4 peaked at day 10. At day 3 transcripts were
detected for several cytokines including IL-la, IL-4, IL-6, IFNy, TNLa, TNFp
and TGFp. There was minimal or no production of transcripts for IL-lp, IL-2,
IL-5, IL-7 and IL-12p35 (Figure 3.4 B, C, G). In the case of the latter there was
no detectable constitutive level of this transcript. This was different to the
brains of the SJL/J mice which had high constitutive levels of IL-12p35,
which were as high as those in the brains of Balb/c and CBA mice. Balb/c
and CBA mice had lower spinal cord levels of IL-12p35. Several cytokines
remained elevated in SJL/J mice at day 35 post infection these included IL-la,
IL-6, IL-13, IFNy, TNFa and TNFp (Figure 3.4 A, E, I-L). Elevation of these
cytokines was consistent with viral persistence (Section 3.3.1).
There were numerous similarities in cytokine expression between brains and
spinal cords in SJL/J mice, however, there were also differences. As in brains
levels of IL-2 and IL-ip were basal. There was little constitutive or inducible
expression of IL-12p35 in the spinal cords, whereas levels were high in the
brains of SJL/J mice. Levels of IL-10 were greater in spinal cords compared to
brain. Maximum levels of IL-la, IL-4, IL-6, IL-12p40, IFNy, TNFa and TNFp
were approximately equivalent in brains and spinal cords. Interestingly, the
time course of the response for most cytokines in the spinal cords of SJL/J
mice is biphasic, with a reduction in titres at day 10.
3.3.11 Spinal cord: consistencies between strains
• As in the brain high levels of TGFp were constitutively expressed.
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• As in the brain the highest levels of transcripts were for TNFa, TNF/3and IL-la.
• As in the brain maximum levels of transcripts were generally found between days
7 and 14.
• In contrast to the brain no transcripts were detectable for IL-5 and IL-7.
3.3.11.1 Balb/c spinal cords
• The first cytokines detectable at day 3 were IL-2, IFNy, TNFa and TNF/3.
• Most cytokine transcripts peaked early at day 7
• Induced maximum levels for IL-1/3, IL-6 and possibly IL-la, IL-10 and IL-13 were
lower in the spinal cord than in the brain.
• Constitutive levels ofIL-12p35 were lower in the spinal cords than the brains.
3.3.11.2 CBA spinal cords
• The first cytokines detectable at day 3 were IL-la, IL-1/3, IL-2, IL-12p40, IL-13,
IFNy, TNFa and TNF/3.
• Most cytokines peaked late at day 14.
• Generally, transcription was lower in the spmal cords than in brains.
• At day 35 post infection levels of IL-la, IL-1/3, IL-2, IL-6, TNFa and TNF/3 were
high and in some cases maximal. This contrasted with the transcript levels in the
brains for these cytokines which were all basal at this time point.
3.3.11.3 SJL/J spinal cords
• The first cytokines detectable at day 3 were IL-la, IL-4, IL-6, IFNy, TNFa TNF/3
and TGF/3.
• Most cytokines peaked at day 7.
• IL-1 a, IL-6, IL-13, IFNy, TNFa and TNF/3 remained elevated in SJL/J spinal cords
on day 35.
• There was minimal or no transcription levels for IL-1 f3, IL-2 and IL-12p35.
• Early levels of IL-10 were greatly increased in the spinal cords compared to the
brains.
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3.3.12 Comparison of cytokine levels in the spinal cords of different
mouse strains
There was a difference in the kinetics of cytokines expressed between the
different mouse strains. In Balb/c and SJL/J mice most cytokines peaked
early (day 7) this contrasted with CBA mice, where most cytokines did not
peak until day 14. Whereas, comparison of spinal cord virus clearance in
Balb/ c and CBA mice correlates with the more rapid cytokine response in the
former this does not seem to be case and effect since in SJL/J mice an equally
rapid cytokine response does not result in viral clearance. Figure 3.6 shows
the averages of the cytokine profiles during the acute phase of disease in the
spinal cords of the different mouse strains. There are various differences
between the cytokine levels in the spinal cords of SJL/J, CBA and Balb/c mice
throughout the acute phase of Theiler's virus infection. Generally the levels of
the pro-inflammatory cytokines TNFp, IL-ip and IL-12p40 were all much
higher in the spinal cords of CBA mice than in SJL/J and Balb/c mice. These
same CBA mice had viral persistence in the brain and previous studies from
this laboratory (Simas and Fazakerley, 1996) have shown that many CBA mice
also have viral persistence in the spinal cords at these time points. It is likely
therefore that as in the brains these high levels of proinflammatory cytokines
reflect viral load.
3.3.12.1 Pro-inflammatory cytokines
The kinetics of IL-la, IL-6, TNFa and TNFp is similar during the first 10 days
post infection. On days 7 and 10 titres rise in all 3 mouse strains, after this
time titres are slightly above basal in Balb/c mice, whereas they remain
elevated in CBA and SJL/J mice. For example on day 10 levels of TNFa are
significantly increased in CBA mice compared to Balb/c mice on days 14, 21
and 35 (p=0.009, p=0.01, p=0.08, respectively); and on day 21 and 35 SJL/J
mice have increased levels compared to Balb/c mice (p=0.01, p=0.04,
respectively). This would be consistent with viral persistence in the spinal
cords of CBA and SJL/J mice but not Balb/c mice, and reiterates the
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correlation observed between viral load and levels of these cytokines in the
brain (see Section 3.3.6).
IL-ip. As in the brains, the levels of IL-ip in the spinal cords of SJL/J mice
were dramatically lower than in the other strains at all time points post
infection (Figure 3.4 B).
3.3.12.2 Anti-inflammatory cytokine
TGFp. As in the brain, transcripts for TGFp were constitutively high in all 3
strains. In all 3 strains at day 7 post infection there was an increase in
expression of TGFp transcripts. Thereafter, there was a large variation in
levels of transcripts in Balb/c and SJL/J mice whereas all CBA mice
maintained an elevated level (Figure 3.4 M).
3.3.12.3 Thl cytokines (IFNy, IL-2 and IL-12p40)
IL-2. The pattern of expression of IL-2 in the spinal cords was similar to that
seen in the brains. Balb/c and CBA mice had comparable levels at all time
points however as in the brains the levels of IL-2 were markedly decreased in
the spinal cords of SJL/J mice at all time points compared to Balb/c and CBA
mice ( Figure 3.4 C).
IL-12p40. IL-12p40 levels were generally similar in all mouse strains at all
time points ( however, levels were elevated on days 10 and 14 in CBA mice
compared to Balb/c and SJL/J mice).
IL-12p35. As with levels of pro-inflammatory cytokines there was an increase
of IL-12p40 in all stains but this returned to basal levels in Balb/ c mice on day
14 but remained elevated in CBA and SJL/J mice after this time point.
Transcripts for this cytokine were detected in control spinal cords of Balb/c,
and CBA mice but not in the spinal cord of SJL/J mice, and were not inducible
after infection (Figure 3.3 I, 3.4 G). This may be relevant to the well
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documented differential clearance of virus from the brains but not the spinal
cords in this mouse strain.
IFNy. Levels of IFNy were similar in the spinal cords of all strains at all time
points (Figure 3.4 I).
3.3.12.4 Th2 cytokines
IL-4. As in the brains there appears to be a stronger IL-4 response in CBA and
SJL/J mice than in Balb/c mice. For example SJL/J mice had increased levels
on day 10 compared to Balb/c mice (p=0.01), and CBA mice have elevated
levels of IL-4 when compared to Balb/c mice on day 14 post infection
(p=0.05).
IL-10. IL-10 remained at basal levels in Balb/c mice. Levels of IL-10 in the
spinal cord were elevated in SJL/J mice on day 7 compared to Balb/c (p=0.03)
and CBA (p=0.004) mice.
• There was a difference between mouse strains in the kinetics of the cytokine
response in the spinal cord. Balb/c and SJL/] mice made a more rapid response
than CBA mice.
• After day 10 levels of pro-inflammatory cytokines IL-la, IL-6, TNTa and TNFJ3
were low in Balb/c mice but remained high in CBA and SJL/J mice. This reflects
the persistence of virus consistently restated in the literature in CBA and SJL/J
mice.
• As in the brain, SJL/J mice made a more pronounced IL-4 and IL-10 response in
the spinal cord.
• As in the brain, levels ofIL-2 and IL-lpwere basal in SJL/J mice spinal cords.
• In the spinal cords of SJL/J mice but not Balb/c and CBA mice levels of IL-12p35
were basal.
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3.3.13 Comparison of different cytokine levels in the same individual
The power of the RPA is in its ability to generate quantitative and qualitative
measures of a large number of different cytokine transcripts in a single
sample. This contrasts with RT-PCR which is difficult to quantitate and
measures only one transcript with each assay. In general, the majority of
individual mice expressed both pro-inflammatory and anti-inflammatory
cytokines. Similar patterns in individual mice were observed in brains and
spinal cords with the majority of individuals from all strains producing
mainly pro-inflammatory cytokines early on during infection, however
differences between individuals of the same strain existed on and after day 7.
Analysis of individual CBA mice suggests that in some CBA mice there is a
clear polarisation of the CNS immune response towards either Thl or Th2
cytokines. For example, on day 7 post infection in the brain of the CBA
mouse depicted by the blue square there are high levels of IFNy but low levels
of IL-4. In contrast the mouse depicted by the green square at this time point
shows low levels of IFNy and higher levels of IL-4. A similar phenomenon is
seen on day 10 post infection in the brains of the CBA mice. The CBA mouse
represented by the green square has high levels of IFNy ( which correlates
with high levels of virus see Figure 3.2), and low levels of IL-10 and IL-13
(Figure 3.3 H, K, L) whereas, the mouse represented by the red square has
high levels of IL-4, IL-5 and IL-10 but low levels of IFNy and IL-12p35 (Figure
3.3 D, E, H, I, L). In the spinal cords of CBA mice on day 10, the mouse
depicted by the blue square had high levels of IL-4, IL-10 and IL-13 and low
levels of IFNy (Figure 3.4 D, F, Fl, I, J). However, in the mouse represented by
the green square there were high levels of IFNy but low levels of IL-4, IL-10
and IL-13 (Figure 3.4 D, I, J).
Clearly individual CBA mice appear to polarise their type 1 or type 2
response as early as day 7 to 10 post infection, in both brains and spinal cords.
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• CBA mice polarise their type 1 or type 2 responses as early as days 7 to 10 post
infection.
3.3.14 Cytokine Levels in SCID mice
SCID mice have a dysfunctional recombinase enzyme and consequentially no
specific B or T cell immune responses. In SCID mice cytokine levels in the
brains and spinal cords were very low from day 3- 14 post infection (fig 3.8).
This indicates that the higher cytokine levels observed in immunocompetent
mice between days 3-14 requires activation of specific immune responses.
However, moribund animals had high levels of TNFa, IL-la, IL-6, IL-2 and
IL-12p40 indicating that these cytokines can be produced by CNS cells in the
absence of specific immune responses. Although transcript levels were higher
in Balb/c, CBA and SJL/J mice than in SCID mice, it is not clear whether
infiltrating cells produce these pro-inflammatory cytokines themselves or
cause intrinsic CNS cells to increase production, or whether there is a
combination of both.
• TNFa, IL-la, IL-6, IL-2 and IL-I2p40 are produced in the infected CNS in the
absence ofspecific immune responses indicating production by resident CNS cells
3.3.15 Antibody isotypes during the acute phase of TMEV.
In addition to cytokine profiles, antibody profiles were determined by ELISA
(as described in the materials and methods) during the acute phase of the
infection, in the different strains. A standard 1:100 dilution of sample sera
was used in ELISA experiments. Therefore these data are not as accurate as
they could be (as discussed previously Section 3.2.2). Therefore caution must
be noted when reading the results for the ELISA's
Levels of antibodies have been shown to be important during picornaviral
infections, and this is the case for TMEV. In particular, it has been shown
that neutralising antibody is important in controlling virus spread in the CNS
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(Borrow et al., 1993). It has been suggested that antibody isotype correlates to
the type of CD4 + T helper cell response (Peterson et al., 1991., Pope et al.,
1996). Therefore, it was of interest to determine whether there was a
difference in the isotype of the serum antibody response in the different
strains of mice in this study.
Antibody isotypes in the serum of Balb/c, CBA, SJL/J and SCID mice were
determined by ELISA. Statistical analysis using Students t-test was
performed on the data.
IgM, IgGl, IgG2a and IgG2b were all generated in mice inoculated with
Theiler's virus, however, there were differences in the kinetics of response
between different strains and in the levels of different subclasses produced
between the strains (Figure 3.11).
There were no consistent differences in the levels of IgM antibody synthesised
by SJL/J, Balb/c and CBA mice up to and including day 35 post infection
(Figure 3.11). All strains of mice produced IgM antibody with the same
kinetics. IgM was first detected at day 7 and levels increased to day 35, at
which time this particular experiment stopped. (Data showing IgM levels at
late time points post infection during the chronic phase of infection are
presented in Section 4.3.3). IgM production is relatively slow compared to
other viruses. For example, mice infected with alphaviruses produce IgM
from day 4 to day 21 with levels peaking around day 7 (Fazakerley et al.,
1993).
Balb/c mice produced significantly higher levels of IgGl, between days 14-35,
compared to SJL/J (p=0.00003) and CBA (p=0.0009) mice (Figure 3.11). IgGl is
associated with the Th2 subset of CD4+ T cells. However, Balb/c mice also
had increased levels of IgG2a compared to susceptible SJL/J (p=0.008) and
CBA (p=0.07) mice (Figure 3.11). IgG2a is associated with the Thl subset of
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CD4+ T cells. It is interesting to note that on day 10 post infection Balb/c
mice make a strong IgGl but weak IgG2a and IgG2b response. This is
consistent with an early Th2 response as previously described in resistant
C57B1/6 mice (Peterson et ah, 1992).
Levels of IgG2b remained similar at all time points during the acute phase for
SJL/J and CBA mice, however, there was a statistically significant increase in
the levels of IgG2b produced in Balb/ c compared to CBA mice between days
14-35 (p=0.01). As expected, at no time post infection could IgGl, IgG2a or
IgG2b be detected in SCID mice.
In summary, Balb/c mice make a higher titre antibody response that CBA and
SJL/J mice. Although not a highly detailed study, with the exception of the
day 10 time point in Balb/c mice there is little indication of a polarisation of
the IgG responses in the different mouse strains as found in a previous study
(Peterson et al,.1992). In addition there were no differences between strains in
the levels of IgM as was documented previously (Pena Rossi et al., 1991).
• Serum IgM responses were similar and slow in all 3 mouse strains.
• Balb/c mice make a higher titre anti-TMEV-lgG (IgGl and lgG2a) response than
CBA and SJL/J mice.
• Balb/c mice make a stronger IgGl than lgG2a response at early time points.
• Virus is cleared between days 10 and 14 in Balb/c mice it is likely that a larger
antibody response is partially responsible.
3.3.16 Immunostaining in CBA mice.
A study to investigate the expression of cytokine proteins was undertaken.
The main objective was to compare and contrast protein expression with the
amount of message generated (data generated by RPA). However, this
proved to be more difficult than originally thought. This was because only a
small area of a small number of samples could be examined by
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immunostaining. Cytokines have very short half-lives therefore the amount
of active cytokine in the CNS may be small, and difficult to detect.
3.3.16.1 Cytokines in the CNS
As a positive control, tissues from mice with chronic relapsing and remitting
EAE (experimental autoimmune encephalitis) were stained. These tissues
were found to be consistently positive for all the cytokines looked at (Table2.4
and 3.2). IL-2 immunostaining was detected in the brains of mice on post
infection day 3 but levels were not different from those seen in the negative
control inoculated ic with PBS. TGFp was expressed in all brains but levels
were no different from the negative controls. TNFa was produced in brains
between days 3-10 and was present in spinal cords as late as day 21. Brain
and spinal cord levels were consistently higher than in the control animals.
Figure 3.13 demonstrates a TNFa positive mononuclear cell infiltrating the
CNS from a blood vessel on post infection day 7. In conclusion, the amount
of staining achieved for cytokines was limited (see Table3.2). From the low
staining achieved for TNFa, which had the highest levels of message, the
immunostaining technique can be judged to be far less sensitive than the RPA
analysis and it is therefore not surprising that expression of other cytokines
with far lower message levels were not detected.
3.3.16.2 Cellular infiltrates in the CNS
Histological examination of normal CBA mice showed no evidence of
mononuclear cell infiltration or paucity of myelin indicative of demyelination.
In contrast to this TMEV infected CBA mice showed a mononuclear cell
inflammation in the brains and spinal cords. Mononuclear infiltrates
increased most between days 7-14. This correlated with the time that virus
was cleared from the CNS in some mice. Numbers of mononuclear cells had
decreased by day 35 post infection by which time virus had usually been
cleared. Characterisation of the infiltrating cells demonstrated that T cells
infiltrated the CNS as early as day 3 post infection. Both CD4 + and CD8 +
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cells were present with CD8 + cells often more numerous than CD4 + cells
(see Table3.3) (Figure 3.12). Expression of F4/80 a marker for macrophages
and microglia was also detected at 3 days post infection, levels in the brain
peaked at day 14 (Figure 3.12).
• CD3+, CD4+, CD8+ and F4/80+ cells all infiltrated the CNS during the acute
phase ofTheiler's virus infection.
3.3.16.3 Adhesion molecules in CNS of CBA mice
CNS tissues were stained for the presence of adhesion molecules including, 1)
LFA-1 (leucocyte function associated antigen) is ubiquitously expressed on all
leukocytes and is involved in their translocation through capillary walls and
in antigen presentation, 2) VLA-4 (very late activation antigen) this is found
on activated T cells and 3) V-CAM-1 (vascular cellular adhesion molecule) an
adhesion molecule found on endothelial cells involved in the recognition of
leucocytes and their transfer into the CNS. Expression of all 3 of these
adhesion molecules was observed in both brains and spinal cords of infected
mice but not in control animals (see Table3.4). In the brain, LFA-1 was
detected on day 3 post infection and reached peak levels on days 10 and 14
and was absent by day 35. Patterns in the spinal cord were virtually identical
although low expression remained at day 35. (Figure 3.12). V-CAM-1 was
also first detected on day 3 post infection and was high on day 10 in the brain
and days 10,14 and 21 in the spinal cord (Figure 3.12). VLA-4 was expressed
in a similar pattern to LFA-1 in the brains, however levels were lower in the
spinal cords. Levels of LFA-1 and V-CAM-1 correlated with numbers of
CD3+ and CD8+ cells in the CNS.
• There was up regulation of adhesion molecules VLA-4, V-CAM-1 and LFA-1 in
the CNS during the acute phase ofTheiler's virus disease.
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3.3.17 Clear and consistent observations
3.3.17.1 Brain and Spinal cord vRNA levels
• Bnlb/c and SJL/J mice clear viral RNAfrom brain by day 14.
• Individual CBA mice vary in their ability to clear brain virus.
• Virus persists in the spinal cords of SJL/J mice on days 21 and 35.
3.3.17.2 Common to Balb/c (3.3.17.2.1), CBA (3.3.17.2.2), and SJL/J
(3.3.17.2.3) mice.
• In the brain, levels oflL-12p40 and IL-2 mere maximal or near maximal by day 3.
• In the brain, high levels of TGF/I were constitutively present, as were lower levels
ofIL-7 and IL-12p35.
• In the brain, the highest levels of inducible transcripts were for IL-la, TNFa,
TNFJ3.
• In the brain, maximum levels of transcripts were generally present at or between
days 7 and 10.
• As in the brain, high levels of TGF/3 were constitutively expressed, in the spinal
cords.
• As in the brain, the highest levels of transcripts were for TNFa, TNFJ3 and IL-la,
in the spinal cords.
• As in the brain, maximum levels of transcripts were generally found between days
7 and 14, in the spinal cords.
• In contrast to the brain, no transcripts were detectable for IL-5 and IL-7, in the
spinal cords.
3.3.17.2.1 Balb/c mice.
• In the brain, the first cytokines detectable (at day 3) were IL-la, IL-1J3, IL-2, IL-6,
IL-12p40, IL-13 and IFNy
• In the brain, maximum levels of Till (IFNy) transcripts were more than 2 fold
higher than maximal levels ofTh2 (IL-4, IL-10) transcripts.
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• In the spinal cord, the first cytokines detectable at day 3 were IL-2, IFNy, TNFa
and TNFfi.
• In the spinal cord, most cytokine transcripts peaked early at day 7
• In the spinal cord, induced maximum levels for IL-1/3, IL-6 and possibly IL-la,
IL-10 and IL-13 were lower in the spinal cord than in the brain.
• In the spinal cord, constitutive levels of IL-12p35 were lower in the spinal cords
than the brains.
3.3.17.2.2 CBA mice
• In the brain, the first transcripts detectable ( at day 3) were IL-la, IL-lfi, IL-2, IL-
6, IL-12p40, IL-13, TNFa and TNFfi.
• In the brain, between days 10 and 35 levels of cytokines showed large variations
between individual mice.
• In the brain, maximal levels of Thl (IFNy, IL-12p40) and Th2 (IL-4 and IL-10)
transcripts were equivalent.
• In the spinal cord, the first cytokines detectable at day 3 were IL-la, IL-lfi, IL-2,
IL-I2p40, IL-13, IFNy, TNFa and TNFfi.
• In the spinal cord, most cytokines peaked late at day 14.
• In the spinal cord, generally, transcription was lower in spinal cords than brains.
• In the spinal cord, at day 35 post infection levels of IL-la, IL-lfi, IL-2, IL-6,
TNFa and TNFfi were high and in some cases maximal. This contrasted with the
transcript levels in the brains for these cytokines which were all basal at this time
point.
3.3.17.2.3 SJL/J mice
• In the brain, the first transcripts detectable ( at day 3) were IL-2, IL-6, IL-7, IL-
12p40, IL-13, IFNyand TGFfi.
• In the brain, transcripts for IL-2 and IL-1 [3 were not present.
• In the brain, maximal levels of IFNy (Thl) were less than IL-4 (Th2).
• In the spinal cord, the first cytokines detectable at day 3 were IL-la, IL-4, IL-6,
IFNy, TNFa, TNFfi and TGFfi.
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• In the spinal cord, most cytokines peaked at day 7.
• In the spinal cord, IL-la, IL-6, IL-13, IFNy, TNFa and TNF/J remained elevated
in S]L/J spinal cords on day 35.
• In the spinal cord, there was minimal or no transcription of IL-l[3, IL-2 and IL-
12p35.
• In the spinal cord, early levels of IL-10 were greatly increased in the spinal cords
compared to the brains.
3.3.17.4 Comparisons.
• In the brain, in addition to the absence of IL-l(3 and IL-2, relative to Balb/c and
CBA mice, SJL/] mice made a slow TNFa and IL-la response, and had lower
titres of IL-la.
• In the brain, S]L/J mice had a delayed but prolonged IFNy response.
• In the brain, Balb/c mice had a low Th2 (IL-4 and IL-10) response relative to CBA
and SJL/J mice. Whereas, Balb/c mice had higher levels of IFNy than IL-4, this
was the reverse in SJL/] mice.
• In the brain, SJL/J mice had an earlier peak of TGF(5 expression (at day 7) than
Balb/c and CBA mice..
• In the spinal cord, there was a difference between mouse strains in the kinetics of
the cytokine response in the spinal cord. Balb/c and SJL/J mice made a more rapid
response than CBA mice.
• In the spinal cord, after day 10 levels of pro-inflammatory cytokines IL-la, IL-6,
TNFa and TNFJ3 were low in Balb/c mice but remained high in CBA and SJL/J
mice. This reflects the persistence ofvirus consistently restated in the literature in
CBA and SJL/J mice.
• In the spinal cord, as in the brains, levels of IL-2and IL-1J3 were basal in SJL/J
spinal cords.
• In the spinal cords of SJL/J but not Balb/c and CBA mice levels of IL-12p35 were
basal.
• In the spinal cords of Balb/c mice there are low levels of IL-4 and IL-10, but high
levels of IL-2 and IFNy.
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• Some CBA mice clearly polarised their type 1 or type 2 responses as early as days 7
post infection.
3.3.17.5 Cytokine levels in SCID mice
• TNFa, IL-la, IL-6, IL-2 and IL-12p40 are produced in the infected CNS in the
absence ofspecific immune responses indicating production by resident CNS cells.
3.3.17.6 Antibody levels during the acute phase of TMEV.
• Serum IgM responses were similar and slow in all 3 mouse strains.
• Balb/c mice make a higher titre anti-IgG (IgGl and lgG2a) response than CBA and
SJL/] mice.
• Balb/c mice make a stronger IgGl than lgG2a response at early time points.
• Virus is cleared between days 10 and 14 in Balb/c mice it is likely that a strong
antibody response is partially responsible.
3.3.17.7 Immunostaining for cellular makers and adhesion molecules
• CD3+, CD4+, CD8+ and F4/80+ cells all infiltrate the CNS during the acute
phase ofTheiler's virus infection.
• There was up regulation of adhesion molecules VLA-4, V-CAM-1 and LFA-1 in
the CNS during the acute phase ofTheiler's virus disease.
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3.4 Discussion
Cytokines play a pivotal role in the orchestration of local immune responses
by regulating and stimulating the activation and differentiation of cells
(Frednl, 1992; Watkins et al., 1995; Vanmeir, 1995;; Navikas & Link, 1996;
Wood & Seow, 1996; Aria et al., 1997). Cytokines are also involved in the
induction of synthesis of adhesion molecules and in chemotaxis. The cytokine
environment within the target organ influences the local immune response,
the manifestation of the disease and the outcome of viral infection (Wesseligh
& Griffin, 1994; Campbell et al., 1994). The precise cytokine profile within the
target tissue is extremely important when considering the pathology and
clinical outcome of a viral infection. Cytokine profiles which are generally
considered to be optimal in clearing an infection and preventing pathology
are those which constitute a Th2 response. Th2 type cytokines are anti¬
inflammatory and are important in generating a good antibody response with
a low cell mediated response. Contrasting this the Thl spectrum of cytokines
is associated with an inflammatory response, increased cell mediated and
decreased humoral immune responses (Mossman et al., 1986; Abehsiraamar et
al., 1992; Heinzel et al., 1995; Romagni, 1996; Sedlik, 1996; Constant &
Bottomley et al., 1997; Umetsu & DeKruyff, 1997).
3.4.1 Source of cytokine transcripts
Production of cytokine mRNA in the CNS can be either by indigenous cells
including neurons, astrocytes, oligodendrocytes and microglia (Rubio et al.,
1991; Torres et al., 1992, 1995; Couraud et al., 1994; Renno et al., 1995;
Tchelingerian et al., 1995; Qi & DalCanto, 1996) or by infiltrating mononuclear
cells including macrophages, CD4+ and CD8+ T cells (Mossman et al., 1986;
Abehsiraamar et al., 1992; Heinzel et al., 1995; Romagni, 1996; Sedlik, 1996;
Constant & Bottomley et al., 1997; Umetsu & DeKruyff, 1997). Infected SCID
mice indicate which cytokine transcripts were elevated in the absence of
specific immune responses. SCID mice lack T and B cells. At late time points
(day 21) in SCID mice there were high levels of IL-la, IL-2, IL-6, IL-12p40 and
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TNFa indicating that these transcripts can be produced by CNS cells.
However, between days 3-14 post infection in SCID mice all cytokine mRNA
levels were very low and contrasted dramatically to the immunocompetent
mice where levels of numerous cytokines were elevated. This shows that
production of high levels of cytokine transcripts requires specific immune
responses. It is unclear from these studies whether the high levels of
cytokines in immunocompetent mice are produced by the infiltrating
mononuclear cells or as a result of mononuclear cells stimulating the intrinsic
CNS cells, or even as a result of high levels of circulating cytokines, or a
combination of these.
It is well documented that cytokines can be produced by CNS cells after
infection with a virus; this includes production of IL-ip, IL-4, IL-6, IL-10 and
TNFa by astrocytes after Sindbis virus infection (Wesselingh & Griffin, 1994),
and production of IL-ip, IL-6 and TNFa by cultured microglia after infection
with Visna lentivirus in vitro (Ebrahimi, personal communication). In vitro
experiments with microglia and astrocytes isolated from the CNS and
infected with Theiler's virus have shown production of IL-ip, IL-6 and TNFa
(Rubio et al., 1991; Couraud et al., 1994; Renno et al., 1995; Qi & DalCanto,
1996).
The pattern of Theiler's virus induced pro-inflammatory cytokine mRNA
expression was similar to that previously seen in the other two acute CNS
virus infections which have been studied in detail, Sindbis virus and LCMV
infections (Wesselingh & Griffin, 1994; Campbell et al., 1994). In all
immunocompetent mouse strains during the acute phase of infection with
Theiler's virus, IL-la, TNFa and TNFp were the cytokines which were most
significantly elevated. These can be produced by a variety of cells of CNS
and immune origin.
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3.4.2.1 Course of events: Initial Events
During the acute phase of Theiler's virus disease, following i.e. inoculation of
BeAn virus, virus titres rise in the brains from 3-7 days Between days 7-10,
levels of genomic RNA are generally maximal in the CNS (Simas &
Fazakerley, 1996). From many previous studies mononuclear cell infiltration
into the CNS is first apparent at about 4 days. As early as day 3 post
infection several pro-inflammatory cytokine transcripts were elevated in both
brains and spinal cords in all 3 mouse strains. These included IL-la, IL-2, IL-
6, IL-12p40, IFNy, TNFa and TNFp. These cytokines were elevated before the
influx of inflammatory cells and are likely therefore to represent the response
of CNS cells to infection. In support of this most of these early transcripts, IL-
la, IL-2, IL-6, IL-12p40 and TNFa were the same transcripts observed in SCID
mice. The actions of the above cytokines vary widely from activation and
stimulation of specific immune response to up regulation of chemokines and
adhesion molecules involved in trafficking of activated lymphocytes.
The original stimulus for the rapid induction of these early pro-inflammatory
cytokines is unknown, but in the first instance it is presumably signals
generated either by damage (ic inoc.), or by the presence of virus. As in other
tissues it is likely that IFNa/p is upregulated in the CNS during infection.
IFNa/p is important in up regulation of MHC class I on the surface of many
cells and is generally seen as one of the first lines of defence. It has been
suggested that induction of CNS cytokines can be triggered by neurones
secreting an active neuropeptide (Cocchiara et al., 1997). In vivo evidence has
shown that numerous neuropeptides can induce the expression of cytokines.
During the acute phase of Theiler's virus infection neurones are the primary
cell type infected (Aubert & Brahic, 1995; Simas and Fazakerley, 1996).
Infected or damaged neurones could therefore release a neuropeptide which
in turn could stimulate other CNS cells to produce cytokines. Alternatively,
IL-12 may be the stimulus for the increase in production of other pro¬
inflammatory cytokines. IL-12 is the first cytokine upregulated after many
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viral infections (Germann and Rude, 1995). Again, IL-12 could be activated
by damage, viral products, viral replication or factors such as interferons. IL-
12 displays a multitude of biological effects with its central role being the
regulation of innate and specific immune responses. This is exemplified by its
ability to stimulate NK cells, Thl cells and CTLs.
Active IL-12 is comprised of two subunits, p35 and p40. Transcripts for p35
were constitutively present in brains of all 3 mouse strains and at lower levels
in the spinal cords of Balb/c and CBA mice but were not detected in the
spinal cords of SJL/J mice. Transcripts for the p40 subunit were not
constitutive but were rapidly induced following infection. In most animals in
all strains and in both brains and spinal cords, maximal or near maximal titres
of IL-12p40 transcripts occurred early at day 3. High levels of IL-12p40 were
observed before high levels of IL-2 and IFNy consistent with a role for IL-12 in
the generation of Thl cell responses.
In many viral infections the first mononuclear cells to be recruited are
natural killer (NK) cells. This is also true for CNS infections as is described for
LCMV (Christian et al., 1996; Zajac et al., 1996). As mentioned above IL-12 is
important in the activation of NK cells which in turn produce IFNy (Orange
& Biron, 1996), which has a plethora of immunological effects and is required
for Theiler's virus clearance (Chapter 5, Fiette et ah, 1995). IL-12 expression is
also known to induce TNFa, which also been shown to have a direct anti-viral
role. High levels of IL-12 also has an affect on inhibiting the development
and stimulation of CD8+ T cells (Orange et ah, 1995). Its expression during
Thieler's virus infection may be important in influencing CTL responses,
which have been shown to be important in clearance of this virus (Larsson-
Sciard et ah, 1997).
Early induction of TNFa has been suggested to contribute a direct role to the
control of virus infections (Paya et ah, 1990). TNFa can up regulate adhesion
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molecule expression and stimulate differentiation of T cells and macrophages,
resulting in an increase in infiltrating mononuclear cells. It is well
documented that TNFa has many effects including cytotoxicity towards
neurones and oligodendrocytes, an ability to stimulate the production of
neurotoxic products which include nitric oxide, platelete activating factor,
prostaglandins and other metabolites of arachadonic acid, and induction of
Thl and inflammatory DTH responses (Beulter, 1993). The cells which
produce TNFa are predominantly macrophages, T cells and astrocytes.
It is well documented that IL-la and IL-ip are produced by macrophages and
astrocytes. IL-la and IL-ip are biologically more or less equivalent
pleiotropic factors that act locally as well as systemically. IL-la and p are
involved in the up regulation of other cytokines including TNFa and IFNy,
and are mediators of B and T cell responses. IL-la transcripts were
consistently upregulated to high levels in both brain and spinal cords of all 3
mouse strains and transcript levels correlated with virus titres. Furthermore,
IL-la transcripts were produced by SCID mice. In contrast, IL-ip transcripts
were not produced in SCID mice and although induced in the brains and
spinal cords of Balb/c and CBA mice there was little or no up regulation in
the brains or spinal cords of SJL/J mice.
3.4.2.2 Course of events: Early events.
Balb/c mice clear Theiler's virus infection within two weeks. This is due to a
combination of factors including humoral and cell mediated immune
responses. Initially, intrinsic cells of the CNS produce IL-la, IL-2, IL-6, IL-12
and TNFa, these cytokines have wide ranging affects. TNFa and IL-6 are
known to have direct anti-viral roles. However, their role in Theiler's virus
infection in the CNS remains unclear. TNFa and IL-6 and are also involved in
the up regulation of V-CAM-1. This facilitates infiltration of activated
lymphocytes into the CNS in response to chemokine gradients (Asensio &
Campbell, 1997). From 7-35 days Balb/c mice make a strong antibody
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response of all isotypes and a good type 1 cytokine response (IL-2 and IFNy).
As discussed previously, IL-12 is important in the activation of NK cells
which produce IFNy. IL-12 is also important in driving ThO cells along the
Thl pathway. The high levels of IFNy transcripts observed in Balb/c mice
could reflect higher NK cell activity but since they occur at day 7 they are
more likely to represent strong Thl T cell responses and or production of
CTLs. In many viral infection high or maximum levels of CTLs are present by
day 7 post infection (Butz and Bevan, 1998), and CTL activity has been
demonstrated to be high in the C57B1/6 mouse strain which is resistant to
TMEV persistence (Dethlefs et al., 1997; LarssonSciard et al., 1997).
The series of events is clearly different in SJL/J mice. SJL/J mice had a poor
humoral response in comparison to Balb/c mice and had little or no
expression of IL-ip, IL-2 and IL-12p35. These above factors may explain why
virus is not cleared from the CNS of SJL/J mice. IL-12 has an important role
in stimulating NK cells as described previously, therefore a reduction in NK
cell activity may result in a decrease in IFNy and in turn a decrease in type 1
and CTL responses, and an up regulation in Th2 type responses as seen in
this mouse strain. Lack of IL-2 has clear effects on clonal expansion of CTLs
which has been described previously (Larsson-Sciard et al., 1997).
Interestingly, there is an early peak of TGFp in SJL/J mice on day 7. TGFp is
an inhibitory cytokine that decreases activity of macrophages, NK, T and B
cells. This may contribute towards the inefficient immune response in SJL/J
mice.
CBA mice are intermediately susceptible to viral persistence, resulting in
viral clearance in some animals and not in others. The present study shows
that individual CBA mice display clear type 1 or type 2 cytokine profiles. It
can be speculated that animals which display a good type 1 response (like
Balb/c mice), make a good CTL response resulting in elimination of virus,
and conversely animals which have a good type 2 response (like SJL/J mice)
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make a poor CTL response resulting in viral persistence. It would be of
interest to determine whether the CBA mice which had a good type 1
response also had a good CTL response and vice-versa. In the brains of CBA
mice, variability in the levels of Thl and Th2 cytokines in individual animals
was observed. Several animals which had high Th2 cytokines had low Thl
cytokines and vice versa, therefore the balance of Thl/Th2 cytokines in the
CNS in individual mice may account for the difference as to why some mice
clear the virus whereas others develop viral persistence (this is illustrated in
Section 3.3.13). CBA mice which had high levels of pro-inflammatory
cytokines at day 21 post infection also had high levels of virus indicating that
the virus is still driving the immune response (see Section 3.3.6).
In CBA mice there was an increase in cellular infiltrates including
macrophages, CD4+ and CD8+ T cells during the acute phase of Theiler's
virus infection, with infiltrates having decreased by day 35 post-infection.
There was also an increase in the expression of the adhesion molecules VLA-
4,1-CAM 1 and LFA-1. Interestingly, VLA-4 is induced on activated T cells by
the cytokines IL-1 and TNFa. Between days 3-14 when this adhesion molecule
was detected high levels of IL-la and TNFa were present.
3.4.2.3 Course of events: Late events
In the brains of Balb/c mice there is a rapid fall in most cytokines after viral
clearance. However, certain cytokines including TNFa and IFNy, remained
elevated in the spinal cords of some CBA mice. Similarly, in the brains of
SJL/J mice although most cytokines returned to basal levels, several
including, IL-la, IL-6, IL-13, IFNy, TNFa and TNF(3 remained elevated in the
spinal cords. The most likely explanation for this is that virus is cleared from
the brains of SJL/J mice and like Balb/c mice, cytokine levels return to basal,
whereas virus persists in the spinal cords of SJL/J and some CBA mice and
continues to drive cytokine responses.
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3.4.3 Predisposition to persistence
In all 3 mouse strains, transcripts associated with specific immune responses
Thl (IL-2, IFNy) and Th2 (IL-4, IL-5, IL-10) were expressed but were low in
comparison to levels of pro-inflammatory transcripts produced by CNS and
probably also infiltrating cells (IL-la, IL-ip, IL-6, TNFa and TNFp). Levels of
IL-2 were lower in the brains and spinal cords of SJL/J mice during the acute
phase of infection compared to CBA and Balb/c mice. Levels of IFNy were
also initially low in SJL/J mice, however they eventually reached similar
levels as to that which were observed in CBA and Balb/c mice. This
correlates with RT-PCR data from Monteyne et al., (personal communication).
This suggests that the SJL/J mice have an inefficient Thl response relative to
Balb/c mice. Other studies have demonstrated that SJL/J mice have low
levels of TMEV-specific CTL precursors. This could be either cause or effect
of the low IL-2 and IFNy transcripts seen early in these mice. Levels of IL-4
and IL-10 transcripts were higher in SJL/J than in Balb/c mice during the
acute phase of disease. Again this data is consistent with RT-PCR studies by
Monteyne et al. (personal communication). Therefore, although SJL/J mice
are documented to produce a Thl response at late time points post infection,
it appears that they generate a strong Th2 response during the acute phase.
This data puts a different slant on the Thl/Th2 hypothesis in TMEV infection
and suggests that Thl cells although causing damage during the chronic
persistent phase may be essential during the acute phase for viral clearance.
In addition to low early or undetectable levels of IFNy and IL-2 SJL/J mice
were deficient in levels of transcripts for several cytokines including IL-ip
and IL-12p35. The absence of IL-12p35 transcripts in the SJL/J spinal cord is
striking and may be one reason why virus persists in the spinal cords but not
in the brains of these mice. It could be speculated that absence of IL-12p35
and therefore active IL-12 results in a poor NK cell response, in combination
with lack of production of IFNy which in turn is important for good Thl and
CTL responses, known to be vital for viral clearance. On the other hand poor
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IL-12p35 may mean that there is deficient macrophage/microglia activity also
known to be important in antigen presentation and viral clearance.
IL-ip is also not expressed in the brains or spinal cords of SJL/J mice. IL-ip is
predominantly produced by mononuclear cells. From the lack of IL-ip it
could be speculated that SJL/J mice have a lack of macrophage activity, which
accounts for the inability of these mice to clear the virus. This hypothesis
would be further supported by the fact that SJL/J mice also have lower levels
of TNFa a cytokine produced partly by macrophages. However, the
histopathology in SJL/J mice is characterised by a florid
macrophage/microglia response. Although there are large numbers of
macrophages/microglia in SJL/J mice it is possible that they are not activated
and this has lead to increased recruitment due to a feedback mechanism.
Deficiencies in levels of transcripts for brain and spinal cord IL-2 also occur in
SJL/J mice. SJL/J mice are deficient in levels of brain and spinal cord IL-2.
This cytokine is important in clonal expansion of T cells, and a deficiency in
this cytokine would result in a reduction of CTLs, which have been shown to
be an important prerequisite for viral clearance. Therefore, in combination
with low levels of IL-ip, IL-2 and IL-12p35, SJL/J mice may have low levels of
activated microglia and CTL activity.
The major differences in antibodies between mouse strains during the acute
phase of Theiler's virus infection were in the levels of IgGl and IgG2a. Levels
of IgGl were dramatically increased in resistant Balb/c mice compared to
intermediately susceptible CBA and susceptible SJL/J mice. The levels of
IgG2a were not as high as the levels of IgGl and the differences between
strains were not as statistically significant. A previous study by Peterson et al
(1992) demonstrated that resistant C57B1/6 mice produced predominantly
antibodies of the IgGl subclass, and susceptible SJL/J and intermediately
susceptible C3H HeY mice produced antibodies of the IgG2a subclass, during
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the acute phase of Theiler's virus infection. Thl cells are associated with a
DTH and promote IgG2a synthesis with the inhibition of other IgG subclasses.
In contrast to this cells of the Th2 subset promote production of IgGl and IgE
synthesis and suppress IgG2a synthesis (Peterson et al., 1992). The results of
Peterson's study support a Thl/Th2 dichotomy, with susceptibility being
associated with Thl cells and resistance being associated with Th2 cells.
Susceptibility to demyelination induced by Theiler's virus is generally
associated with an increased DTH caused by CD4 + T cells and infiltrating
macrophages (Clatch et al., 1986,1987,1988; Peterson et al., 1992; Gerety et al.,
1994; Karpus et al., 1995; Pope et al., 1996). Further support for the
association between Thl responses and disease is provided by an adoptive
transfer study. An anti-TMEV CD4+ Thl (IL-2, IFNy producing) cell-line
when transferred into susceptible SJL/J mice which had previously been
inoculated with Theiler's virus resulted in acceleration of onset of
demyelination and increased areas of demyelination (Karpus et al., 1995).
The antibody profiles described in this chapter provide little support for the
Thl/Th2 hypothesis with regards to Theiler's virus infection. Resistant
Balb/c mice did produce more IgGl than susceptible SJL/J mice and
intermediately susceptible CBA mice. This is consistent with the hypothesis,
implicating Th2 cells in clearance, however the cytokine profiles in Balb/c
mice contradicts this suggest that there is more of a type 1 response in Balb/c
mice during the acute phase of the disease. Also both resistant and
susceptible strains produced IgG2a (which according to the hypothesis is
associated with Thl cells and demyelination). It is clear there is not a
polarised IgG isotype response during the acute phase of Theiler's virus
infection, but all isotypes are upregulated particularly in Balb/c mice. It is
likely that the CD4+ Thl and Th2 cells are both present and disease or
resistance to disease is not mutually exclusive to one particular subset of
helper cells. However, recent evidence has elucidated that animals which are
MHC class II deficient (on a resistant H2-b background) which therefore lack
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any functional CD4+ T cells, produce lesions of demyelination (Njenga et al.,
1996). This data suggests that demyelination cannot simply be explained by a
Thl versus Th2 hypothesis, and that other factors are also involved.
A previous study (Pena Rossi et al., 1991) shows that levels of IgM are higher
in the spleens of C57B1/6 mice than that of susceptible SJL/J mice on post
infection day 7. However, the data presented in this chapter suggests that
there is no difference in the levels of IgM in the serum between the mouse
strains.
3.4.4 Concluding remarks.
Clearly there are differences between mouse stains during the acute phase of
Theiler's infection (Figure 3.14). In both resistant Balb/c and SJL/J mice
neurones and microglia are the primary cell types infected. This causes an up-
regulation in pro-inflammatory cytokines, interestingly SJL/J mice little or no
expression of IL-ip and IL-12p35 compared to Balb/c mice, this may be
indicative of a dysfunctional macrophage/microglial response (Figure 3.14).
Between days 7 to 10 there is an increased in trafficking of primed CD4, CD8
and F/80 positive cells as well as an up regulation of adhesion molecules in
the CNS. In summary in Balb/c there is a good anti-viral IgG response with
an up-regulation of IgGl, IgG2a, IgG2b this is coupled with an increase in IL-2
and IFNy as well as an increase in several pro-inflammatory cytokines (Figure
3.14). It was not verified as to which cell types produced individual type 1
cytokines however it could be suggested that they were produced by either
CD4+ helper cells, CD8+ CTLs or a combination of both. In contrast to this
the inflammatory response in SJL/J mice is not as strong, this is coupled with
a poor IgGl and IgG2a antibody response. However in SJL/J mice there is an
up regulation of type 2 cytokines, IL-4 and IL-10 and an early peak in TGFp
(Figure 3.14). The results from both strains suggest that a good antibody
response is important in controlling the spread of virus whereas a good
perforin mediated CTL response is required for complete clearance. (see
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Chapter 6, Larsson Sciard et al., 1997), however the precise role of type 1 and
type 2 responses is still a matter of debate.
In conclusion, there are multiple cytokines expressed in the brains and spinal
cords of mice and there are differences in antibody isotypes generated in the
serum of infected mice during the acute phase of Theiler's virus infection.
However, the nature of the cytokine and antibody response is a elaborate and
diverse network. With the expression of different cytokines occurring at
different levels and at different time points post-infection. It is clear that the
cytokine response during Theiler's virus infection is multifaceted with the
expression of many cytokines influencing, co-ordinating and controlling each
others expression. The intricate and complex nature of the cytokine response
during Theiler's virus infection adds further caution to the safety and efficacy
of using a single cytokine therapy when considering treatment for a CNS
inflammatory disease, such as M.S.
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Figure 3.3 Levels of mRNA transcripts in the brains of Balb/c, CBA and SJL/J mice infected with
Theiler's virus during the acute phase of the disease. Brain RNA samples were isolated from days 3
to 35 post infection, from mice inoculated i.e. with 104 PFU of TMEV (BeAn). mRNA transcripts
were detected by RNase Protection Assay as described in the materials and methods. Transcripts
were visualised by autoradiography and quantitated by densitometry. Levels of various transcripts
were determined in the brains of Balb/c ) CBA P ) and SJL/J P ) mice. Each individual mouse
is colour coded and is represented by the same colour at the same time point in each graph '1 he solid
pink line represents the average {nr 4) level of transcript determined in uninfected control mice. The
SD error bars were not included for control mice as there was minimal variation between control
animals. Graph A) IL-la, B) IL-ip, C) IL-2, D) IL-4, E) IL-5, F) IL-6, G) IL-7, H) IL-10, I) 1L-
12p35, J) IL-12p40, K) IL-13, L) IFNy, M) TNFa, N) TNFp, O) TGFp. The x-axis represents the
day post infection and the y- axis represents the intensity of the band on the gel, which is directly
proportional to amount of transcript.
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Figure 3.4 Levels of mRNA transcripts in the spinal cords of Balb/c, CBA and SJL/J mice infected
with Theiler's virus during the acute phase of the disease. Spinal cord RNA samples were isolated
from days 3 to 35 post infection, from mice inoculated i.e. with 104 PFU of TMEV (BeAn). mRNA
transcripts were detected by RNase Protection Assay as described in the materials and methods.
Transcripts were visualised by autoradiography and quantitated by densitometry. Levels of various
transcripts were determined in the brains of Balb/c (o ) CBA ( □) and SJL/J ( a ) mice. Each
individual mouse is colour coded and is represented by the same colour at the same time point in
each graph The solid pink line represents the average (n=4) level of transcript determined in
uninfected control mice. The SD error bars were not included for control mice as there was minima!
variation between control animals Graph A) IL-la, B) IL-ip, C) 1L-2, D) IL-4, E) IL-6, F) IL-10, G)
IL-12p35, H) IL-12p40,1) IL-13, J) IFNy, K) TNFa, L) TNFp, M) TGFp. The x-axis represents the
day post infection and the y- axis represents the intensity of the band on the gel, which is directly
proportional to amount of transcript.
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Figure 3.5 The averages of the expression of selected cytokines in the brains of
Balb/c. CBA and SJL/J mice during the acute phase of infection of Theiler's virus
infection. Brain RNA samples were isolated from days 3 to 35 post infection, from
mice inoculated i.e. with 104 PFU of TMEV (BeAn). mRNA transcripts were
detected by RNase Protection Assay as described in the materials and methods.
Transcripts were visualised by autoradiography and quantitated by densitometry. The
x-axis represents the day post infection and the y-axis represents intensity. Different
coloured lines represent different cytokines.
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Figure 3.6 The averages of the expression of selected cytokines in the spinal cords
of Balb/c, CBA and SJL/J mice during the acute phase of infection of Theiler's virus
infection. Spinal cord RNA samples were isolated from days 3 to 35 post infection,
from mice inoculated i.e. with 104 PFU of TMEV (BeAn). mRNA transcripts were
detected by RNase Protection Assay as described in the materials and methods.
Transcripts were visualised by autoradiography and quantitated by densitometry. The
x-axis represents the day post infection and the y-axis represents intensity. Different
coloured lines represent different cytokines.
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Figure 3.7 Comparison of levels of vRNA with the levels of transcripts for
pro inflammatory cytokines. CBA mice were inoculated i.e. with 104 PFU of
TMEV (BeAn) and sampled on various days post infection, during the acute
phase of disease. Each symbol represents an individual animals sampled
between days 10 and 21 post infection. The x-axis represents the amount of
total brain RNA required to get a positive signal by a dot blot assay. The y-
axis is a measure of the quantity of cytokine message. The animals with the
highest cytokine levels require only a small amount of total brain RNA to
detect virus, indicating that there is more vRNA in the brains of these mice.
On the other hand, animals with the least amount of cytokine require greater
amounts of total RNA to get a positive signal..
Relationship between levels of cytokine mRNA and viral RNA.
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Brains
Cytokine Balb/c Day max. CBA Day max. SJI/J Day max.
max. level max. level max. level
level occurred level occurred level occurred
TNF(3 88 10 76 10 44 14
TNFa 149 7 148 7 120 10
IL-4 11 10 43 7 45 10
IL-5 16 10 27 10 25 7
IL-la 88 7 89 7 40 10
IFNy 30 7 44 7 17 10
IL-2 57 7 44 3 12 7
IL-6 48 7 49 7 36 10
IL-lp 48 10 65 7 2 7
IL-10 27 7 28 7 27 7
IL-13 37 3 47 14 40 3
IL-12p40 40 3 48 3 37 3
Spinal cords
Cytokine Balb/c Day max. CBA Day max. SJI/J Day max.
max. level max. level max. level
level occurred level occurred level occurred
TNFp 76 7 130 35 44 14
TNFa 113 7 114 14 120 10
IL-4 17 7 52 7 45 10
IL-la 51 7 85 35 38 7
IFNy 28 7 31 7 19 10
IL-2 110 35 133 35 12 7
IL-6 15 7 93 35 36 10
IL-ip 13 35 30 35 5 14
IL-10 10 7 23 14 120 10
IL-13 16 7 37 7 35 10
IL-12p40 34 7 87 10 34 7
Table 3.1 Comparison in levels of different cytokines in the brains and spinal cords of
Balb/c, CBA and SJL/J mice during the acute phase of Theiler's virus infection. The
table indicates the different cytokines mRNAs which were detected during the acute
phase of disease and shows the differences in their levels of expression. The figures
represent the densitometery reading of the particular band of interest after
normalisation.
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Figure 3.9 Titration of purified viral antigen for use in TMEV specific ELISA.
Immulon 4 plates were coated with purified BeAn antigen (EH ) and different
concentrations of 10% BSA (□ ). Sera were pooled from CBA mice 28 days
after inoculation with 104 PFU of TMEV (BeAn) i.e. Anti-TMEV antibody was
detected with anti-mouse total immunoglobulin conjugated to HRP as
described in the Materials and methods. A dilution of 1 /10 was elected to be
used in the ELBA, as it gave the highest absorbance, with the lowest
background.
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Figure 3.10 Dilution curve of anti-TMEV. Sera were pooled from CBA mice
28 days after i.e. infection with 104 PFU of TMEV BeAn. The anti-TMEV IgM
(E3) and total anti-TMEV immunoglobulins (D)were measured by TMEV
specific ELISA as described in the materials and methods.
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Figure 3.11 Anti-TMEV antibody isotypes in the serum of Balb/c, CBA and
STL/1 mice during the acute phase of Theiler's virus disease. Serum were
collected from mice inoculated i.e. with 104 PFU of TMEV (BeAn), from days
3 to 35 post infection. Antibody isotypes were determined for Balb/c ( H ),
CBA( II ) and SJL/J ( H ) by TMEV specific ELISA as described in the
materials and methods. The solid line represents the background absorbance
which is the mean plus 2 standard deviations of the absorbance given by a
1/100 dilution of serum from a group of mice inoculated with the non-cross
reacting Semiliki Forest virus and the dotted line represents the average
absorbance throughout the course of infection for individual strains.
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Figure 3.12 This figure illustrates the expression of different cellular
infiltrates in the brains and spinal cords during the acute phase of Theiler's
virus infection in CBA mice. Immunostaining occurred by method 1 as
described in the materials and methods. The information regarding the
antibodies used can also be obtained in table 2.4. Immunostaining was
visualised using DAB. The brains were cut sagitally and the spinal cords
were cut longitudinally, all tissues were counterstained with haematoxylin.
A) CD3+ cells in the spinal cord on post infection day 7 B) CD3+ cells in the
spinal cord post infection day 10, C to E expression of CD4+ in the brains on
post-infection day 14. F and G, CD8+ expression in the spinal cords on post
infection days 14, H to J, CD8 + staining in the brains on post infection day
14. K to M, F4/80+ cells (a macrophage marker) in the brains on post
infection day 7, and O and P, F4/80+ staining in the spinal cords on post
infection day 10. Magnification x 25 (A, K); x 100 (D, F, II, J, M, O); x 200 (B,
C, E, G, I, L, N),
 
 
Figure 3.13 This figure illustrates the expression of different adhesion
molecules and cytokines in the brains and spinal cords during the acute
phase of Theiler's virus infection in CBA mice. Immunostaining was by
method 1 as described in the materials and methods. The information regarding
the antibodies used can also be obtained in table 2.4. Immunostaining was
visualised using DAB. The brains were cut sagitally and the spinal cords
were cut longitudinally. All tissues were counterstained with hematoxylin.
A) LFA-1 in the brains on post infection day 10. B) V-CAM-1 staining in the
brains on post infection day 10. C) mononuclear cells around a blood vessel
expressing TNFa in the brain on post infection day 7 and D) expression of
VLA-4 in the brains of CBA mice on post infection day 14. Magnification all
x 100.
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Brains
CD3 CD4 CD8 F4/80 IL-2R
Day post infection
3 + + +/- + ++ -
3- - - - ++ -
7 + + + + ++ -
7- - - +/- ++ -
10 + +++ + ++ ++ -
10- - - - +/- -
14 + ++ + ++ +++ -
14- - - - + -
21 + ++ ++ + + -
21 - - - - +/- -
35 + + +/- + + -
35- - - - +/- -
Spinal cords
Cellular infiltrate CD3 CD4 CD8 F4/80 IL-2R
Day post infection
3 +
■x
_
+/- +/- +/- + -
vJ
7 + +/- + +/- + _
7- - - - +/- -
10 + + ++ +++ ++ -
lO- - - - +/" -
ll + ++ ++ ++ ++ -
14- - - - +/- -
21 + ++ + ++ + -
21 - - - - - -
35 + - - + +/- -
35- - - - - -
Table 3.3 Expression of cellular markers in the CNS of CBA mice during the
acute phase of Theiler's virus disease. CBA mice were inoculated with 104
PFU of TMEV (BeAn) i.e. CNS tissues were frozen in isopentane and sagital
and longitudinal cryostat sections were cut for brains and spinal cords,
respectively. Immunostaining was as described in the Materials and methods.
Detection was visualised by DAB. Tissues were counter stained with
haemotoxylin. A minimum of 3 mice were stained for immunological
markers at each time point studied. After the day post infection + represents
animals inoculated with virus and - represents mock infected animlas
inoculated with PBS. The various levels for the various markers was
recorded as - no expression, +/- 1-2 positive cells at high power fields ( x
400), + < 10 positive cells at high magnification ( x 400), ++ 10-30 positive
cells at lower power fields ( x 200), and +++ 30< positive cells at observed in
lower power fields of magnification ( x 100).
Brains
Adhesion VLA-1 V-CAM-1 LFA-l
molecule
Day post
infection
3 + + +/- +/-
3- - - -
7 + +/- +/- +/-
7- - - -
10 + ++ ++ +++
10- - - -
14 + ++ +/- +++
14- - -
21 + ++ - ++
21 - - - -
35 + - - -
35- - - -
Spinal cords
Adhesion VLA-1 V-CAM-1 LFA-l
molecule
Day post
infection
3 + +/- +/- +
3- - - -
7 + +/- + ++
7- - - -
10 + +/- ++ +++
10 - - - -
14 + + ++ +++
14- - +/- -
21 + - ++ ++
21- - - -
35 + - + +
35- - - -
Table 3.4 Expression of adhesion molecules in the CNS of CBA mice during;
the acute phase of Theiler's virus disease. CBA mice were inoculated with
104 PFU of TMEV (BeAn) i.e. CNS tissues were frozen in isopentane and
sagital and longitudinal cryostat sections were cut for brains and spinal
cords, respectively. Immunostaining was as described in the Materials and
methods. Detection was visualised by DAB. Tissues were counter stained with
haemotoxylin. A minimum of 3 mice were stained for immunological
markers at each time point studied. After the day post infection + represents
animals infected with virus and - represents PBS mock infected controls. The
various levels for the various markers was recorded as - no expression, +/- 1-
2 positive cells at high power fields ( x 400), + < 10 positive cells at high
magnification ( x 400), ++ 10-30 positive cells at lower power fields ( x 200),
and +++ 30< positive cells at observed in lower power fields of magnification
( x 100).
Figure 3.14 Summary of the immune response occurring in Balb/c (A) and
STL/T (B) mice during the acute phase of Theiler's virus infection. (A & B, 1)
Neurones, macrophages and astrocytes are infected early, resulting in an
increase in expression of IL-12, interferon, MHC class I and II, (A & B, 2)
contributing to an increase in expression of pro-inflammatory cytokines (A &
B, 3) and adhesion molecules. (A, B 4 & 5) Viral antigen is presented to
primed infiltrating CD4+ and CD8 + T cells with generation of anti-viral
antibodies. (A, 6 & 7) In resistant Balb/c mice there is a predominantly type 1
cytokine response and an increase in virus specific anti-viral antibodies of all
IgG subclasses, resulting in clearance of virus. (B, 6 & 7) In susceptible SJL/J
mice there is a predominantly type 2 cytokine response and lower antibody
levels of all IgG subclasses compared to Balb/c mice, resulting in persistence
of virus and demyelination (see Chapter 4). * Levels of antibody were detected
in the serum as opposed to CSF.
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4.1 Introduction
Theiler's virus disease is generally divided into two phases, the acute phase
which occurs during the first three weeks post infection and the chronic phase
after this time (Daniels et al., 1952; Lui et al., 1967; Lipton, 1975; Dal Canto &
Lipton, 1975; Lipton et al., 1980; Tsunoda et al., 1996). The chronic phase is
associated with white matter disease and demyelination. The cytokine
response during the acute phase of Theiler's virus infection was discussed in
Chapter 3. Theiler's virus persists in the CNS of susceptible mice and leads to
demyelination (Lipton et al., 1995; Simas & Fazakerley 1996; Brahic et al.,
1996; Rodriguez et al., 1996). The exact mechanism(s) of persistence and
demyelination remain a matter of debate and were discussed in Section 1.11.
The immune response is known to be important in clearing and controlling
Theiler's virus infection (Oleszak et al., 1995; Monteyne et al., 1997).
However, the immune response has also been shown to have pathogenic
actions involved in the demyelinating process (Clatch et al., 1985, 1986, 1987;
Peterson et al., 1991, 1992; Gerety et al., 1994; Karpus et al., 1995; Pope et al.,
1996). Investigators have suggested that CD4+ T cells of the Thl subset are
involved in demyelination and there is much evidence to substantiate this.
Including 1) the inoculation of Thl cells into susceptible SJL/J mice after
infection results in an early onset of disease with an increase in extent of
demyelinating lesions; 2) production of IgGl which is associated with Th2
cells is increased in resistant mice and, IgG2a which is associated with Thl
cells is elevated in susceptible mouse strains, and therefore disease pathology
(Peterson et al., 1991; Gerety et al., 1994).
CBA (H2-k) mice are intermediate in susceptibility to developing chronic
demyelinating disease after intracerebral inoculation with Theiler's virus. In
an earlier study from this laboratory the proportion of CBA mice which had
levels of persisting virus in their CNS, between days 50 and 268 post infection,
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as determined by RT-PCR-SB was 53% (16/30). The majority of animals which
had detectable levels of persisting virus also displayed clinical signs of
chronic disease, however 16% (5/30) of persistently infected animals
displayed no clinical signs (Simas and Fazakerley, 1996).
The objective of this chapter was to investigate the cytokine and antibody
profiles during the chronic phase of Theiler's virus disease; in a number of
intermediately susceptible CBA mice and determine whether there is a
difference in cytokine and/ or antibody responses between mice which clear
the infection and those in which virus persists.
4.2 Experimental design
Sera and RNA samples from a previous study performed in this laboratory
were analysed. In this study, a large group of CBA mice had been inoculated
intracerebrally with 104 PFU of TMEV (BeAn) and animals were sampled at
various time points post infection from 50-268 days post infection. At each
sampling point RNA was isolated from brain and spinal cord and levels of
persisting virus determined by RT-PCR and Southern blotting (see Section
2.13). The animal sampling, RNA extraction, RT-PCR and Southern blotting
for CBA mice was undertaken by Dr JP Simas. These same samples were
used in this study to investigate levels of cytokine transcripts by RPA (see
Section 2.11). Sera were collected to determine the levels of anti-viral
neutralising antibodies and levels of the different isotypes of antibodies. Sera
were also taken at late time points post infection from SJL/J and C57B1/6
mice, which had been inoculated i.e. with 104 PFU of TMEV (BeAn). This was
also to determine the levels of antibody isotypes by ELISA. The ELISA
experiments were not carried out as accurately as they might have been
therefore the value of these experiments is questionable. In these ELISA
experiments for convenience a standard 1/100 dilution of serum was used for
all samples. However, if ELISA experiments were to be carried out more
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thorough, the total immunoglobulin level in individual samples should be
determined by a separate ELISA. Therefore when reading the ELISA data this
point should be remembered.
4.3 Results
4.3.1 Cytokine mRNA transcript levels during the chronic
phase of Theiler's virus infection
The RPA analysis was carried out using aliquots from the same RNA samples
used to determine viral persistence. Levels of mRNA transcripts for several
cytokines were determined by RPA, to see whether there was a difference in
profiles or distinctive Thl or Th2 profiles in mice with viral persistence
compared to those which had cleared the virus. Brain RNA samples from 6
animals with viral persistence and 6 without were assayed for the presence of
mRNA for TNFp, TNFa, IL-4, IL5, IL-la, IL-2, IFNy, IL-6, IL-lp, IL-3, 1L-10,
TGFp, IL-13, IL-12p40, IL-12p35 and IL-7. There were no differences in the
levels of mRNAs for TNFp, IL-4, IL-5, IL-la, IL-2, IFNy, IL-6, IL-ip, IL-3, IL-
10, TGFp and IL-13 between the two groups as determined by Students t-test.
However, there were significantly increased levels of mRNA for TNFa (p=
0.05), IL-12p35 (p=0.01) and IL-12p40 (p= 0.02) in mice which had persisiting
virus (Figure 4.1). Levels of IL-2, IL-ip and TGFp appear to be different
between the two groups when looking at Figure 4.1 however, this was not
statistical significant.
4.3.2 Antibody isotypes in the serum of CBA mice with and
without viral persistence.
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Antibody isotype levels were obtained for CBA mice which had viral RNA
persisting in their CNS, and for CBA mice which had cleared the virus
(between days 50 to 268 post infection). Anti-viral IgM, IgGl, IgG2a and
IgG2b were detectable in the sera of mice with viral persistence and of mice
which had cleared the virus. There were no differences in the levels of IgM,
between animals which had viral persistence and those which had cleared the
virus (Figure 4.2A). However, there were several statistical differences
between the two groups of animals, as determined by students t-test for anti¬
viral IgGl, IgG2a and IgG2b (Figure 4.2 B, C, D). There were significantly
elevated levels of anti-viral IgGl (p=0.07), IgG2a (p=0.049) and IgG2b
(p=0.0085) in mice which had viral persistence compared to animals which
had cleared the virus. Animals were all monitored for the development of
clinical signs. Several animals had virus detectable in their CNS but
displayed no visible clinical signs. There were no differences in the levels of
antibodies in animals which had viral persistence and displayed clinical signs
and those which had viral persistence but did not display clinical signs.
4.3.3 TMEV specific antibody isotypes in SJL/J, C57B1/6 and CBA
mice during the chronic phase of disease.
Antibodies to TMEV of the IgM, IgGl, IgG2a and IgG2b isotypes were also
measured in susceptible SJL/J and resistant C57B1/6 mice during the chronic
phase (>50 days post infection). There were several statistically significant
differences between the strains, as determined by Students t-test. Levels of
IgM were significantly elevated in CBA mice during the chronic phase of
Theiler's virus infection compared to susceptible SJL/J mice (p=0.0001) and
resistant C57B1/6 mice (p=0.0001) (Figure 4.3 A). There were differences in
the classically defining Thl and Th2 associated isotypes which are IgG2a and
IgGl, respectively. Both resistant and susceptible strains of mice generated
equivalent levels of IgG2a antibodies, however, there were significantly
higher levels of IgGl in susceptible SJL/J, and intermediately susceptible CBA
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mice compared to resistant C57B1/6 mice (p=0.01/ p=0.02, respectively)
(Figure 4.3 B, C). There were no differences in the levels of IgG2b in the
strains studied (see Figure 4.3D). Antibody levels in different mouse strains
during the acute phase of Theiler's virus infection are discussed in Chapter 3.
4.3.4 Comparison of the levels of cytokines with antibody isotypes in
CBA mice with and without persistent infection
CBA mice with viral persistence had statistically elevated levels of the pro¬
inflammatory cytokines TNFa, IL-12p35 and IL12p40, and also had
significantly increased anti-viral antibodies of the IgGl, IgG2a and IgG2b
isotypes. The most likely explanation for these findings is the continual
stimulation of the immune response by virus.
4.4 Discussion
During the acute phase of Theiler's virus infection numerous cytokines are
expressed in the brains, these range from pro to anti-inflammatory, see
Chapter 3. In contrast, during the chronic phase fewer cytokines were
expressed and there was a difference between animals which had viral
persistence and those which had cleared the virus. CBA mice which had
virus persisting in their CNS had increased levels of TNFa, IL-12p35 and IL-
12p40. These cytokines are associated with Thl responses and support the
hypothesis that Thl cells cause the demyelination. Evidence supporting Thl
cells as the effector cells in demyelination includes, 1) the acceleration of
disease onset in infected recipients of a TMEV specific Thl cell line (Gerety et
al, 1994); 2) correlation of disease susceptibility with development of chronic
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high levels of MHC class II-restricted virus specific DTH (Clatch et al 1985,
1986,1987); 3) demonstration of activated Theiler's virus specific CD4+ T cells
in the CNS of infected mice (Pope et al., 1996); 4) a dramatically reduced
disease incidence in mice tolerised with intact Theiler's virus virions results in
anergy of Thl cells causing a reduction in demyelination and clinical signs
(Karpus et al., 1995); 5) an increased IgG2a:IgGl ratio in the serum of
resistant mice compared to susceptible mice (Peterson et al., 1991).
Although it is probable that TNFa and IL-12p40 are produced by cells of the
Thl lineage (Germann & Rude, 1995; Romagnani et al., 1996; Sedlik, 1996) it is
also possible that they are produced by intrinsic cells of the CNS. It has been
shown that astrocytes produce TNFa in vitro (Rubio et al., 1991,1993). It is
also possible that these two cytokines are produced by infiltrating
macrophages or other as yet uncharacterised cell types (Germann & Rude,
1995, Beutler, 1992). The presence of these pro-inflammatory cytokines in the
CNS during persistent infection suggests that the constant immune stimulus
provided by the virus results in their upregulation, however the precise cell
type which produces them is not known. It has been well documented that
cytokines play an important destructive role during a persistent viral
infection and upregulation of several pro-inflammatory cytokines may cause
direct pathology. For example high levels of TNFa can be destructive to
oligodendrocytes (Dofferhoff et al., 1991; Raine, 1994).
TNFa is also upregulated in other latent and persistent viral infections.
Infection of the trigemimal ganglion with HSV 1 results in expression of
TNFa, IFNy and IL-10 two months post infection (Halfod et al., 1996).
Cytomegalovirus (CMV) infection results in increased levels of TNFa and IL-2
at late time points post infection (Fietze et al., 1994; Geist et al., 1994). Studies
by Shearer et al, (1994) have implicated the importance of the cytokine
response during infection with HIV. There is a switch from Thl type
cytokines (IFNy and IL-2) during HIV infection to Th2 (IL-4, IL-10) with the
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onset of AIDs dementia, however in the later stages of dementia there is a
decrease in IL-4 and an increase in TNFa which is though to be one of the
major mediators of the wasting syndrome associated with the later stages of
AIDS dementia. Shearer hypothesised that Thl cells are associated with
increased levels of cell mediated immunity, and CTLs which are protective,
however when the switch is made from Thl to Th2, humoral immunity takes
over from cell mediated immunity and is thought to be less protective and the
final stages of dementia set in. This hypothesis was supported by two lines of
evidence which include 1) many HIV exposed individuals from a high risk
group generated HIV specific CTLs and remained seronegative despite
several exposures (Shearer, manuscript in preparation) and also 2)
preimmunisation of macaques with SIV results in a strong cell mediated
response with no antibody production. After tolerisation these animals were
resistant to infection, even when inoculated with high doses (Tyor et al.,
1992). This illustrates the importance of the protective cell mediated
immunity to HIV. In vitro studies of a vascular endothelial cell line infected
with Cocksackie B virus results in the establishment of a persistent infection
with the subsequent production of TNFa. This may contribute to the direct
pathology caused by this virus in cardiac muscle and CNS tissue in vivo
(Conaldi et al., 1997). The above examples illustrate TNFa's important
functional role in the persistent phase of many viral infections. The role of this
cytokine is further discussed with regards to the acute phase of Theiler's virus
infection in Chapter 3.
In the present study, relative to mice which had cleared the infection there
was clearly an increase in levels of anti-viral IgGl, IgG2a and IgG2b in CBA
mice which had a persistent infection. This is not consistent with the Thl
hypothesis for demyelination. A likely explanation for this is those animals
which had a persistent infection had a continuous stimulus to their immune
system inducing higher levels of antibody of all isotypes during the chronic
phase of Theiler's virus induced disease. In a study of CBA mice these same
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sera showed an increase in neutralising antibody titre in those animals with a
persistent infection as determined by in situ hybridisation between days 50-
268 (Simas & Fazakerley, 1996).
There was no single isotype which was particularly upregulated during the
chronic phase of in CBA mice. This was not as expected because previous
investigations have reported an upregulation in IgGl levels in resistant
C57B1/6 mice and an upregulation of IgG2a in susceptible SJL/J mice
(Peterson et al., 1992) . These reports have suggested a Thl versus Th2
dichotomy with IgGl associated with Th2 cells, viral clearance and resistance,
and IgG2a associated with Thl cells, viral persistence and susceptibility. The
antibody isotypes generated in CBA mice with and without viral persistence
did not correlate with the Thl/Th2 hypothesis, because IgGl, IgG2a and
IgG2b antibody isotype levels are all up regulated, in animals with a
persistent infection.
In this study when looking at differences between strains of mice, there was
only an increase in anti-viral IgGl isotype in SJL/J and CBA mice compared
to C57B1/6 mice at late time points post-infection. However, the implications
and relevance of having an increase in IgGl is associated with Th2 cells, and
it had been suggested by Miller's current model for demyelination that Thl
cells are partly responsible for the demyelination, and therefore from this
isotype evidence it can be suggested that Th2 cells are also present during the
demyelinating phase of the disease.
It is thought that the cytokine response during the acute phase of Theiler's
virus infection plays an important role in determining viral persistence, and
CBA mice are more variable in their cytokine responses between days 10-35 in
brains and spinal cords compared to the other mouse strains (see Chapter 3).
Therefore the cytokine array during the acute phase may play a important
role in determining whether virus persists or not and leads to demyelination
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and disease. This could be examined by trying to manipulate the cytokine
responses.
CBA mice which are intermediate in susceptibility to viral persistence and
therefore demyelinating disease leave an intriguing question to be answered.
Why do mice of an inbred mouse strain with exactly the same genetics lead to
differences in susceptibility to developing demyelinating disease? The role of
the immune system in individual CBA mice has been discussed above.
However, there are other reasons rather than the immune system which may
explain the differences in susceptibility in CBA mice. The sex of the animal
may influence the outcome of viral infection, This was illustrated by a study
by Kappel et al., (1991) who demonstrated that males were more likely to
develop demyelinating disease as opposed to females. It has been suggested
that females have a different hormonal mileu when compared to males, the
ability of a virus to persist may be linked to hormonal status of the infected
host i.e. depending of what time of the esterous cycle the female is at upon
inoculation, or depending on whether the female is pregnant when inoculated
may have an important influence. Oestrogen, a steroid hormone produced
predominantly by females, can have effects on humoral and cell mediated
immunity. I.e. inoculation of female mice with LCMV results in a fatal
leptomeningitis mediated by CD4+ T cells. Males are less susceptible however
males become susceptible if treated with oestrogen (Muller, 1995).
Psychological status of the host may be an important factor. Stress may have
an effect on the outcome of viral infection. Animal heirarchies exists in
groups of animals, the position of an individual within this hierarchy and the
associated stress may affect ability to clear virus. Both these suggestions are
speculative and there is little evidence to support them. However, it is known
that when an animal is stressed, steroid hormones are released which can
regulate the immune response (Hermann 1994, 1995). Animals which
experience restraint stress are differentially affected with regards to
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pathogenesis during experimental influenza virus infection. Virally infected
animals which are subjected to physical restraint stress were observed to
recover from influenza infection. This was documented to be due to the
increased levels of circulating glucocorticoids when compared to lower levels
of glucocorticoids in the unrestrained control group. Glucocorticoids have a
role in modulating the immune response and restricting inflammation,
therefore they increase the animals chances of survival (Hermann, 1993).
Glucocorticoids also play an important role in EAE infection. EAE infected
rats which underwent physical restraint stress had significantly suppressed
clinical signs and a quicker recovery, compared to the unrestrained control
group (Kuroda, et al., 1994). In a separate study glucocortocoids were also
directly implicated in the spontaneous recovery of rats from EAE (Mac Phee,
1989). Adrenalectomy of these rats results in fatality but if adrenalectomized
animals are treated with steroids they develop the same disease course as the
control group. These above studies highlight the importance the
physiological endocrine balance may have in affecting the clearance of
Theiler's virus. Also when an animal is stressed increased levels of TNFa are
produced by the HPA. This also may have important implications in Theiler's
virus pathology, as discussed in Chapter 8. Variability in the immune
response may also arise in CBA mice due to a number of factors. It is
accepted that i.e. inoculation results in the introduction of part of the
inoculum into the blood stream. It has now been shown that Theiler's virus
priming of the immune system occurs via the spleen and this favours a Th2
immune response, which is associated with IL-4, IL-5, IL-6 and IL-10 and a
good IgGl response (Peterson et al., 1992). Therefore the variabilities in viral
persistence may be due to the variability of individual CBA mice in splenic
priming of their immune response.
In conclusion, there is a increase in levels of IgM and IgGl when comparing
strains at late time points post infection. SJL/J (susceptible) and CBA
(intermediately susceptible) have increases in levels of IgGl when compared
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to C57Bl/6's (resistant). Levels of IgM are elevated in CBA mice when
compared to SJL/J and C57B1/6 mice. Evidence from the cytokine profiles
and ELISAs imply that CBA mice with viral persistence have significantly
elevateci levels of TNFa, IL-12p35, IL-12p40, IgGl, IgG2a and IgG2b when
compared to animals which have cleared the virus, therefore implicating that
there are both Thl and Th2 responses occurring during the demyelinating
process.
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Figure4.1 Levels of cytokine mRNA transcripts in the CNS of CBA mice with
and without viral persistence at late time points post infection. CBA mice
were inoculated with 104 PFU of TMEV (BeAn) i.e., and sampled between
days 50 and 268 post-infection. Viral persistence was determined by RT-PCR
and Southern blotting. This technique has a sensitivity such that 33 molecules
of vRNA could be detected. Cytokine mRNA transcripts were detected by
RNAse Protection Assay as described in the materials and methods. Transcripts
were visualised by autoradiography and quantitated by densitometry. Total
RNA was isolated from the brains of CBA mice which had cleared the virus
(•), those which had viral persistence (•) and from uninfected control mice (
). Graph A, represents the ML-11 probe set and graph B, represents the ML-
26 probe set.
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Figure4.2 Levels of specificanti-viral antibodies in the sera of CBA mice with
and without viral persistence at late time points post infection. CBA mice
were inoculated with 104 PFU of TMEV (BeAn) i.e., and sampled between
days 50 and 268 post-infection. Viral persistence was determined by RT-PCR
and Southern blotting. The anti-TMEV antibody isotypes were determined
by ELISA at a 1/100 dilution as described in the materials and methods. Levels
of various isotypes were isolated from the brains of CBA mice with
persistence (■) and without persistence (II). The solid line represents the
background absorbance which is the mean plus 2 standard deviations of the
absorbance given by a 1/100 dilution of serum from a group of mice
inoculated with the non-cross-reacting Semiliki Forest virus. The antiviral
IgM OD reading for mice with viral persistence and for mice which had
cleared the virus was 0.158 and 0.145, respectively (p=0.4, by Students t-test).
The antiviral IgGl OD reading for mice with viral persistence and for mice
which had cleared the virus was 0.187 and 0.158, respectively (p=0.07, by
Students t-test). The antiviral IgG2a OD reading for mice with viral
persistence and for mice which had cleared the virus was 0.215 and 0.127,
respectively (p=0.049, by Students t-test). The antiviral IgG2b OD reading for
mice with viral persistence and for mice which had cleared the virus was
0.225 and 0.143, respectively (p=0.009, by Students t-test).
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Figure 4.3 Anti-TMEV antibody isotypes in the serum of Balb/c, CBA,
C57B1/6 and STL/T mice during the acute and chronic phases of Theiler's
virus disease. Serum were collected from mice inoculated i.e. with 104 PFU of
TMEV (BeAn), from days 3 to 268 post infection. Antibody isotypes were
determined for Balb/c (•), CBA(«), C57B1/6 (•) and SJL/J (•) by TMEV
specific ELISA as described in the materials and methods. The solid line
represents the background absorbance which is the mean 2 standard
deviations of the absorbance given by a 1/100 dilution of serum from a group
of mice inoculated with the non-cross reacting Semiliki Forest virus.
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Chapter 5
The roles of IFNa/p and IFNy in mice infected with
the BeAn strain of Theiler's murine
encephalomyelitis virus.
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CHAPTER 5 TMEV INFECTION AND THE ROLES OF IFN'S
5.1 Introduction
The interferon family of cytokines consists of a series of evolutionarily
conserved molecules, which were discovered on the basis of their anti-viral
activity (Isaacs and Lindenman, 1957). The interferon family can be sub¬
divided into two classes. The two classes are distinct from each other and are
simply called type I interferons and type II interferons (Weissmann and
Weber, 1986).
Type I interferons (IFN) which include IFNa, IFNff and IFNco are encoded by
a cluster of over 20 genes (Weissmann and Weber,1986). In contrast, type II
IFN (IFNy) is structurally unrelated to type I IFNs and is encoded by a single
gene ifiig (Shepard, 1981). The two classes of IFN bind to separate receptors.
Class I IFNs bind to a multi-subunit receptor with one receptor subunit which
is fundamental for ligand binding (Uze et al., 1990; Muller et al., 1992; Novick
et al., 1994). The type II IFN receptor is composed of two subunits one which
is again essential for ligand binding (Aguet et al., 1988). The other is a species
specfic accessory subunit which is essential for function (Hemmi et al., 1994;
Soh et al., 1994).
IFN molecules mediate their effects upon binding to their receptors via the
JAK/STAT signalling transduction pathway (Darnell et al., 1994; Schindler
and Darnell 1995). The JAK/STAT pathway transcriptionally regulates a
variety of genes which are essential for initiating the effects of IFNs. As well
as their anti-viral effects IFNs also have a wide array of other functional
effects which include an involvement in cell growth, haematopoesis, anti
tumour activities and wide effects on humoral and cellular immune responses
(DeMaeyer and DeMaeyer-Guignard 1988; Sen and Lengyel, 1992; Farrar and
Schreuber, 1993).
153
CHAPTER 5 TMEV INFECTION AND THE ROLES OF IFN'S
Genetic manipulation has made it possible to construct mice which have no
functional type I or type II IFN receptors. This was achieved by homologous
recombination. There are two separate strains of mice, one which lacks a
functional receptor for IFNa/p (Muller et al., 1994) and the other which lacks a
functional receptor for IFNy (Huang et al., 1993), designated by IFNaf3R°/()
and IFNyR°/°, respectively.
The generation of these mice has enabled researchers to ascertain the roles of
the different classes of IFNs with regards to viral, bacterial and parasitic
infections (Huang et al., 1993; Kamijo et al., 1993). The importance of both
classes has been investigated in viral infectons including LCMV, VSV, VV,
SFV and TMEV (Fiette et al., 1995, Van den Broek et al., 1995). IFNaP has
been shown to play an important role in the early stages of all the above viral
infections, and is important in preventing viral spread. On the other hand
IFNy seems to be of little importance until there is the generation of a specific
immune response. Once the specific immune response is generated IFNy
plays an essential role in clearing virus from the host in both TMEV and VV
infections.
A gene near ifng locus has been associated with Theiler's virus persistence in
the SJL mouse strain, and IFNy is considered to be a prime candidate in
determining viral persistence due to its immunoregulatory properties (Bureau
et al., 1992). The objective of this chapter was to asses the roles of IFNaP and
IFNy following infection with the BeAn strain of TMEV.
5.2 Experimental design
Experiment 1
Following i.e. inoculation with 104 PFU of TMEV (BeAn), three IFNa/pR°/°
and three WT 129 mice were sampled at each of days 3, 5 and 7 post-infection.
At each time point brains, small intestine, heart and muscle were fixed in 10%
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formal saline for histological purposes. These tissues were cut and used for
ISH and immunocytochemistry to determine the areas of viral spread,
tropism and to examine cell death. Sera were also taken to determine levels
of antibodies.
Experiment 2
Ten IFNyR°/° and ten WT129 mice were inoculated i.e. with 104 PFU of TMEV
(BeAn). All animals were sampled at day 60 post infection. At this time point
half of the brain and spinal cord was snap frozen in liquid nitrogen and RNA
was subsequently extracted. This brain and spinal cord RNA was used in an
RNase protection assay to determine levels of different cytokine mRNA
transcripts (as described in Section 2.11), and in a nested PCR to determine
whether virus persisted in these tissues ( as described in Section 2.13). The
other halves of the brains and spinal cords were frozen in isopentane for
cryostat histology. Tissues were then cut and subsequently used for
immunostaining to determine the cellular tropism of any persisting CNS
virus. Serum was also taken to assess levels of neutralising antibody and the
isotypes of virus specific antibodies. These were determined by neutralisation
assay (Section 2.8) and a series of ELISAs (Section 2.14), respectively. The
ELISA experiments were not carried out as accurately as they might have
been therefore the value of these experiments is questionable. In these ELISA
experiments for convenience a standard 1/100 dilution of serum was used for
all samples. Fiowever, if ELISA experiments were to be carried out more
thorough, the total immunoglobulin level in individual samples should be
determined by a separate ELISA. Therefore when reading the ELISA data this
point should be remembered.
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5.3 Results
5.3.1 Clinical signs in IFNaPR0/0 mice inoculated with TMEV (BeAn).
Animals were assessed daily to see if there was any development of clinical
disease. IFNaf3R°/° animals showed signs of acute TMEV disease as early as
day 3 post-inoculation with all animals showing signs of encephalitis
including photophobia. By day five post inoculation all IFNaPR0/0 mice
appeared extremely unwell, they were hunched and grouped together with
their fur looking stark, by day 7 post infection the IFNaPR0/0 mice had started
to die and the surviving animals were all moribund. By day 8 post inoculation
all animals had died. In contrast, at all time points studied the infected WT
129 mice remained well.
5.3.2 Tropism of TMEV in IFNa/pR°/° mice.
The tropism of the virus varied greatly between the IFNaPR0/0 and wild type
animals. As early as day 3 post infection IFNapR0/0 animals had virus in the
gray and white matter tracts of the CNS, and by day 5 the virus had spread
throughout the CNS. This was different from the wild type mice which only
developed focal infection of the gray matter. Therefore this suggests that
IFNa/p is essential to prevent virus from entering cells of the white matter
during the acute phase of infection Figure 5.1.
5.3.3 Clinical signs of IFNyR°/° mice inoculated with TMEV (BeAn)
The clinical signs seen in IFNyR°/° mice inoculated with TMEV contrasted
dramatically to that seen in the IFNapR°/o. Of the 10 IFNyR°/° animals
inoculated only 3 developed clinical signs. Animals started to develop clinical
signs at 2 weeks post inoculation. Animals which developed clinical signs
during the acute phase continued to show clinical signs during the chronic
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phase of disease, and had hind limb paralysis until they were sampled at day
60 post-infection. The control group of infected WT129 mice remained well at
all time points post infection.
5.3.4 Cytokine profiles in IFNyR°/° mice inoculated with TMEV (BeAn)
RNA was made from CNS tissues and examined for mRNA transcripts for
various cytokines including IFNy, TNFp, TNFa, IL-4, IL-5, ILla, IL-2, IL-6, IL-
lp, IL-3, GM-CSF, IL-10, TGFp, IL-13, IL-12p40, IL-12p35 and IL-7. At day 60
post infection, there was no statistical difference in the levels of message for
any of the cytokines between the IFNyR°/° mice and the contol WT129 mice,
as determined by Student's t-test (Figure 5.2 and Table 5.1).
5.3.5 Neutralising antibody levels and specific antibody isotypes generated
during the chronic phase of TMEV infection in IFNyR°/° mice.
As detailed in the Introduction, neutralising antibody has been shown to be
important in controlling the spread of TMEV infection, therefore it was of
interest to discover if there was any difference in levels of neutralising
antibodies and specific antibody isotypes between the IFNyR°/° mice and the
control WT129 mice. By neutralisation assay IFNyR°/° mice had a significantly
(Student's t-test) increased amount of neutralising antibody compared to the
control WT129 mice (P=0.0001) (Figure 5.3). The different anti-viral isotypes
of antibodies generated during infection with TMEV were determined at day
60 by ELISA. IgM, IgGl, IgG2a, and IgG2b antibodies specific for TMEV were
significantly elevated in the IFNyR°/° mice when compared to control WT129
mice as determined by Student's t-test (IgGl p=0.0001, IgG2a p=0.049, IgG2b
p=0.006 and IgM p=0.001) (Figure 5.4 and Table 5.2). These data indicate that
IFNyR°/° mice have elevated levels of all antibody isotypes during the chronic
phase of disease (>60 days post-infection). This can probably be attributed to
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continual stimulus generated by persisting virus within the CNS (see Section
5.3.6).
5.3.6 Persistence of virus in the CNS of IFNyR°/° mice
It has been suggested that susceptibility to TMEV induced demyelination is
associated with a genetic loci near the ifng gene therefore it was of interest to
determine whether Theiler's virus persisted in the CNS of inoculated
IFNyR°/° mice or whether virus was cleared independently of IFNy. RNA
was made from CNS tissues and examined for viral sequences by nested PCR.
The technique of nested PCR was developed for the detection of TMEV
genome. This assay was developed as it offers a high degree of sensitivity for
viral genome, and it also offers confirmation of the identity of the first round
RT-PCR amplification product. Initially, first round RT-PCR was undertaken
using primers 2A and 2B, see Section 2.13. Subsequently second round nested
PCR was undertaken using primers N1 and N2. Primers were designed by
using the published sequence data (Pevear et al., 1987). Figure 5.5 shows the
RT-PCR products of the external ( 408 bp) and the internal (182 bp) nested
primer sets analysed by an ethidium bromide stained agarose gel (lanes, 6, 8,
10, 12, 13, 14, 15). The specificity of the RT-PCR and nested PCR products
were confirmed by Southern blot analysis. The sensitivity of this assay was
calculated to be such that 3 molecules of viral RNA could be detected per
brain (lane 15). This method is of great significance for the future study of
TMEV pathogenesis and persistence as it offers an assay with an increased
sensitivity as opposed to first round RT-PCR with subsequent Southern
blotting, and therefore produces a more accurate readout of whether virus is
persisting in the CNS.
TMEV sequences were detected in all ten of the brains and all ten of the spinal
cords examined from IFNyR°/o mice at day 60. In contrast, sequences were
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only found in three of the WT129 animals brains and spinal cords sampled at
this time (Figure 5.6). As a point of interest it was noted that the IFNyR°/°
animals which had visible clinical signs had the greatest amounts of virus,
since this could be detected after first round RT-PCR.
5.4 Discussion
5.4.1 The role of IFNa/(3 during Theiler's virus infection
IFNa/p vs known to be important during the acute phase of a virus infection
(Nemes et al., 1969; Hilleman, 1970; Sen and Ransohoff, 1993; Van den Broek
et al., 1995). Mice which lack the IFNa/p receptor are extremely susceptible to
a number of viral infections including VSV, SFV, VV and LCMV, even at very
low inoculation doses (Van den Broek et al., 1995). There are several
examples of IFN-induced proteins with anti-viral properties these include, Mx
proteins which inhibit for example influenza virus (Samuel, 1991), p68 protein
kinase which is important in a wide range of RNA and DNA viruses (Pain,
1986; Galabru and Hovanessian, 1987; Samuel, 1988, 1991), but perhaps the
most relevant is the 2'5'-oligoadenylate synthase system which inhibits the
action of picornaviruses (Chebath et al., 1987; Rysiecki et al., 1989; Coccia et
al., 1990). Picornaviruses such as TMEV induce the 2'5'-oligoadenylate
synthase system. 2'5'-oligoadenylate synthase is activated by IFNa/p and
causes the degradation of viral and cellular RNAs by cleaving ssRNAs on the
3' side of the UpXp sequence (Samuel et al., 1991). It could be that in the
absence of this pathway picornaviral replication continues unchecked.
One of the most striking observations in IFNa/pR°/° mice is that TMEV
produces widespread infection of cells in the white matter tracts during the
acute phase of infection. A previous study indicated that grey matter areas
were exclusively infected during the acute phase of infection of IFNa/p R°/°
mice (Fiette et al., 1995). The present data suggests that IFNa/p has an
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important role in preventing infection of oligodendrocytes in the white
matter, and that lack of a functional IFNa/(3 system results in susceptibility of
oligodendrocytes to TMEV. This has important implications, because of the
important role oligodendrocytes play in myelin production and maintenance.
Viral infection of oligodendrocytes may lead to oligodendrocyte and myelin
destruction. These data suggest that the IFNa/p system may play an
important role in preventing demyelination, by limiting viral spread in
oligodendrocytes.
IFNs a, (3, and y all promote NK cells to become cytolytically activated and
proliferate. NK cells are large granular cytolytic lymphocytes which
represent a large proportion of the infiltrating lymphocytes generally during
a viral infection. A peak in NK cell activity and proliferation occurs in
parallel with the IFNa/p response during the acute phase of a viral infection.
IFNy promotes NK cell activity once the specific immune response is
activated. The increase in viral dissementation in the IFNa/pR°/° mice during
TMEV infection could be accounted for due to the lack of NK cell activity. It
has been shown that NK cell activity is important early in Theiler's virus
infection (Paya et al, 1989).
5.4.2 The role of IFNy during Theiler's virus infection
Several genes have been linked to susceptibility to persistent Theiler's virus
infection. One of the most interesting genes is Ifg (Bureau et al., 1993). Ifg is
the gene which encodes IFNy. This gene and its product is of great interest
primarily because of its known immunomodulatory and anti-viral roles.
IFNy's functions are numerous (Farrar and Schriber, 1993), and include the
activation of macrophage, involvement in T cell proliferation (Gajewski et al.,
1989), upregulation of MHC molecules expression on APC's and other,
upregulation of adhesion and costimulatory molecules involved in T cell
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activation and generation of antibodies of the IgG2a subclass (Snapper and
Paul, 1987).
Pullen et al (1994) reported that a neutralising monoclonal antibody directed
against IFNy resulted in exacerbation of TMEV induced disease in a
susceptible mouse strain. Just after this thesis was started Fiette and colleages
(1995) demonstrated that TMEV infection of IFNyR°/° mice on a resistant H2b
genetic background resulted in viral persistence and chronic white matter
disease. The present data confirms these results.
Virus was able to persist in IFNyR°/° (FI-2b) mice. Complete viral clearance
occurred in the control wildtype animals. It has been well documented that
TMEV clearance is MHC class I restricted and is associated with the action of
CD8+ T cells (Pena Rossi et al., 1991; Rodriguez et al., 1993; Pullen et al., 1993;
Fiette et al., 1993; Azoulay et al., 1994). Lack of a functional IFNy system may
prevent the generation of significant numbers of CTLs or may cause a
decrease in the expression of MHC class I molecules, either or both of these
could explain why the virus is not cleared. IFNy plays a direct role in antigen
presentation by activation of antigen processing via the proteosome (Driscoll
et al., 1993; Gaczynska et al., 1993; Boes et al., 1994). Lack of IFNy could
therefore prevent or impair antigen presentation to CD8+ T cells. In this
regard infection of IFNyR°/o mice with LCMV results in an impairment in
CTL responses (Van den Broek et al., 1995). It would be of interest to further
characterise the importance of CTL responses in IFNyR0/" mice and discover
whether there was any impairment of the response generated towards TMEV.
Virus persists and demyelination occurs in the IFNyR°/° mice indicating that
IFNy is not required for demyelination. Studies in IFNyR°/o mice infected
with LCMV and VV have shown a specific antibody profile with increase in
levels of IgGl (Van den Broek et al., 1995). It is known that IFNy down
regulates IgGl (Snapper and Paul, 1987; Finkelman et al., 1990). However,
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TMEV infected IFNyR°/° mice had significantly increased levels of antibodies
of all subclasses and had significantly increased levels of neutralising
antibody in their serum compared with the control group. Increased
antibody levels in the IFNyR°/° mice is likely to be due to the amount of
antigen in the CNS, IFNyR°/° mice all had persisting virus, which presumably
constantly stimulated the immune response.
In conclusion IFNs play a non-redundant role in TMEV infection. IFNa/(3
plays an important role in acute infection. Contrasting to this IFNy's effects
are not noticeable until the immune response is activated. IFNy is essential
for clearance of virus from the CNS, however, the exact role(s) IFNy plays in
TMEV clearance are not known. That it affects antigen presentation and CTL
generation seems most likely.
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Figure 5.1 Represents images illustrating the distribution of BeAn virus in
the brains of IFNa/[3R0/0 mice. 3-4 week old mice were inoculated with 104
PFU of TMEV BeAn i.c and sampled early after infection. Viral positivity
was determined by ISH using a digoxigenin labelled riboprobe which has
been described previously in the materials and materials, tissues were
counterstained with haemotoxilyin. A) Low magnification showing viral
positivity. B to F) Individual stained virus positive cells (brown). G)
Negative control. Magnification x 10 (A), x 100 (B-G).
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Figure 5.2 mRNA cytokine profiles in the brains of IFNyR0/0 and control
WT129 mice infection with TMEV (BeAn), at day 60 post infection. All mice
were inoculated i.e. with 104PFU of TMEV (BeAn). mRNA cytokine levels
were determined by RNase Protection Assay as described see materials and
methods, and measured by densotometry. Graph A represents ML-26 which is
a template probe set for different cytokines including IL-10, GM-CSF, TGF-p,
IL-13, IL-12P40, IL-12p35, IL-7 and L32. Graph B represents the ML-11
template set which includes probes for TNFp, TNFa, IL-4, IL-5, IL-la, IL-2,
IFNy, IL-ip, IL-6, IL-3. Both ML-11 and ML-26 probe sets had a probe for L32
which is a ubiquitously expressed ribosomal protein. The L32 band was used
as an internal control and all samples were standardised against the density
of their L32 band. INFyR°/° were represented by (•) and control WT 129 mice
were all represented (®).
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Figure5.3 TMEV- specific neutralisation antibody titres present in the serum
of IFNyR°/° and WT129 mice at 60 days post-infection. All mice were
inoculated i.e. with 104 PFU of TMEV (BeAn). The x-axis represents time and
the y-axis represents the 50% neutralisation titre. The neutralisation titres
were calculated as described in the materials and methods. The graph shows
the reciprocal of the neutralisation titre (e.g if 1/100 dilution of serum gave a
50% in reduction of plaque formation it is shown as 100 on the y-axis)
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Figure5.4 Anti-TMEV antibody titres of BeAn-infected IFNyR0/0 and WT 129
mice at 60 days post-infection. Sera were collected at day 60 post-infection
from IFNyR1'/0 (#) and WT 129 mice (®) inoculated i.e. with 104 PFU TMEV
(BeAn). The anti-TMEV antibody was isotyped by TMEV ELISA as described
in the materials and methods. Each symbol represents the serum from an
individual mice. The solid line represents the background absorbance, which
is the mean plus 2 standard deviations of the background absorbance given
by a 1/100 dilution of serum from a group of mice inoculated with the non-
cross-reacting Semiliki Forest virus.
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Figure 5.5 Products of first round RT-PCR and second round nested PCR
of BeAn viral RNA concentrations. Lane 1 and 19 ((>174 DNA size markers,
lanes 7, 9 and 11 show 2 pg, 200 fg and 20 fg respectively, of amplified BeAn
viral RNA after first round RT-PCR. Lanes 6, 8, 10, 12, 13, 14, 15, 16 and 17
indicate 200 pg, 2 pg, 200 fg, 20 fg, 2 fg, 0.2 fg, 0.02 fg, 0.002 fg and 0.0002 fg
respectively of amplified BeAn sequences after second round nested PCR.
The PCR conditions and primer sequences have been described previously in
the materials and methods. After second round nested PCR a product of 182
bp is visualised when 0.02 fg of vRNA is amplified indicating the sensitivity
of the assay is such that 3 molecules of virus can be detected. 408 bp and 182
bp are the lengths of the products obtained with the primers from first round
RT-PCR and second round N-PCR respectively. The products were
visualised by ethidium bromide staining of the agarose gel.
409 hp
182 hp
Figure 5.6 N-PCR amplified BeAn sequences from the brains of Sv 129
and IFNyR0/0 mice, at 60 days post infection. 10 fold serial dilutions of
purified vRNA from 2 fg to 0.02 fg was assayed as a positive control to
determine the sensitivity of the assay. The sensitivity of the assay was such
that 3 molecules of viral RNA could be detected by N-PCR. From the figure
it can be seen that all (n=10) of the IFNyR°/° mice had detectable levels of
persisting virus in their CNS compared to only 3 out of 10 of the wild type
animals examined. The products were visualised by ethidium bromide
staining of the agarose gel.
IFNyR°/° IFNyR°/° WT 129 WT 129 t-Test
Average SD Average SD
TNFp 0.51 0.25 0.612 0.058 0.46
TNFcc 0.96 0.1 0.86 0.3 0.49
IL-4 0.132 0.13 0.15 0.13 0.82
IL-5 0.122 0.15 0.14 0.146 0.86
IL-la 0.398 0.07 0.3175 0.09 0.2
IFNy 0.172 0.163 0.09 0.04 0.37
IL-6 0.11 0.11 0.1275 0.026 0.74
IL-ip 0.41 0.12 0.41 0.07 0.92
IL-3 0.026 0.016 0.04 0.01 0.14
IL-10 0.066 0.067 0.012 0.018 0.17
GM-CSF 1058 0.03 0.0375 0.005 0.23
TGFP 0.934 0.13 0.965 0.11 0.72
IL-13 0.09 0.1 0.11 0.13 0.87
IL12p40 0.13 0.06 0.225 0.316 0.5
IL-12p35 0.48 0.27 0.625 0.037 0.35
IL-7 0.11 0.08 0.11 0.03 1
Table 5.1 Statistical Analysis comparing cytokine levels in IFNyR°/° and WT
129 mice. Statistical analysis was carried out on the standardised
densitometry readings from mRNA for ML-11 and ML-26 template sets
between the IFNyR°/° mice (n=5) and WT129 (n=4) mice at day 60 post
infection. The analysis indicates that there were no differences at the p<0.05
level or even at the p< 0.1 level. The figures represent the densitometery reading of
the particular band of interest after nonnalisation.
IFNyR°/° IFNyR°/° WT129 WT129 t-Test
Average SD Average SD
N-Ab
IgM 0.2260 0.029 0.16 0.021 0.001
IgGl 0.278 0.036 0.17 0.023 0.0001
IgG2a 0.326 0.04 0.27 0.04 0.049
IgG2b 0.39 0.074 0.25 0.06 0.006
Table 5.2. The statistical analysis carried out on IFNyR°/° and WT 129 mice,
for TMEV specific neutralisation antibody and TMEV specific isotypes to
determine differences between the two groups. The figure represent the OD's
at 570 nm.
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CHAPTER 6 THEILER'S VIRUS AND PERFORIN
6.1 Introduction
CD8+ T cells and natural killer (NK) cells play important roles in clearance
and protection from Theiler's virus and the demyelination induced by
Theiler's virus as discussed in the Introduction (see Section 1.14.4). CD8+ T
cells function by recognising target cells presenting processed antigen in their
MHC class I molecules, whereas NK cells lyse a variety of target cells without
the classical restriction by MHC molecules. There are 4 independent
pathways which account for CD8+ T cell effects following the recognition of a
virus infected cell, these include 1) degranulation leading to the release of
perforin and granzymes, 2) engagement of Fas receptor on target cells with
Fas ligand on CTLs, 3) surface bound TNFa and 4) the release of soluble
bioactive molecules such as the cytokine IFNy (Lui et ak, 1987; Kagi et al.,
1994b; 1995). The first three mechanisms generally lead to death of
susceptible cells. In the case of granzymes, fas and TNFa this is by induction
of programmed cell death. In the case of perforin it is by cell lysis following
compromisation of the plasma membrane by the perforin pore complex.
Although CTLs may employ any of the above effector mechanims, NK cells
exclusively lyse target cells via the perforin-dependant pathway (Young et al.,
1986b).
The perforin system of cytotoxicity was established by isolating and cloning
the perforin molecule from cytolytic lymphocytes (Podack et al., 1985; Young
et al., 1986a, 1986b, 1986c). Perforin is a glycoprotein of 534 amino acids in
length and has sequence homology with C9 a component of the membrane
attack complex of the complement system (Shinkai et al., 1988). Following
interaction with Ca2+ perforin has the ability to integrate into target cell
membranes where the perforin molecules polymerise with each other and
form aggregates which produce pores of 10-20 nm in diameter in the target
cell membranes (Litchenhels et al., 1988; Podack et al., 1988). Permeablisation
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of the target cell membrane results in death of the target cell and the effector
cell (CTL or NK cell) moves on to continue lysing other infected target cells.
The perforin-dependant pathway of cytotoxicity has been shown to be vital in
clearing LCMV from infected hosts and limiting pathology (Kagi et al., 1994).
On the other hand, the ability to clear other viral infections by a non-perforin
dependant pathway has been documented with vaccinia virus (Kagi et al.,
1995), vesicular stomatitis virus (Kagi et al., 1995), mouse hepatitis virus (Lin
et al., 1997), mouse herpes virus -68 (Usherwood et al., 1997) and murine
rotavirus (Franco et al., 1997). The aim of this chapter was to determine the
role of the perforin dependant pathway of cytotoxicity in Theiler's virus
infection. This was undertaken by studying Theiler's virus infection in
perforin deficient mice and comparing the course of infection with the
infection in resistant C57B1/6 mice.
6.2 Experimental design
Three to four-week old, female and male C57B1/6 and genetically engineered
mice deficient in perforin on a C57B1/6 resistant (H-2b) background were
inoculated intracerebrally with 104 PFU of TMEV (BeAn). 4-6 mice were
sampled on days 3, 5, 7, 9, 11 and 60 post-infection, brains, spinal cords and
sera were taken from individual animals at each time point (Section 2.5). Half
of the brain and spinal cords were immediately placed into 10% formal saline
and processed for histology, cut tissues were subsequently used for ISH and
immunostaining to determine the areas of virus spread, the cell types infected
and the mechanism by which infected cells died. From the other halves of the
brains and spinal cords RNA or tissue culture homogenates were made. RNA
was made to determine whether or not virus persisted at late time points
post-infection, using nested PCR as described in the materials and methods.
Homogenates were used in plaque assays to determine the virus load. Sera
were taken to determine and compare the levels of neutralisating antibodies
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and the isotypes of the antibodies (there are problems with the ELISA data see
Section 3.2.2).
6.3 Results
6.3.1 Acute phase clinical signs
Animals were regularly assessed at the various time points to monitor for any
development of clinical signs (as detailed in materials and methods). As early as
days 3 and 5 post-inoculation there were visible differences between the
groups. Mice which lacked the perforin molecule appeared moribund,
hunched and their fur was ruffled. This group of mice contrasted
dramatically to the C57B1/6 animals, throughout the course of infection these
animals remained well and alert at all time-points. At day 7 mice which
lacked the perforin molecule showed the typical clinical signs of mice
susceptible to acute Theiler's virus infection, which included poliomyelitis
and hind limb paralysis. These signs remained in all the animals which
survived until the animals were sacrificed at day 60 post-inoculation.
6.3.2 Acute phase plaque assay and virus spread
The course of virus infection ciuring the acute phase of TMEV infection was
typical. A productive round of viral replication peaked at day 5 in both
groups and gradually decreased from day 7 to low levels at day 11 post¬
infection. This general pattern of infection was seen in both groups, however
there were differences between the perforin deficient and wild type mice
(Figure 6.1). There were statistically significant differences as early as day
three between the two groups (p=0.002), as determined by Student's t-test.
These statistical differences remained at days nine and eleven post inoculation
with p values of 0.006 and 0.008 respectively. This suggests that virus
replication occurred unchecked in the animals which lacked perforin when
compared to the control group.
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6.3.3 CNS virus spread and distribution.
The neuroanatomical distribution of Theiler's virus sequences in perforin
knock out and C57B1/6 mice was determined by in situ hybridisation (Section
2.15.9) ISH uses a radiolabeled riboprobe complementary to viral genomic
RNA, followed by autoradiographic and microscopic analysis. The specificity
of the riboprobe was tested on aged matched non-infected murine CNS
tissues and at no point was there ever positive signals detected. The virus
spread in brains of infected animals was consistent with the infectious virus
assays (Section 6.3.2.). It can clearly be seen from Figure 6.2 that there was
more virus present at all time points in the knockout mice compared to the
control group. This is consistent with the infectious virus assay (Figure 6.1.).
Areas of positivity were the same in both groups however there were fewer
virus positive cells observed in the control group. Positive cells were
identified in the cortex, hippocampus, thalamus, hypothalamus particularly
in the mammiliary nucleus, substantia nigra and the brain stem. There was
little or no positivity found in the cerebellum, olfactory bulb, dentate gyrus,
striatum, inferior or superior colliculi, pons or white matter tracts in either the
perforin knock-out mice or the control C57B1/6 mice. Together with the virus
titre data this clearly demonstrates increased levels of infectious virus in the
perforin knock out mice at early time-points post-infection, when compared
to the control group.
6.3.4 Chronic phase clinical signs and levels of viral persistence
As mentioned above all mice which lacked perforin displayed clinical signs at
60 days post inoculation, however, none of the wild type C57B1/6 mice
showed any signs of disease. This left the imposing question, did the perforin
knock out mice which displayed clinical signs have persisting virus in their
CNS? This question was addressed by analysing spinal cord RNA by nested
PCR as described in Section 2.13. At day 60 post-infection 7/7 perforin knock
out mice had Theiler's virus sequences persisting in their CNS. This compared
dramatically to the control C57B1/6 mice where 0/7 animals had detectable
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levels of Theiler's virus RNA. The limit of sensitivity of this assay was 0.002
fg of viral RNA, which is equivalent to 3 molecules of virus, see Figure 6.3.
These results demonstrate the importance of the perforin molecule and
cytolytic lymphocytes, CD8+ T cells or NK cells in the elimination of TMEV
from the CNS.
6.3.5 Levels of antibodies and levels of neutralisation antibody
Neutralising antibody has been shown to be important in TMEV infection,
and the subclasses of antibody produced in response to TMEV infection has
been shown in some studies to be of significance, with IgGl being associated
with resistance and IgG2a being associated with susceptibility to
demyelinating disease. The levels of neutralising antibody and of the
different subclasses of antibodies produced during the acute and chronic
phases were determined in the two groups of mice by neutralisation assay
and ELISA as described in Sections 2.8 and 2.14. Figures 6.4 and 6.5
demonstrate that there were no differences in the levels of neutralising
antibody and no differences in antibody subclasses between the perforin
knockout mice and the control C57B1/6 mice at any time point. These data
show that lack of perforin has no effect on the level or class of neutralising
antibodies produced during Theiler's virus infection. From the ELISA data
obtained from mice with a persistent Theiler's virus infection it was expected
that the perforin deficient mice would have elevated antibody levels due to
persisting virus. However in the perforin deficient animals, antibody levels
remained the same as the wild type animals. This may be explained by the
fact that the amount of virus persisting in the perforin deficient animals was
not sufficient enough to drive a good immunoglobulin response.
6.3.6 TUNEL evidence for apoptosis ?
There is evidence to suggest that different strains of Theiler's virus have
differing abilities to induce apoptosis in different cell types in vitro. GDVII
has a 50 fold greater capacity to induce apoptosis than the avirulent BeAn
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strain of the virus in BSC-1 and BHK-12 cell lines (Lipton et al., 1997). The
ability of BeAn to induce apoptosis in perforin knock out and control C57B1/6
mice was determined by using the TUNEL technique as described in Section
2.15.4. There were differences between the perforin knock-out mice and the
wild type C57B1/6 mice. The mice which lacked perforin had an increase in
levels of apoptosis, with cell death peaking at around day 7 post inoculation.
This coincided with the high levels of infectious virus in the CNS. After day 7
the levels of cell death diminished to background levels. The area in which
cell death was most obvious was the hippocampus, particularly the virally
infected hippocampal neurones (see Figure 6.6). These data are the first to
show that an avirulent strain of Theiler's virus induces programmed cell
death in vivo.
6.4 Discussion
This study was undertaken to identify the contribution of perforin-dependent
cellular cytolysis in the pathogenesis of TMEV infection. A perforin-
dependant pathway has been shown to be essential for the clearance of the
non-cytopathic LCMV whereas non perforin-dependant pathways are
essential in clearing cytopathic viral infections such as VSV, VV and SFV
(Kagi et al., 1995). These cytopathic viruses are cleared either via one of the
other pathways used by CTL's, or by the generation of specific neutralising
antibodies. It was of interest to discover what role perforin played in TMEV
infection, primarily because TMEV is cytopathic during the acute phase of the
disease but establishes a non-cytopathic phase during chronic infection.
There was no difference in the brain regions infected during the acute phase
of the disease between the perforin deficient and control mice. Virus
remained exclusively in grey matter areas. However, the levels of virus were
greater at all times post-infection in the perforin deficient mice. This may be
accounted for by the fact that at early time points post-infection when virus
levels were at their highest in both the perforin deficient and C57B1/6 mice,
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NK cells are likely to be particularly important. Unlike CTLs which lyse
infected cells by a variety of mechanisms, NK cells exclusively lyse cells via a
perforin-dependent pathway. The early increased levels of virus in the
perforin-deficient mice compared to the C57B1/6 mice is likely to be
attributable to the lack of NK cell activity. This is supported by the fact that it
has previously been demonstrated that NK cells play an important protective
role during the acute phase of infection with TMEV (Paya et al., 1989). The
precise role of NK cells in the demyelinating process remains as yet
unknown, therefore it would be interesting to determine whether perforin
deficient mice had an increased or reduced degree of demyelination during
infection with Theiler's virus infection.
It could be argued that early virus load is an important factor in determining
the clinical disease phenotype. At early time points post infection (days 3 and
5) perforin deficient mice had an increase in virus load in their CNS which
could have resulted in an increase in the levels of cell lysis or programmed
cell death leading to clinically apparent disease. No clinical signs were seen
in the C57B1/6 mice with lower CNS virus titres.
From day 7 and there after levels of infectious virus decreased in both the
perforin-deficient and C57B1/6 mice. This may be attributable to the
generation of either an antibody, a specific non-perforin dependant cellular
immune response to TMEV, or both. Although perforin deficient mice have
CTLs which cannot lyse cells via the perforin pathway they still have normal
levels of Fas dependant cytotoxicity and produce cytokines (Lowin et al.,
1994; Walsh et al 1994a, 1994b). Various cytokines are known to modulate the
activities of CTLs in other viral models. It has been demonstrated that TNFa
released by CD8 + T cells can inhibit gene expression of hepatitis B virus
(Guidotti et al., 1995) and has also been shown to act against cytomegalovirus
(Pavic et al., 1993). Other cytokines such as MlP-la and MIP-ip have been
shown in vitro to be produced by CD8+ T cells and have a suppressive affect
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on HIV infection (Cocchi et al., 1995). Perhaps the best recognised cytokine
involved in anti-viral activity produced by CD8+ T cells is IFNy (Kundig et
al., 1996; Ruby et al., 1997). It has been shown that CD8+ T cell mediated
clearance of murine rotavirus does not involve perforin, fas or IFNy, therefore
clearly there are other anti-viral mechanisms present (Lin et al., 1997). During
CNS infection with Theiler's virus it has been noted that macrophages, CD4+
T cells, and neutralising antibody as well as CTL's infiltrate the CNS (Oleszak
et al., 1995).
Theiler's virus infection of perforin deficient mice resulted in persistence of
virus during the chronic phase of the disease. This compared dramatically to
the C57B1/6 mice where virus was cleared by approximately 11 days post¬
infection. Although virus levels decreased to very low levels in the perforin
deficient animals they were never eliminated, indicating that perforin
dependant cytotoxicity is essential for the clearance of Theiler's virus from the
CNS. Lack of perforin leads to low levels of persisting virus which in turn
may lead to demyelinating disease.
In summary, these data suggest that functional perforin is a prerequisite for
Theiler's virus clearance from the CNS. Lytic NK cells (which are perforin
dependant for function) most likely contribute to disease prevention in the
early phases of the acute diseases by decreasing viral load. CTL's which
function via perforin had little or no direct role in primary demyelination
associated with TMEV infection of this mouse strain, except as a mediator of
virus elimination. In these studies perforin has been shown to play an
essential role in the acute phase of the disease by facilitating a reduction in
viral load, and in the chronic phase of disease by its requirement to eliminate
virus from the CNS.
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Figure 6.1 Brain virus titres in Perforin deficient and C57B1/6 mice during the
acute phase of infection with TMEV (BeAn). Perforin deficient mice (•) and
C57B1/6 mice (©) were inoculated i.e. with 104 PFU of TMEV (BeAn). Each
symbol represents the brain virus titre of an individual mouse. The dotted
line represents the limit of detection of the plaque assay. The red and green
dashes represent the average of the brain virus titres for each group.
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Figure 6.2 Neuroanatomical distribution of BeAn RNA sequences in the
CNS of perforin deficient and C57B1/6 mice during the acute phase of
infection. Autoradiographic images demonstrate the spread of BeAn viral
RNA in sagital sections of brains from perforin deficient and wild type
C57B1/6 mice inoculated with 104 PFU of TMEV (BeAn) at 3-4 weeks old.
ISH was the technique used to detect viral sequences using a 33S-labelled
riboprobe complementary to virus RNA sequences. Areas of positivity
appear black in colour. Numbers on the x-axis represents the days post
infection, and the y-axis represents the group of animals inoculated.
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Figure 6.3 N-PCR amplified BeAn sequences from the spinal cords of
C57B1/6 and perforin deficient mice, at 60 days post infection. Purified
vRNA of 2 fg and 0.02 fg was assayed as a positive control to determine the
sensitivity of the assay. The sensitivity of the assay was such that 3 molecules
of viral RNA could be detected by N-PCR. From the figure it can be seen
that all (n=7) of the perforin deficient mice had detectable persisting virus in
their CNS. None (n=7) of the wild type animals examined had detectable
viral RNA. The N-PCR products were visualised by ethidium bromide
staining of the agarose gel.
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Figure 6.4 TMEV- specific neutralisation antibody titres in the sera of
perforin deficient and C57B1/6 mice during the acute phase of TMEV
infection. Perforin deficient (•) and C57B1/6 (#) were inoculated i.e. with 104
PFU of TMEV BeAn. The x-axis represents time and the y-axis represents
50% of the neutralisation titres. The neutralisation titres were calculated as
described in the materials and methods. The graph shows the reciprocal of the
neutralisation titre (e.g if 1/100 dilution of serum gave a 50% in reduction of
plaque formation it is shown as 100 on the y-axis)
Figure 6.5 Anti-TMEV antibody titres of perforin deficient and C57B1/6 mice
during the acute and chronic phases of disease. Sera were collected at day 3
to day 35 post-infection from perforin deficient (•) and C57B1/6 mice (#)
inoculated i.e. with 104 PFU TMEV (BeAn). The anti-TMEV antibody was
isotyped by ELISA as described in the materials and methods. Each symbol
represents the serum from an individual mouse. The solid line represents the
background absorbance, which is the mean plus 2 standard deviations of the
absorbance given by a 1/100 dilution of serum from a group of mice
inoculated with the non-cross-reacting Semiliki Forest virus..
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Figure 6.6 Immunostaining for viral proteins and TUNEL staining as a
marker for apoptosis after infection of perforin deficient mice which were
inoculated with the BeAn strain of Theiler's virus. Perforin deficient mice
were inoculated with 104 PFU of BeAn, i.e., and sampled on days 3, 5, 7, 9
and 11 post infection. CNS tissues were snap frozen in isopentane and
cyrostat sections were subsequently cut. Immunostaining and the TUNEL
assay were performed on a number of tissues as described in the materials
and methods. Viral staining is visualised by DAB (brown) and TUNEL
staining is visualised by BCIP/NBT (blue/black), tissues were counterstained
with methyl green as described in the materials and methods. A-B) Double
stained hippocampal neurones stained brown for virus and blue black for
TUNEL positivity (x25) . C-E) Double stained hippocampal neurones stained
brown for virus and blue black for TUNEL positivity (xlOO).
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7.1 Introduction
Strains of Theiler's virus are generally divided into two distinct subgroups,
the avirulent subgroup and the neurovirulent subgroup. These were
discussed in the Introduction. The avirulent subgroup consists of the BeAn,
DA, Yale, and WW strains (Daniels et al., 1952; Lipton et ah, 1975; Dal Canto
& Lipton, 1975; Lehrich et ah, 1976), whereas the neurovirulent subgroup
contains the GDVII and FA strains (Theiler and Gard, 1940b; Liu et ah, 1967;
Lipton, 1980). Over the past two decades most research has concentrated on
characterising the genetics, immunology and pathology of the avirulent
subgroup, because it is the strains in this subgroup which induce
demyelination, and infection of laboratory mice with these strains is used as
an animals model for MS. Less work has been undertaken on the
characterisation of the neurovirulent strains.
Following intracerebral inoculation of all strains of neonatal and adult mice
the neurovirulent GDVII and FA strains cause severe encephalitis (Lui et al,
1967), resulting in fatality in all mice several days post inoculation. Clinical
signs associated with GDVII infection include circling behaviour, breathing
difficulties, phototaxis, ruffled fur and flaccid paralysis (Theiler and Gard,
1940b; Olistky, 1945). An in depth study discovered that dose and route of
inoculation were important factors in affecting clinical outcome after GDVII
infection (Lui et al., 1967). Intracerebral inoculation was found to be the most
lethal route of inoculation with an LD50 of 0.1 PFU. Intranasal,
intraperitoneal and oral routes of inoculation were less efficient, resulting in a
lower incidence of CNS disease, but these still demonstrated the
neurovirulent properties of the GDVII strain.
After i.e. infection GDVII virus is detected in several areas of the brain and
spinal cord these include, the cerebral cortex, in particular the deep layers (IV,
V, VI), basal ganglia, thalamus, hypothalamus, predominantly in the
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mamilliary nucleus, substantia nigra, pons, and also in the anterior thalamic
nuclei, and pyramidal layers of the hypocampus and the grey matter of the
spinal cord in both the dorsal and ventral areas and particularly in the
ventral motor neurones (Stroop et al., 1981; Simas et al., 1995). Neurones are
the predominant cell type infected by GDVII, but astrocytes and
oligodendroctes can also be infected (Simas et al., 1995). Infection of neurones
and astrocyes was lytic, but infection of oligodendroctes was a rare event and
appeared to be restricted.
No work has been done to characterise the CNS cytokine response during
GDVII infection and this is the main objective of this chapter. The levels of
programmed cell death (apoptosis) occurring in the CNS of mice after
infection with GDVII were also measured.
7.2 Experimental Design
Three experiments were carried out. Experiment A was to determine the
average time of death of animal after GDVII infection. Experiment B was
carried out to examine cytokine transcript levels in the CNS and antibody
levels in the serum of mice inoculated with GDVII. Experiment C to
determine the level of infectious virus in the CNS of mice after infection with
GDVII. Experiment A identified post infection day 5 as the average time of
death after GDVII infection. Therefore to investigate the cytokine profiles and
levels of apoptosis in the CNS after GDVII infection 20 mice were inoculated
with 104 PFU of TMEV (GDVII) i.e. Three to five mice were sampled on days
1, 2, 3, and 4 post-infection. At each sampling point brains were divided
sagitally with one half being used for RNA purification and subsequently
used in an RPA, to determine the cytokine profiles (see materials and methods).
The other half of the brain was fixed in 4% phosphate buffered formal saline,
and cut for immunostaining to determine viral spread and the ability of virus
to induce apoptosis in the cell(s) it infected. The same was done for the two
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separate halves of the spinal cords. Sera were also collected to determine if
there was any generation of antibodies by ELISA as previously described in
the materials and methods. In experiment C, 20 mice were inoculated with 104
PFU of TMEV (GDVII) i.e., animals were sampled on days 1-5 and whole
brains and spinal cords were snap frozen and used to determine infectious
virus titres by plaque assay.
7.3 Results
7.3.1 Clinical signs and virus titres in the CNS of mice following
GDVII infection ( experiments A and C)
Animals were observed daily for clinical signs associated with CNS disease.
These were first apparent at 2 days post infection. All animals showed
characteristic signs of acute encephalitis which included phototaxia, circling
behaviour with occasional fitting. The fur of most animals appeared ruffled,
and some mice displayed breathing difficulties and flaccid paralysis of the
limbs. Clinical signs worsened until the animals died. Animals began to die
at 3 days post infection and all were dead by 5 (Figure 7.1). The levels of
infectious virus in the CNS were determined by plaque assay. Brain virus
titres increased rapidly and peaked at 3 days post infection. Levels of
infectious virus remained consistently high at days 4 and 5 post-infection
(Figure 7.2A). Titres were more variable in the spinal cords as compared to
the brain but titres increased with time and reached similar levels to that
observed in the brains (Figure 7.2B).
7.3.2 Cytokine and antibody levels (experiment B)
The levels of mRNA for different cytokine transcripts in the brains and spinal
cords at different time points post infection were determined by RNase
protection assay (see materials and methods). Several cytokines were probed
for including TNFp, TNFot, IL-4, IL-5, IL-la, IL-6, IFNy, IL-ip, IL-10, TGF-p,
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IL-13. IL-12p40, IL-12p35 and IL-7. There were few clear differences
observed during the time course of GDVII infection (Figure 7.3). Changes in
the levels of pro-inflammatory cytokines in the brains of infected animals
were the most noticeable. Levels of TNFa were low at days 1 and 2 post
infection but were elevated dramatically at days 3 and 4 post infection (Figure
7.3 A). This pattern was also observed for IL-la and IL-12p40 transcripts, but
lower levels were observed for these cytokines (Figure 7.3 B, E). Increased
levels of IFNy and IL-2 were also observed on days 3 and 4 post infection
(Figure 7.3 C, D). There was no consistent difference in the levels of any of
the other cytokine transcripts probed for. The kinetics of the upregulated
cytokines, correlated with the virus titres.
Expression of cytokine transcripts in the spinal cords was limited compared
to the brains. TNFa, IL-12p40 and IL-2 were elevated in the spinal cords on
post-infection days 3 and 4 (Figure 7.4 A, B, C ), however, there was no
differences in any of the other transcripts at any of the time points. Perhaps
an explanation for this is that the virus is directly inoculated into the brain
therefore the cytokine response here starts immediately, whereas virus does
not reach high levels in the spinal cords until day 4 post-infection. This may
account for the response in the spinal cord being slower. Sera from animals
were examined for levels of antibody by ELISA. No virus specific antibody
was detected. This was as expected because levels of specific neutralising
antibody are normally not detected before day 7 post infection (Lipton and
Gonzalez-Scarano, 1978).
7.3.4 Viral tropism and levels of apoptosis
The CNS histopathology induced by GDVII was studied by a combination of
immunocytochemistry and terminal deoxynucleotidyl transferase-mediated
dUTP nick-end labelling (TUNEL). The objectives were to determine the
levels of programmed cell death (apoptosis) after GDVII infection, the areas
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affected and the cell type undergoing cell death, and whether any cells
undergoing cell death were infected with virus. The areas of double stained
positivity for virus and TUNEL were variable and included cerebral cortex, in
particular the deep layers (IV, V, VI), basal ganglia, thalamus, hypothalamus,
predominantly the mamilliary nucleus, substantia nigra, pons, and also the
anterior thalamic nuclei, and the pyramidal layers of the hippocampus. Virus
staining was exclusively in the cytoplasm, and TUNEL positive cells had the
characteristic appearance of cells undergoing apoptosis with condensation
and marginalisation of chromatin in the nuclei and the occassional
appearance of small satellite apoptotic bodies (Figure 7.5).
Viral antigen positive cells were widely distributed and appeared to be
predominantly neurones. Classification of infected cell type was undertaken
by morphological analysis. Areas of TUNEL positivity corresponded with
areas of viral positivity, and many cells were double-labelled for viral antigen
and TUNEL (Figure 7.5), however some cells were negative for TUNEL and
positive for virus and vice versa ( Figure 7.5 ), some infiltrating monocytes
also stained positive for TUNEL ( Figure 7.5). Throughout the course of
GDVII infection as the levels of infectious virus increased and the virus
spread throughout the CNS, levels of apoptosis increased. These were
maximal at day 4 post infection. It was at this time point that messages for
TNFa, ILla and IL-2 were also maximal.
7.4 Discussion
Fatal encephalitis is the clinical outcome following intracerebral inoculation of
the GDVII strain of Theiler's virus regardless of the genetic background of
the mouse. This contrasts with the avirulent TO strains (Theiler and Gard,
1940b; Lui et al., 1967; Lipton, 1980). GDVII has a LD50 of 0.1 PFU after
intracerebral inoculation. Animals start to die around day 3 post infection
(Lui et al., 1967; Simas et al., 1995). The GDVII strain of Theiler's virus is more
179
CHAPTER7 GDVII INFECTION
neurovirulent than any of the TO strains, infecting approximately ten times
more cells than the avirulent subgroup (Aubert and Brahic, 1995). GDVII has
the ability to spread rapidly through the grey matter layers of the brains of
infected mice, virus spreads from cell body to cell body and along neuronal
pathways (Stroop et al., 1981; Simas et al., 1995). It was originally thought that
neurones exclusively were infected with GDVII (Lui et al., 1967; Stroop, 1981),
however more detailed studies have shown that astrocytes and to a lesser
extent oligodendrocytes can also be infected by GDVII (Simas et al., 1996).
Numerous cytokine messages were upregulated during GDVII infection these
included those for TNFa, IL-la, IL-12p40 and to a lesser degree IL-2 and IFNy.
However, that for TNFa was the most dramatically upregulated. High levels
of TNFa have been associated with a phenomenon called TNFa shock
(Trgovcich et al., 1996). This has been observed in neonatal mice inoculated
with another neurotropic virus, Sindbis virus (Trgovcich et al., 1996).
Therefore, it is possible that animals inoculated with the GDVII strain of
Theiler's virus undergo TNFa shock. It was also noted that TNFa was
dramatically elevated in neonatal mice inoculated with Theiler's virus see
Chapter 8.
Other pro-inflammtory cytokines were also upregulated including IL-la and
IL-12p40, both of these cytokines are produced by macrophages and can
upregulate the production of TNFa or be themselves upregulated by TNFa.
These cytokines may contribute to the disease pathology either directly or
indirectly.
Apoptosis has been observed in many persistent viral infections in vivo,
including HIV encephalitis, HTLV-1 associated myelopathy, and its animal
model HAM rat disease and recently apoptosis has also been observed in
oligodendrocytes in MS patients and in animals with experimental allergic
encephalitis (Petito et al., 1994; Umehara et al., 1994; Seto et al., 1995; Tomaru
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et al., 1995; Yoshiki et al., 1995; Gray, 1996; Masliah et al., 1996; Shearer et al.,
1996). It has also been well documented that infection of cultured cells with a
wide variety of viruses including herpesviruses, parvoviruses, retroviruses,
paramyxovirus, myxoviruses, alphaviruses and picornaviruses result in
activaton of a programmed cell death pathway (Johnson et al. ,1992; Ishii et
al., 1993; Kawanishi et al., 1993; Koga et al., 1994; Morey et al., 1993; Laurent-
Crawford et al., 1991; Meyaard et al., 1992; Ohno et al., 1994; Rey-Cuille, 1994;
Esolen et al., 1995; Takizawa et al., 1993., Fesq et al., 1994; Hinshaw et al.,
1994; Levine et al., 1993; Ubol et al., 1994; Tolskaya et al., 1995; Jeurissen et al.,
1992; Auwaerter et al., 1995., Allsopp et al., 1998). Various in vitro studies
have shown that inoculation with BeAn and GDVII causes apoptosis in a
variety of cell lines (Jelachich et al., 1995; Jelachich et al., 1996; Obuchi et al.,
1997; Tsunoda et al., 1997), however this has not been characterised in vivo. To
determine whether programmed cell death is an important phenomenon in
vivo during picornavirus infection, levels of apoptosis were determined
during GDVII infection of mice. Apoptosis was observed in the CNS of mice
inoculated with GDVII when compared to controls, and the levels of
apoptosis increased with the time post-infection. Therefore it could be stated
that GDVII infection and its ability to induce apoptosis is directly related to
mortality levels in adult mice. It may be that this cell suicide program is an
important host defence mechanism in eliminating a virally infected cell,
however apoptosis of irreplaceable cell types such as neurones, which are
non-mitotic, may have detrimental effects. However, there are important
genes which are anti-apoptotic, p35 and inp in baculovirus (Clem et al., 1997;
Vucic et al., 1997), and Elb in adenovirus (Han et al., 1996; Querido et al.,
1997). These anti-apoptotic genes may allow virus to replicate and, or persist.
It may be that these vital cellular anti-apoptotic genes are switched off or
over-ridden during GDVII virus infection of neurones resulting in an increase
in apoptosis and therefore in host mortality. The ability of the neurovirulent
GDVII strain of Theiler's virus to induce cell death may be a direct result of
their ability to overcome a protective host factor and therefore induce
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apoptosis. GDVII virus induced apoptosis in vivo could be partially
responsible for increased mortality.
Poliovirus, a representative of the picornaviridae encodes products which
prevent apoptosis (Leonmonzon & Dalakas, 1995; Raikhlin & Agol, 1995)
therefore BeAn infection may encode a genetic component that prevents
apoptosis. This could explain why very little cell death is seen in BeAn
infection in comparison to the levels seen in the infection with GDVII.
Many viruses have the ability to induce apoptosis in vitro and in vivo as
discussed above. The mechanism by which apoptosis is induced is variable
depending on the type of infecting virus. It has been well documented that
TNFa has a plethora of effects, but perhaps one of its most interesting and
relevant is its ability to induce apoptosis. (Beutler, 1993; Tartaglia et al., 1993;
Alderson et ah, 1994; Takahashi et ah, 1994; Smith et ah, 1994; Daniels &
Krammer, 1994; Wiley et ah, 1995). TNFa functions through two receptors
TNFR60 (p55-60) and TNFR80 (p70-80), these receptors are expressed on a
variety of tissues including haematopoetic cell types, although membrane
expression is independently regulated and may differ considerably
depending on cell type (Lazdins et ah, 1997). Once the receptor is activated it
has the potential to induce apoptosis. Recently, the ability of TNFa to induce
apoptosis has been documented during FIIV infection. TNFa has been
shown to induce apoptosis of CD4+ T lymphocytes from HIV infected
individuals (Clerici et ah, 1997). The ability of TNFa to induce apoptosis of
virally infected cells may be more general. It can be hypothesised, given the
correlation between TNFa and apoptosis, that during GDVII infection TNFa
induces apoptosis.
Virus induced apoptosis has been shown to be an important factor in other
viral diseases such as that produced by Chicken anemia virus where infection
results in complete destruction of the thymic cortex in hatchlings (Noteborn &
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Koch, 1994, 1995), also measles virus induces apotosis in thymocytes (Esolen
et al., 1995; FugierVivier et al., 1997; McQuaid et al., 1997), also several
retroviruses are capable of inducing apoptosis in culture (Laurent- Crawford
et al., 1991; Ohno et al., 1994; Rey-Cuille , 1994), however, apoptosis of CD4+
T cells and neurones in AIDS pathogenesis appears to be indirect as these
cells are largely uninfected (Estus et al., 1994; Ameisen et al., 1995).
In summary, this chapter illustrates the ability of GDVII to induce apoptosis
in neurones in vivo. Levels of TNFa are dramatically increased with time post
infection and this correlates with mortality levels. Whether there is a
relationship between levels of TNFa and amount of apoptosis is as yet still to
be further characterised.
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Figure 7.1 Mortality profiles in Sv 129 mice infected with the neurovirulent
GDVII strain of Theiler's virus. Animals were inoculated with 104 PFU of
TMEV (GDVII) i.e., and monitored daily. The x-axis represents day post
infection and the y-axis represents the number of living animals.
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Figure 7.2 Brain and spinal cord infectious virus titres of Sv 129 mice after
GDVII infection. Sv 129 mice were inoculated with 104 PFU of TMEV
(GDVII) i.c, and levels of infectious virus was determined for A) brains and
B) spinal cords by plaque assay, which has been described in the materials and
methods. The limits of detection of this assay were 101-7 and 102 PFU/g for
brains and spinal cords, respectively.
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Figure 7.5 Immunostaining for viral proteins and TUNEL staining as a
marker for apoptosis after infection with the GDYII strain of Theiler's virus.
Animals were inoculated with 104 PFU of GDVII, i.e., and sampled on days 1,
2, 3 and post infection. CNS tissues were snap frozen in isopentane and
cyrostat sections were subsequently cut. Immunostaining and the TUNEL
assay were performed on a number of tissues as described in the materials
and methods. Viral staining is visualised by DAB (brown) and TUNEL
staining is visualised by BCIP/NBT (blue/black), tissues were counterstained
with methyl green as described in the materials and methods. A) Wider spread
staining for virus in the brain (x4). B) Red arrow points to a double stained
neurone double labelled for virus (brown) and TUNEL (blue/black) staining
(x25). C) Red arrow points to a double stained neurone labelled for virus and
TUNEL staining (xlOO). D) Individually stained TUNEL positive cell
(blue/black) and individually stained cell labelled for virus (brown) (xlOO).
E) Blue arrow points to cells undergoing apoptosis with condensed nucleus
and apoptotic bodies (xlOO). F) Blue arrow points to single TUNEL positive
cell, brown are points to single stained virus infected cell.
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8.1 Introduction
It is well documented that there is a noticeable change in the susceptibility of
rodents to neurotropic virus infections during the first few weeks post birth
(Sigel, 1952; Johnson et al., 1971; Fleming, 1977; Ogata et ah, 1991). There are
numerous neurotropic viruses where susceptibility to clinical signs or disease
is age related, examples include Sindbis, Japanese encephalitis, St. Louis
encephalitis, Herpes simplex, Yellow fever, Measles, Eastern equine
encephalitis, Bwamba fever, West Nile, Semiliki forest and Theiler's murine
encephomyelitis viruses (Theiler, 1940; O'Leary et al., 1942; Lennette &
Koprowski, 1944; Melnick et al., 1951; Sigel, 1952; Johnson, 1964; Flemming,
1977; Penney & Wolinsky, 1976; Rodriguez et al., 1983b; Steiner et al., 1984;
Swoveland & Johnson, 1989; Ogata et al., 1991). In all of these viral infections,
infection of neonates or suckling animals results in a fatal encephalitis,
however, in contrast to this infection of weaned animals results in a non-lethal
infection. Why are levels of susceptibility linked to age? Many arguments
have been considered, however it seems likely that developmental maturity of
the CNS plays an important role (Pathak et al., 1976; Pathak & Webb, 1978;
Fazakerley et al., 1993; Oliver et al., 1996, 1998; Oliver & Fazakerley, 1997)
whereas the maturity of the specific immune reponse is documented to have
no effect (Johnson et al., 1972; Griffin et al., 1976; Flemming, 1977; Schneider-
Schaulies et al., 1989; Swoveland & Johnson 1989; Sharpe et al., 1989;
Fazakerley et al., 1993). However, the contribution of these two factors may be
different in different viral infections.
Infection of neonates with Theiler's virus results in fatal encephalitis which is
associated with high CNS virus titres and an extensive mononuclear cell
inflamation (Wroblewska et al., 1977; Penney & Wolinsky 1979; Rodriguez et
al., 1983) similar to that seen after infection with the neurovirulent GDVII
strain of Theiler's virus in adults (Lui et al., 1967; Stroop et al., 1981; Simas
thesis, 1994). The studies in this chapter investigated the expression of
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various cytokine transcripts in the CNS to determine if there were any
differences between Theiler's virus infected and mock infected neonatal
animals.
8.2 Experimental design
Cytokine profiles in neonatal mice were determined for animals at different
time-points post-infection by RPA (as previously described see material and
methods). Seven day old (P7) mice were inoculated with 104 PFU of TMEV
(BeAn) intracerabrally. From previous pilot experiments it was known that
suckling animals inoculated with TMEV die around day seven post-infection,
therefore animals were sacrificed on days 2, 4 and 7 post infection. When
animals were sacrificied whole brain was taken and snap frozen. RNA was
later purified from this and used in an RPA. Sera were also collected to
determine antibody profiles by ELISA (as previously described see materials
and methods).
8.3 Results
8.3.1 Clinical signs in neonatal mice (P7)
Infected animals showed signs of encephalitis around day 4 post infection,
and were moribund by day 7, by day 8 post infection all animals had died
(Figure 8.1). Virus was distributed extensively throughout the brains of the
infected mice in both grey matter and white matter tracts (Figure 8.2). There
were also major histopathological changes observed with areas of extensive
necrosis and a massive cellular infiltrate (Figure 8.3), as early as day 2 post
infection.
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8.3.2 Cytokine expression
RPA allows the detection of various cytokines including TNFp, TNFa, IL-4,
IL-5, IL-6, IL-la, IL-ip, IFNy, IL-2, IL-10, TGFp, IL-13, IL-12p40, IL-12p35 and
IL-7. During infection of neonates the expression of different cytokines
varied at different time points and between individual mice.
Proinflammatory TNFa was expressed in the largest amounts and its
expression was varied in different mice at different time points. There was
very little difference between the levels of TNFa at day 2 between the virus
infected and mock infected mice, however at day 4 and 7 post infection there
was a massive increase in levels of mRNA for TNFa in the animals infected
with Theiler's virus compared to controls (Figure 8.4 B). It is at these time
points that levels of virus are at their highest. By this time virus had spread
throughout the CNS. This was accompanied by infiltrates of mononuclear
cells, and after these time points animals start to die.
Levels of TNFp, IL-4, IL-6 and IL-la followed similar kinetics to that seen
with TNFa, with very little difference in expression between infected and
mock infected animals at day 2 post infection. Llowever, by day 4 and 7 levels
of TNFp, IL-4, IL-6 and IL-la were increased compared to the controls
(Figure 8.2 A, C, D, E). The expression of these cytokines on days 4 and 7
were not as high as that seen for TNFa. By days 4 and 7 post infection levels
of all 5 of these cytokines had increased and were higher than controls, (apart
from IL-6 which had returned to the same levels as that seen in the control
animals) (see Figure 8.2 A, C, D, E). There was no detectable difference in the
expression of mRNA for any of the other cytokines transcripts probed for. At
days 4 and 7 post infection there was no detectable anti- TMEV IgM, IgGl,
IgG2a or IgG2b in the serum of these mice.
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8.4 Discussion
Neonatal animals infected with Theiler's virus usually die around seven days
post infection, at this time a massive mononuclear cell infiltrate is observed
with widespread viral distribution in the CNS (Penney & Wolinsky 1979;
Rodriguez et al 1983b). In contrast to this in adult mice (3-4 weeks old), CNS
infection is usually focal (Simas and Fazakerley, 1996). In most mouse strains
these foci of infection are cleared by an activated immune response 2-3 weeks
post infection (Oleszak et al., 1995; Montenye et al., 1997). There has not yet
been any clear cut explanation as to why this is the case for Theiler's virus
although various hypotheses have been suggested, which include 1) how
developed the CNS is, at the time of infection, 2) the ability of the neonatal
animal to constitute a fully functional immune response and 3) the TNFa
shock hypothesis as has been described for Sindbis virus (Trgovcich et al.,
1997).
During the first two post natal weeks, there are major changes in CNS cells.
During this time period many physiological developments occur which
include synaptogenesis, axonogenesis and myelination (Larramendi, 1969;
Altman, 1971, 1972b, Rees et al., 1976; Landis, 1983). It has been suggested
that viral age-related neurovirulence may be due to the differential ability of
viruses to interact with cells of the CNS in the developing and mature mouse.
These changes could affect viruses at any one or more of a variety of levels
including viral entry, replication, maturity and release.
The widespread virus distribution in the developing brain could be due to a
differential affinity of the virus receptor, or a change in the expression of the
virus receptor between neonatal and adult animal, which has been suggested
for Semiliki Forest virus (Altman, 1971, 1972b; Pathak et al., 1976; Rees et al.,
1976; Flelenius et al., 1980; Marsh & Helenius, 1989; Kielian, 1995). In the
developing brain endocytosis occurs at post synaptic membranes (Altman,
1971, 1972b; Rees et al., 1976; Landis, 1983), this could result in non-specific
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uptake of virus, and in older animals the virus may rely on receptor mediated
endocytosis to enter the target cell. This may explain why several viruses
including SFV can be taken up by the immature neurones and not by adult
neurones.
After entering the cell the process of virus replication has to be supported by
the host cell, it is well documented for a number of viruses that replication
relies on the the ability of the infected cell to produce smooth membranes
(Dales & Siminovitch, 1961; Amako & Dales, 1967; Caliguri & Tamm, 1970;
Schlesiner & Malfer, 1982; Katch et al., 1986; Kuge et al., 1986; Guinea &
Carrasco, 1990). In the immature CNS there is an abundance of smooth
membrane prduction due to the amount of axonogenesis and synaptogenesis
occuring during the first two weeks post natal (Altman, 1971, 1972b; Rees et
ah, 1976; Landis, 1983). Theiler's virus may use this smooth membrane
production for viral replication. As the CNS matures the production of
smooth membranes decreases, and this is one possible mechanism which
could result in restriction of viral replicaton.
It is unknown which developmental changes within the CNS and at what
level they occur whether it be entry, replication or release actually effect the
spread of Theiler's virus infection. A more neuroanatomical study with this
virus must be undertaken as has been done for other virus systems (Oliver &
Fazakerley, 1997).
Whether or not neuronal maturation has an effect on BeAn infection, it has no
effect on infection with the more neurovirulent GDVII strain of TMEV. This
causes widespread neuronal distruction irrespective of age of animal (Stroop
et al., 1981; Simas Thesis, 1994, Aubert et al., 1995). This is due to differences
in viral sequence/genome between the two strains. Differences in receptor
binding site between the two strains have already been documented on the
viral capsid, this may explain why different strains of the same virus have
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differing abilities to spread in different mouse strains (Kilpatrick et al., 1991;
Lou et al., 1996; Seto et al., 1996).
100% mortality has been described before in neonates, infected with low
levels of Sindbis, Semiliki Forest and West Nile viruses, whether inoculated
intracerebrally, intranasally or orally. This was also true for Theiler's virus.
Death in neonatal mice was attributable to virus induced encephalitis because
virus replicates to high titres in the brains of the infected animals, this is due
to the permissive of murine CNS tissues for Theiler's virus growth (Penney &
Wolinsky, 1979; Rodriguez et al., 1983). However, other immunological,
metabollic, endocrine and physiological parameters are also likely to be
involved.
The role of LPS (bacterial endotoxin) in the pathogenesis of septic shock has
been studied extensively (Dofferhoff et al., 1991; Vanderpoll et al., 1995).
Endotoxic shock does not seem to exert its effects on the host directly but
rather elicits the production of host factors, including cytokines IL-la, IL-6
and TNFa which may inturn lead to shock and death of the host (Chirigos &
Desimone; Glauser, 1996). The cytokines produced by LPS are all
proinflammatory and all play important roles in shock, however, TNFa is the
most important mediator of shock. The cytokines TNFa, ILla and IL-6 which
are expressed in response to stress activate the Hypothalamus-Pituatry-
Adrenal (HPA) axis which in turn causes a cascade of cytokine and hormonal
upregulation which results in severe metabolic and haemodynamic
dysfunction (Tracey et al., 1989; Jaattela, 1991). It is possible that a virus
could, like an endotoxin, mediate shock. It has been reported that infection of
neonatal mice with the TRSB strain of Sindbis virus results in death, the
animals which died had an increase in levels of TNFa and the steroid
hormones adrenocorticotropic hormone and corticosterone (Trgovcich et al.,
1997). The production of TNFa, adrenocorticotropic hormone and
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coticosterone are therefore associated with the phenomenon of "shock", and
may be causing the death of the animal.
Although hormone levels after Theiler's virus infection were not meaured,
levels of mRNA for TNFa in the CNS were, and these were dramatically
elevated. It can be hypothesised that TNFa elicits a shock phenomenon in
young mice after Theiler's virus infection through stimulation of the HPA axis
(Sapolsky & Meaney, 1986, Trgovcich et al., 1997). Levels of TNFa were also
measured in adult mice which is discussed in Chapter 3. Interestingly,
although levels of TNFa are high during the acute phase of infection in adult
SJL/J, Balb/c and CBA mice, they are not as high as those seen in neonatal
animals. It can be stated that levels of TNFa are highest in the brains of the
CBA mice on post infection day 7 when compared to the SJL/J and Balb/c
mice, and it is in adult CBA mice that mortality levels are highest during the
acute phase of infection, compared to any other strain (15%). This suggests
that although only a small percentage of adult CBA mice die during the acute
phase of infection when compared to the neonatal mice, these adult mice may
also be dying due to TNFa related shock.
Previous studies with the endotoxin LPS have shown that C57B1/6 (H2-b)
mice which are normally resistant to TMEV persistence and chronic disease
become increasingly susceptible treated with LPS (Pullen et al., 1995). LPS
stimulates the HPA to produce TNFa, IL-la and steroids, which results in an
increase in susceptiblity and demyelination. It could be speculated that
increased levels of TNFa, IL-la, IL-6 and steroid hormones in (resistant)
C57B1/6 mice caused by LPS, results in an increase in susceptibility due to
induced shock or perhaps increased levels of apoptosis of infected cells due to
higher levels of TNFa. Levels of apoptosis in neonatal mice were not looked
at, however as levels of apoptosis correlated with levels of TNFa in GDVII
infection, it is possible that neonatal mice die of overwhelming neuronal
distruction due to increased levels of TNFa causing widespread apoptosis.
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The consequences of proinflammatory cytokine induction and the TNFa
shock response may constitute a previously unrecognised aspect of Theiler's
virus induced disease in neonatal mice which could lead to the mortality
observed in this infection.
In summary, neonatal mice die after BeAn infection, with widespread
distribution of virus throughout the CNS. This spread of infection may be
attributable to CNS cell maturation. However, it is also noted that levels of
TNFa are exceptionally high therefore animals may be dying as a result of
septic shock. This TNFa production is a previously unrecognised aspect of
Theiler's virus pathology.
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The presented data has been discussed in detail at the end of each chapter
therefore the aim of this chapter is to summarise the basic findings and to
suggest areas of future research. The immunology of the avirulent BeAn and
neurovirulent GDVII strain of Theiler's virus, has been investigated in detail
in different mouse strains. Chapter 3 investigated the cytokine and antibody
profiles in different mouse strains inoculated with BeAn i.e. during the acute
phase of infection. Chapter 4 examined the cytokine and immunoglobulin
profiles in CBA mice which had viral persistence and compared the levels to
those of animals which had cleared the virus during the chronic phase of
disease. Chapter 5 and 6 characterised the roles of type I and type II
interferons and perforin during Theiler's virus infection. Chapter 7
investigated the cytokine profiles in the brains of adult mice inoculated with
the GDVII strain of virus and examined the levels of on going cell death
(apoptosis) in the tissues of the CNS. Cytokine profiles in the CNS and
mortality levels of Theiler's virus infected neonatal mice were examined in
Chapter 8.
The pathogenesis induced by Theiler's virus is complex. Initially virus predominantly
infects neurones, this mediates an acute encephalitis in all strains infected.
Encephalitis is followed by a rapid cell mediated response with a slower humoral
response. In resistant strains virus is cleared, however in susceptible strains which
have an inadequate immune response virus persists at low levels in oligodendrocytes,
in white matter tracts of the CNS. It is during infection of oligodendrocytes that
chronic demyelinating disease occurs. Over the past decade much evidence has
accumulated to suggest that CD4 + T helper cells and the cytokines produced by them
are the key effector during the demyelination process (Miller et al., 1987; Gerety et al.,
1994; Karpus et al., 1995). It is thought that in persistently infected cells antigen is
presented in the CNS which is recognised by circulating CD4+ Thl cells, these cells
then produce cytokine which mediate the recruitment of macrophages/microglia.
These large phagocytic cells elicit more proinflammatory cytokines and free radicals
which further contribute to myelin damage. Initially the autoimmune component of
Theiler's virus induced demyelination was not recognised however recently new
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evidence has emerged which suggests that there is both B and T cell epitopes to CNS
myelin at late time points during Theiler's virus disease (Miller et al., 1997). This
thesis is very pertinent to current research because it investigated cytokine profiles
during the chronic demyelinating disease, but more importantly it determined cytokine
profiles during the acute phase of Theiler's virus disease in different mouse strains,
which may explain why virus persists and therefore causes demyelination, in
susceptible mice. The cytokine information elucidated during the acute phase of
disease extended on the information which was previously known and suggested
reasons as to why virus may be persisting and causing demyelinating disease.
9.1 Cytokine and antibody profiles during the acute phase of Theiler's
virus infection.
Cytokine and antibody profiles were determined in several different mouse
strains during the acute phase of Theiler's virus infection including Balb/c
(resistant), CBA (intermediately susceptible), SJL/J (susceptible) and SCID
mice. There were several similarities in different mouse strains in the levels of
pro-inflammatory cytokines expressed during acute disease. During the first
two weeks post infection IL-la, TNFa, TNF(3, IL-12p40's expression was up
regulated in all immuocompetant strains. This correlated with the infiltration
of mononuclear cells into the CNS. Production of cytokines in the CNS was
not associated with indigenous CNS cells, as determined by examining
cytokine levels in SCID mice inoculated with Theiler's virus. Despite there
being similarities in the proinflammatory cytokines during the acute phase of
disease there were also differences between the strains. Interestingly, levels of
ILip were undetectable in the brains and spinal cords of SJL/J mice. SJL/J
mice also had decreased levels of IL-2 when compared to CBA and Balb/ c
mice, however levels of IL-10 and IL-4 were increased in SJL/J mice when
compared to Balb/c mice. Antibody levels were also different between the
strains. All strains produced similar levels of IgM, however Balb/c mice
produce high levels of IgGl and IgG2a when compared to CBA and SJL/J
mice. The above data suggests that Thl cells may be important in clearing
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the virus in the resistant Balb/c strain which had higher levels of IL-2 , IFNy
and IgG2a when compared to the susceptible SJL/J strain. Conversely the
SJL/J strain produces a predominantly Th2 response during the acute phase
of disease with low levels of IgG2a and higher levels of IL-4 and IL-10 when
compared to Balb/c mice. Therefore, indicating that although Thl cells have
been implicated in the chronic demyelinating phase of Theiler's virus they
appear to play a protective role in Balb/c mice during the acute phase of
disease.
All the above data was determined using CNS tissues, however no data was
obtained about cytokine profiles in peripheral immunological tissues such as
the peripheral lymph nodes (more specifically the cervical lymph nodes
which drain antigen from the brain) and in particular the spleen. All these
tissues are important sites for T and B cell priming. It is unlikely that T or B
cell priming occurs in the CNS, as no evidence for this phenomenon exists.
Therefore although the cytokine profiles were determined in the brains and
spinal cords it is unlikely that the cytokines generated in the CNS are going to
effect T helper of CTL generation in the periphery. Therefore the cytokines
detected in the CNS which are produced by infiltrating cells are unlikely to
have an effector T or B cell functions but are rather more likely to act locally
as chemoattracts or local effector molecules. Therefore, in light of this it
would be of interest to determine the cytokine profiles of the spleen and the
regional lymph nodes in the different mouse strains to elucidate what is
occurring in the periphery. Isolation of particular T cell subsets from the
blood of different mouse strains and characterisation of their cytokine
profiles would elucidate a more specific set of results and may determine the
likelihood of particular subsets involved in disease pathogenesis or viral
clearance.
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9.2 Cytokine and antibody profiles during the chronic phase of disease
Levels of TNFa, IL-12p35 and IL-12p40 were upregulated in CBA mice
persistently infected with Theiler's virus when compared to CBA mice which
had cleared the virus, therefore suggesting that Thl cells are active during the
chronic phase of Theiler's virus disease. On the other hand anti-viral isotypes
IgGl, IgG2a and IgG2a were all up-regulated in animals with a persistent
infection therefore indicating that the anti-viral antibody profile does not
agree with the Thl/Th2 hypothesis. Therefore it is likely that both Thl and
Th2 cells are present during the chronic phase of disease and whether one
subset is exclusively associated with the demyelinating process still has to be
characterised.
A way of determining whether a particular T helper subset is involved in the
demyelinating process during chronic infection with Theiler's virus would be
to manipulate the T helper cell response. It has been well documented that
the use of drugs (pentoxifylline), parasites (Schistosome eggs) and
monoclonal antibodies (B7-1) affect the T helper subsets. The maturation of
CD4+ T precursor helper cells is complex and they mature along two separate
pathways. Both Thl and Th2 cells produce different cytokine profiles with
IFNy being produced predominantly by Thl cells and IL-4, IL-6 and IL-10 are
predominantly produced by Th2 cells. The type of T helper cell response
being elicited can have important implications in pathology. Upregulation
and expansion of T cells of a particular subset is dependant on certain
signals. The first signal is the binding of the TcR with the MHC associated
antigen, the second signal is provided by costimulatory molecules on the
antigen presenting cells. Emerging is the importance of a family of co-
stimulatory molecules called the B7 family. B7-1 (CD80) is exclusively on
APCs and is involved in the interaction between the CD28 or CTLA-4
molecules on Thl cells. B7-2 is predicted to have a similar role as B7-1 except
for Th2 cells. Experiments in animals inoculated with EAE and a monoclonal
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to B7-1 causes a decrease in Thl cells and an increase in Th2 cells which
results in the prevention of onset of clinical signs. On the other hand
treatment with a monoclonal to B7-2 causes the reverse and results in
increased disease severity. Therefore implicating Thl cells in the pathology of
the disease. It would be of great interest to use these monoclonals in Theiler's
virus research to determine the exact role of the Thl and Th2 cells.
Interestingly, TNFa and IL-12 are up regulated in mice with a chronic
persistent infection and therefore during demyelination. TNFa has been
implicated in causing demyelination in vitro however IL-12's direct role in
demyelination has not been investigated. Therefore it would be of fascinate
to further investigate the direct role of theses specific cytokines during the
demyelinating process. This is now possible through the use of genetically
engineered mice which are deficient in the receptors for TNFa and also for IL-
12. Nitric oxide has also been implicated in demyelination therefore its role in
Thieler's virus induced demyelinatin could also be determined through the
use of iNOS deficient mice.
9.3 The roles of interferon
Interferons are very important in most if not all viral infections due to their
anti-viral properties. The role of IFNa/p was discovered to be in protecting
oligodendrocytes (the myelin maintaining and producing cell) from infection,
as lack of functional IFNa/p results in extensive viral dissemination through
out white matter areas in the brains, and eventually death of the infected
animal. IFNy's role, although not vital, appears to be essential if virus is to be
cleared from the CNS of infected animals. This could be due to IFNy
important functions in innate and specific immunity with its involvement in
NK, CD4+ Thl cell and CD8+ T cell activities. However, the precise role of
IFNy is yet to be discovered. Further characterisation of the immunology of
the IFNy R°/° mice would be instrumental in determining the precise roles of
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IFNy in Theiler's virus infection. This could include an in depth time course
study exploring the expression of Theiler's virus specific CTLs, T helper cells
and antibodies.
9.4 The roles of perforin
The presence of perforin during Theiler's virus infection is also essential to
prevent wide spread dissemination of virus throughout the CNS during the
acute phase of disease, probably due to its important role in NK cell activity.
The rapid dissemination during the acute phase of Thieler's virus disease
posed an interesting question and that is, what is the role of NK cells during
Theiler's virus infection? The role of NK cells in Theiler's virus could be
examined by infecting NK cell deficient mice and following the course of
infection to see whether virus infection was cleared controlled or increased.
Perforin mediating killing is only one type of CTL killing. There are several
other mechanisms CTLs use to mediate their killing such as Fas and TNFa.
The roles of Fas and TNFa could now be examined due to the generation of
knock out mice. If this data was obtained then it would be possible to
ascertain the exact roles that different types of CTL killing fulfil during
Theiler's virus infection. Perforin is equally important during the chronic
phase of disease in eliminating the virus. Virus persists in perforin deficient
mice whereas it is cleared in infected wild type mice, illustrating the
importance of perforin for viral clearance. Although virus persists in
perforin deficient mice levels of demyelination were not looked at, therefore it
would be of interest to determine how extensive the demyelination was in
perforin deficient animals, and to establish whether perforin was ultimately
required in the demyelinationg process.
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9.5 GDVII infection
GDVII causes a fulminant encephalitis in mice of all genetic backgrounds.
The GDVII strain of virus disseminates quickly throughout the CNS infecting
predominantly neurones of the grey matter. Levels of infectious virus
increased in parallel with levels of TNFa, TNFp, IL-2, IL-12p40 and IL-6 in the
brains of animals infected with GDVII. Interesting cells undergoing
programmed cell death correlated with the increase in levels of infectious
virus and pro-inflammatory cytokines.
9.6 Theiler's virus infection in neonates
Infection of neonatal mice with Theiler's virus resulted in widespread
dissemination throughout the CNS. Virus levels correlated with levels of
TNFa, IL-la, IL-6, TNFp. Increases in the levels of TNFa were the most
different from the PBS inoculated control group. It has previously been
suggested that high levels of TNFa are associated with a shock phenomenon
which results in death of animals. Therefore hypothetically mortality in
neonates may be due to the fact that they have very high levels of TNFa and
are therefore are dying from TNFa shock.
TNFa is massively up regulated in neonatal mice infected with BeAn and
adults infected with GDVII. This massive up regulation in TNFa correlates
with massive cell death which eventually leads to death of the animal. The
implication of TNFa in septic shock have been described previously.
Flowever its implications in Theiler's virus infection has not been noted. It
would be of interest to determine the levels of steroid in the serum of neonatal
animals infected with BeAn and adults infected with GDVII because these are
also indicators of septic shock and would further substantiate the evidence
that these animals are dying form septic shock. The importance of TNFa in
inducing cell death in neonatal animals infected with BeAn and in adults
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infected with GDVII could be further investigated by inoculating TNFa
receptor deficient mice. If the neonatal mice recovered for BeAn infection and
adults recovered from GDVII infection that would then decipher whether
TNFa was the essential component for triggering cell death which gradually
leads to death of the animal.
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Figure 8.1 Mortality levels in neonatal mice infected with TMEV (BeAn).
Neonatal mice (P7) were inoculated with 104 PFU of TMEV (BeAn) i.c, and
observed daily. The x-axis represents day post infection and the y-axis
represents the number of living animals.
Figure 8.2 Autoradiographic images of BeAn sequences in a neonatal
mouse brain on post infection day 7. Neonatal mice brains which had been
inoculated with Theiler's virus were snap frozen on post infection day 7, and
sagital sections were subsequently cut and ISH performed using a 35S labelled
riboprobe, which has been described previously in the materials and methods.
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Figure 8.3 Represents photomicrographs illustrating the histopathology of
BeAn infection in an neonatal mouse brain. Neonatal mice were inoculated at
7 days of age, and animals were sampled and at 7 days post infection. Viral
positivity was determined by ISH using a 35S labelled riboprobe which has
been described previously in the materials and methods, tissues were
counterstained with hemotoxylin and eosin. The photomicrograph shows the
widespread infection with perivascular and parenchymal mononuclear cell
infiltration.
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Appendix 1
(reagents listed in alphabetical order)
Denhardt's Solution (50X)
Ficoll 5g
Polyvinylpyrrolidone 5g
BSA 5g
Dissolve the above in distilled water and make up to 500 ml.
ELISA Coating Buffer
Na2C03 21.1 g/LpH 9.6
NaHCCb 16.8 g/L
To prepare 20 ml of carbonated buffer mix 1.6 ml Na2C03 with 3.4 ml
NaHC03 and make up to 20 ml with distilled water
Growth Medium (BHK cells)
Tryptose phosphaye broth 50 ml (10%)
New born Calf serum 50 ml (10%)
Add above to Glasgow's modified Eagles medium (GMEM) and mix
thoroughly. Store at 4 0C.
Hybridization Buffer
The following is prepared per 25 slides ( allowing 25 ul/slide).
Deonised Formamide 400 pi (50%)
ISH Salts (20x) 200 pi (50%)
Denhardfs (50%) 80 pi (5X)
Dextran sulphate (50%) 80 pi (5%)
ssDNA (10.5mg/ml) 20pl (263 pg/ml)
tRNA (10 mg/ml) 20 pi (250 pg/ml)
Heparin (2000 U/ml) 8 pi (20 U/ml)
10% SDS 8 pi (0.1%)
Prepare on use of day.
Phosphate buffered formal saline (4%)
NaCl 8.75g
Na2HP0.H20 4g
NaH2PO (anhyd) 6.5g
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Make up to 1 L with distilled water, pH to pH 6.7 with HC1 and autoclave.
Usally diluted 1/10 prior use.
Prehybridization Buffer
Deonised Formamide 400 pi (50%)
ISH Salts (20x) 200 pi (50%)
Denhardt/s (50%) 80 pi (5X)
ssDNA (10.5mg/ml) 20pl (263 pg/ml)
tRNA (10 mg/ml) 20 pi (250 pg/ ml)
Heparin (2000 U/ml) 8 pi (20 U/ml)
10% SDS 8 pi (0.1%)
Sterile distilled water 400 pi
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